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The purpose of the study was to explore the experiences of female nyaope injectors 
residing in City of Tshwane Municipality, Gauteng. The study was conducted at 
COSUP sites namely; Soshanguve, Pretoria CBD, Sunnyside, Mamelodi, Eersterust, 
and Attridgeville. The study focused on females who have a history of injecting 
nyaope, accessing substance use related services at a registered service provider 
within City of Tshwane Municipality, Gauteng.  
Research design of the study was exploratory, which is basically used to explore a 
new topic or learn more about phenomenon where little is known. The research 
approach was purely qualitative methodology. This permitted the researcher to deeply 
explore the lived experiences of female nyaope injectors residing in City of Tshwane 
Municipality, Gauteng. A qualitative in-depth interview method was used to collect data 
from 24 participants who took part in the study.  
Questions of the interview were semi-structured, in-depth one-on-one interviews and 
were used to explore the lived experiences of female nyaope injectors residing in City 
of Tshwane Municipality, Gauteng.  
The findings of the study revealed that females who are injecting nyaope, are at risk 
of contracting HIV and other blood-borne infections. The stigma that is perpetuated by 
families, intimate partners, communities, health care professionals, and police officers 
is creating a hostile environment for female nyaope injectors; which increases the risk 
of contracting HIV and other blood-borne infections. Harm reduction services have the 
potential to address the needs of female nyaope injectors if fully implemented.  
It can be concluded that there is a need for substance abuse service providers to 
implement comprehensive harm reduction services to curb HIV prevalence amongst 






Nyaope, HIV, Female nyaope injectors, Harm reduction, NSP, People who inject 
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DEFINITION OF KEY CONCEPTS 
• Experience: Things that have happened to you that influence the way you think 
and behave (Oxford Dictionary, 2015:524).  
• Female nyaope injectors: In this study, female nyaope injectors refers to any 
women between the ages of 18–35 with a history of injecting nyaope for non-
medical use and accessing substance abuse or related services.  
• Harm reduction: “Harm reduction refers to policies, programmes and practices 
that aim to reduce the harms associated with the use of psychoactive drugs in 
people unable or unwilling to stop” (International Harm reduction association 
https://www.hri.global). 
• Needs: What one requires because it is essential or very important (Oxford 
Dictionary, 2015:1002). In this study, the needs refer to what is necessary for 
people who inject drugs to live a healthy, stable and safe life with low risk of 
contracting HIV. 
• Nyaope: Nyaope is a relatively new designer drug which is commonly used in 
many Black townships in South Africa. The full composition of nyaope is generally 
not known, although most agree that heroin is the main ingredient, and rumors of 
the inclusion of ARVs have been documented (Mokwena, 2015:138). 
• People who inject drugs: People who inject drugs refers to people who inject non-
medically sanctioned psychotropic (or psychoactive) substances (WHO, 2015:3). 
• Recovery: A process of change through which individuals improve their health and 
wellness, live a self-directed life, and strive to reach their full potential. (SAMHSA’s 
WORKING DEFINITION OF RECOVERY). In this study, recovery means the 
process through which a female nyaope injector has taken a step to stop using 
nyaope through a professional intervention.  
• Risk: To do what might get you into an unpleasant situation (Oxford Dictionary, 
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1. CHAPTER ONE 
Orientation of the Study 
1.1 Introduction 
A significant decrease in HIV prevalence and mortality were observed from 2009 to 
2013 globally; mostly within sub-Saharan Africa. However, a decrease in HIV 
prevalence amongst people who inject drugs (PWID), more especially female nyaope 
injectors, has not been good (Springer, Larney, Alam-mehrjerdi, Altice, Metzger and 
Shoptaw, 2016:2). It is estimated that females account for 27% of all people who inject 
drugs in South Africa, and 19,4% of female nyaope injectors are HIV infected (Springer 
et al, 2016:6). HIV prevalence, among drug injectors, is normally exceedingly higher 
than it is among the adult population; with people who inject drugs accounting 28 times 
higher prevalence (UNAIDS, 2014:2). Global HIV prevalence for all ages has 
decreased by 25% from 2010–2017. However, HIV infection amongst people who 
inject drugs has risen (UNAIDS, 2019:2). The prevalence of HIV infection amongst 
people who inject drugs seems to have risen over the previous years; from 1,2% in 
2011, to 1,4% in 2017 (UNAIDS, 2019:11). 
This research explored the experiences of female nyaope injectors residing in City of 
Tshwane Municipality, Gauteng. The drug injecting practice has brought together the 
field of substance use with that of HIV prevention. Injecting heroin is becoming an 
increasing trend in most regions of South Africa (Weich, 2017:26). Sharing of needles 
for injecting drugs contributes to the spread of HIV and other blood-borne viruses 
(Degenhardt, Peacock, Colledge, Leung, Grebely, Vickerman, Stone, Cunningham, 
Trickey, Dumchev, Lynskey, Griffiths, Mattick, Hickman and Larney, 2017:1192). 
Nyaope is a novel fashionable drug that is normally used in many townships in South 
Africa. The full make-up of nyaope is not known, even though most researchers concur 
that heroin is the main component, with rumors of the inclusion of ARVs having been 
documented (Mokwena, 2015:138). 
Females are not exempt, as active members of the society, they are also participating 
in drug use. It is reported that substance abuse in our society is rampant, and data 
has suggested that the statistics of female drug users is fast approaching that of male 






Consequently, it is critical to understand the experiences of female nyaope injectors, 
so that we can mitigate factors that contribute to HIV prevalence within their 
population.  
The City of Tshwane has an HIV prevalence that is marginally lower than the national 
average, however, not significantly (Shisana, Rehle, Simbayi, Zuma, Jooste, Zungu, 
Labadarios, Onoya, 2014:46). It is of great importance that the City of Tshwane 
Municipality and South African National Department of Health address HIV prevention 
amongst key population, more especially female nyaope injectors, if it is determined 
to improve the HIV prevalence. 
Some of the female nyaope injectors participate in transactional sex to sustain their 
drug use habit. Asher, Hahn, Couture, Maher, and Page (2013:6) argue that due to 
the considerably higher rates of transactional sex work by people who inject drugs 
(PWID), combined with poor condom use, females are at a higher risk than males. In 
Tanzania, women who inject drugs reported low condom use, as many as 12 times 
the number of sexual partners as their male counterparts. 
Female nyaope injectors are hardly the focus of research, and as a result, their 
injecting practices are poorly understood (UNAIDS 2014:4 & El-Bassel and Strathdee, 
2016:3). The experience of female nyaope injectors are not well documented as it is 
a neglected field. The need to explore the experiences of female nyaope injectors was 
long overdue. 
1.2 Background of the problem  
Nyaope injection has brought the focuses of HIV prevention and substance abuse 
together. It has called for an integrative approach. According to Dada (2013:21), there 
are not enough substance use interventions and integrated HIV services that focus 
particularly on Injecting Drug Users (IDU) in South Africa.  
Observing the risky behaviour of people who inject drugs, specifically female nyaope 
injectors, demands attention by researchers. Despite a slow increase of heroin use 
over the previous 10 years, research on injecting drugs in South Africa remains limited 
(Dada, 2013:8). There is limited research on the drug injection practice, yet the number 






The drug injection practice is linked with social and health harms such as hepatitis and 
other infections, specifically, HIV (Dada, 2013:19). Needle sharing is problematic. 
Dada (2013:20) reports a study where 89% of people who inject drugs shared needles 
in the past 30 days, 6% had been paid for sex, and 1% never used condoms. Sharing 
needles increases the risk of contracting HIV. Contracting HIV through using used 
injecting equipment is six times more likely to result in infection than contraction 
through unprotected sexual intercourse (WHO, 2015:8). 
Female nyaope injectors have considerably diverse needs and have higher risks of 
infections and violence than male injectors. A focus on female nyaope injectors is 
imperative for several reasons, including; 
• Their higher death rates; 
• Increased chances of experiencing injection-related problems; 
• Higher rates of the Immuno-deficiency virus (HIV); and  
• Elevated injection and sexually risky behaviour (Robert, Mathews and 
Degenhard, 2010:8).  
It is important that the research study focuses on female population of drugs users in 
the City of Tshwane Municipality. 
The effects of drug use are more severe in females than in males. They are associated 
with problems such as economic hardship, greater drug dependence, health risks, as 
well as involvement in HIV-related high-risk behaviour (Jamshidimanesh, Mousavi, 
Merghati-Khoei, Emamian, Keramat, 2016:158). It is therefore necessary to 
understand the experiences of female nyaope injectors so that we are able to address 
their needs and influence policy making with regards to HIV prevention. 
1.3 Rationale of the study 
HIV prevention amongst people who inject drugs is an important strategy in reducing 
HIV infections and related deaths. United Nations Office on Drugs and Crime 
(UNODC) reported that sharing of injecting equipment is one of the main drivers of 
HIV transmission amongst people who inject drugs (UNODC, 2019:19). 
Studies conducted in a number of countries have indicated a significantly higher 
prevalence of HIV amongst females who use drugs than their male counterparts. 






be as high as 85%, compared to rates of up to 65% amongst all people who use drugs 
in the worst affected countries (GCWA, 2011:3).  
Women who use drugs face multiple individual, social, and structural factors that fuel 
their vulnerability to HIV and other blood-borne infections (El-bassel, Wechsberg and 
Shaw, 2012:2 & Azima, Bontell, Steffanie and Strathdee,2015:17). A study conducted 
in South Africa has highlighted that women who use drugs suffer human rights abuses 
at all levels (UNODC, 2019:21). 
There is less literature on the experiences of women who inject drugs in South Africa. 
In 2018, UNODC funded a consultation in major cities in South Africa; Pretoria, Cape 
Town and Johannesburg, to get a better understanding of the lived experiences of 
women who use drugs (UNODC, 2019:3). The study included women who inject drugs 
and those who do not inject drugs in their sample.  
The researcher is of the view that studying the experiences of women who inject drugs 
will assist in understandings their lived experiences, needs, challenges, risks, coping 
strategies, and their vulnerabilities. The research findings will enable practitioners and 
policy makers to utilise context based research findings instead of relying on 
international literature. 
Reducing HIV incidences by improving HIV prevention and treatment for PWID is an 
urgent international priority; as identified by several high level initiatives, including the 
Global Fund to Fight AIDS, Tuberculosis and Malaria and the UNAIDS 90-90-90 
targets. These initiatives are aimed at substantially scaling up access to, and the effect 
of, HIV treatment by 2020 (DeBeck, Cheng, Montaner, Beyrer, Elliott, Sherman, Wood 
and Baral, 2017:358).  
1.4 Problem statement  
For those who started using nyaope, there is little hope as many who are seen going 
to rehabilitation centers return to their community and use nyaope again. In their study, 
Mokoena and Huma (2014:360) discovered that those who went to inpatient treatment 
centers stated that the programme did not benefit them at all, and that almost all of 
them continued using nyaope a few days after being discharged.  
The researcher has observed that more people are transitioning from smoking to 






they share. The practice of sharing injections exposes the users to HIV and other 
blood-borne diseases. Females are not left out; they are also part of those 
communities which inject themselves with nyaope.  
Female nyaope injectors have significantly diverse necessities and experience 
increased risks of infections and violence than men who inject drugs. A study focusing 
on females who inject drugs is overdue, and it needs the attention of all stakeholders. 
It is therefore important to explore the experiences of female nyaope injectors residing 
in City of Tshwane Municipality, Gauteng. 
1.5 Significant of the study 
The study is expected to enlighten the City of Tshwane Municipality; Gauteng 
Department of Social Development; substance abuse service providers; and 
concerned stakeholders about the experiences of female nyaope injectors. The study 
will add to literature in the field of drug injecting. The study will provide practical 
strategies in order to mitigate the incidences of HIV amongst female nyaope injectors 
as well as address the challenges they experience in their daily lives. 
1.6 Research purpose  
The purpose of the study is to explore the experiences of female nyaope injectors 
residing in City of Tshwane Municipality, Gauteng. Furthermore, it is to gain an 
accurate and deep understanding of factors contributing to females injecting nyaope 
and how they can be aided to reduce the risks associated with nyaope injection. 
1.7 Research objective  
De Vos, Strydom, Fouche, and Delport (2011:94) describe research objective as more 
precise, measurable and more speedily attainable conception of such a "plan to do or 
achieve". The research objectives are specific little steps the researcher has taken in 
order to achieve the research goal.  
The research objectives were as follow: 
• To identify factors contributing to females injecting nyaope; 
• To explore the experiences of female nyaope injectors; and 







1.8 Research question  
Research question is described as the main emphasis of the research in question 
form, integrating the important ideas that seek to investigate or explain the main 
concepts of the research (Maggie, 2013:26). The following research questions will be 
addressed. 
• What are the factors contributing to females injecting nyaope? 
• What are the experiences of female nyaope injectors? 
• What are the services/programmes that can reduce the HIV prevalence amongst 
female nyaope injectors? 
1.9 Scope of the study 
The study focused on female nyaope injectors residing in City of Tshwane 
Municipality, Gauteng. 24 research participants aged between 19–35 years old 
residing in City of Tshwane Municipality were interviewed. 
1.10 Theoretical foundation of the study 
Social Ecological Model and Health Belief Model were utilised to understand the 
experiences of female nyaope injectors residing in City of Tshwane Municipality, 
Gauteng. These models were considered as they are able to examine environmental 
circumstances that affect health and wellbeing, as well as health behaviours by 
concentrating on the beliefs and attitudes of females who have a history of injecting 
nyaope.  
1.11 Research process 
A qualitative and exploratory research was followed in this study. Purposive sampling 
was employed to select 15 participants from females who were still injecting nyaope 
and 9 from females who recovering from injecting nyaope. The participants were 
between the ages of 19–35 and reside in the City of Tshwane Municipality. An in-
depth, semi-structured interview was employed for data collection on 24 research 
participants. Field undertaken notes were also kept by the researcher to record some 
of his own perceptions and observations. Data was analysed using six phases as 






The research methodology will be explained in more details in chapter three of this 
study.  
1.12 Outline of the dissertation 
Chapter 1: Overview of the Study 
This section presents the research title, introduction, and background of study, 
rationale of the study, research problem, significant of the study, research purpose, 
objectives and research questions, definition of key concepts, scope of research, 
theoretical foundation of study, research process, research outline and summary.  
Chapter 2: Literature Review and theoretical frame work 
This chapter will present the theoretical framework which guides the study and 
relevant literature related to female nyaope injectors.  
Chapter 3: Research Methodology and Design 
This chapter will present the research methodology and provides detailed research 
approach, research design, data collection, data analysis, measures to ensure 
trustworthiness, and ethical consideration. 
Chapter 4: Data Collection and Findings 
This chapter will present the interpreted data as research findings from the interviews 
conducted.  
Chapter 5: Conclusion and Recommendations 
This chapter will present the conclusion and recommendations of the study based on 
said findings. 
1.13 Summary  
This chapter has outlined the background of the study, research rationale, problem 
statement, significance of the study, research purpose, research objectives and 
question, definition of key concepts, theoretical foundation of the study, research 
process, outline of the dissertation, and summary. The next chapter will present the 







2. CHAPTER TWO 
Literature Review  
2.1 Introduction 
This section reviews different literature on the female drug injecting phenomenon and 
their vulnerability to contracting HIV. A literature review gives a chance for the 
researcher to classify, evaluate and combine current body of scientific work produced 
by researchers (Booth, Papaioannou and Sutton. 2012:2). Like all other research, 
most original research is seen as an extension of what has previously been learnt 
about a particular topic. Literature review is the way we learn what is already known 
and unknown on the specific topic (Babbie, 2010:506). 
2.2 South African HIV epidemic  
South African HIV prevalence has escalated from an estimated 4,25 million in 2002 to 
7,52 million by 2018. Almost one in five of South African females in their child-bearing 
ages (15–49 years) is HIV positive. HIV prevalence amongst youth aged 15–24 has 
decreased from 6,7% in 2002 to 5,5% in 2018. It is estimated that 19% of adults 
between the ages of 15–49 years are living with HIV. The total number of people living 
with is projected at about 7,52 million in 2018 (StatsSA, 2018:7). 
2.3 Female nyaope injectors and HIV 
It is a general knowledge that alcohol and other drugs are known to have a direct and 
indirect impact in increasing the risk of HIV transmission. This take place directly 
through sharing of used injecting equipment, and indirectly, as alcohol and other drugs 
can decrease inhibitions and impair decision making. As a result this influences risky 
sexual encounters such as having multiple sexual partners and increased length of 
sexual encounters (Parry, Carney and Williams, 2017:111). 
Significant decreases in HIV prevalence and mortality were observed from 2009–2013 
globally; mostly within sub-Saharan Africa. However, decreases in HIV prevalence 
amongst people who inject drugs, more especially female nyaope injectors, has not 
been good (Springer et al, 2016:2).  
Worldwide, the statistics of people who inject drugs is about 16 million, of whom, three 






females account for 27% of all people who inject drugs in South Africa, and 19,4% of 
female nyaope injectors are HIV infected (Springer et al, 2016:6). 
Different studies have stressed that people who inject drugs are at higher risk of 
contracting HIV. People who inject drugs do not have equal risk of contracting HIV. 
Female drug injectors are at higher risk of contracting HIV. There are several reasons 
why female nyaope injectors may have a higher risk of contracting HIV infections as 
compared to man who inject drugs. Females may struggle in accessing sterile injection 
equipment. They may experience extreme stigma when they seek treatment for 
substance use. As mentioned above, female nyaope injectors are quite likely to have 
a male injector as a sexual partner. There are also substantial gender inequalities in 
many countries that may add to increased HIV risk for females in general (Des Jarlais, 
Freelemyer, Modi, and Arasteh, 2013:2).  
• Their higher death rates; 
• Increased chance of experiencing injection-related problems; 
• Increased rates of HIV; and  
• Elevated injection and sexual risk behaviour (Robert et al, 2010:8).  
The effects of drug use are more severe in females than in males and are associated 
with problems such as economic hardship, greater drug dependence, health risks and 
involvement in HIV-related, high-risk behaviour (Jamshidimanesh, Mousavi, Merghati-
Khoei, Emamian and Keramat, 2016:158). 
Female nyaope injectors are more likely to participate in drug and sexual risks than 
males who inject drugs due to severe discrimination and cultural stigma perpetuated 
on them (Marottaa, Gilberta, Terlikbayevab, Wua and El-Bassela, 2018:97). Female 
nyaope injectors tend to be dependent on drugs faster than their male counterpart, 
inject more frequently per day, have intimate partners who inject, contract and die from 
HIV/AIDS, and have severe combined risks. This is partly because most of them 
engage in sex work to raise money for drugs (Khuat, Morrow, Nguyen and Armstrong, 
2015:1). The mean age of first drug injection by female nyaope injectors is 19,5 years, 
and mean number of injection used is normally twice per day. Drug injecting is most 
widespread during late adolescence and early to mid-adulthood; overlapping with a 






2.4 Use and challenges of nyaope in South Africa 
Nyaope is a drug preferred by many drug users in townships, especially in Gauteng. 
It is reported that hundreds of nyaope users are dying in the City of Tshwane from 
Nyaope overdose, some as young as 9 years old (Masombuka, 2013:29). Heroin is 
the main ingredient in nyaope (Mokwena, 2015:138). The use of nyaope and its effects 
on the lives of those who use drugs, their communities, their families and the country 
has been most covered by media. There is as assumption that nyaope can be the 
worse drug in South Africa. Those who use nyaope are identified easily by their poor 
personal hygiene, their slowness of movement and their half-dazed looks. 
In townships, they are often labelled to as “nyaopers” and are known for committing 
petty crimes in order to maintain their habit. The author believes “nyaopers” as a name 
is derogative and perpetuates stigmatisation on people who inject drugs (Mokwena, 
2016:138). The stigmatisation contributes to people distancing themselves from 
individuals who use drugs and are afraid of those with drug use problems, viewing 
them as dangerous (Paquettea, Syvertsenc and Pollinia, 2018:3). 
Nyaope was declared an illegal drug when the amendments (amendment of schedule 
1 and 2) to the Drug Trafficking Act of 1992 (Act 140/1992) were signed in 2014. Before 
2014, there were no laws to regulate new narcotics created by modifying the chemical 
structure of certain substances, or finding chemicals with entirely different chemical 
structures that produced similar effects. Nyaope was easily accessible in the 
communities, drug dealers sold it freely without fear of being arrested (Mokwena, 
2016:138 & Dintwe, 2017:160).  
The use of nyaope presents an immense social and health problem and affects users, 
families and their community. The problem of nyaope is worsened by being easily 
accessible in townships where black people mostly live. Furthermore, being fairly 
cheap and therefore, enticing large numbers of unemployed youth who are mostly 
poorly educated, with poor employment opportunities, and fewer opportunities for 
rehabilitation (Mokwena and Huma, 2014:360). 
Nyaope is a concoction of low quality heroin smoked with dagga or injected. The abuse 
nyaope, in South Africa, has escalated in recent years mainly amongst young African 






dropping out of schools. Nyaope users are mostly from poor backgrounds, they often 
resort to criminal activities to finance their drug habit. Females are not left out, they 
are also using nyaope. Heroin is an addictive drug and the presence of ARVs makes 
nyaope an even more addictive drug mixture which can cause violent stomach 
cramps. Users experience extreme difficulties when attempting to stop using nyaope 
on their own (Mthembi, Mwenesongole and Cole, 2018:115-116 & Mokwena, 
2016:138 & Meel and Essop, 2018:588).  
Nyaope use is consequently a major problem, followed by HIV epidemic in South 
Africa. Studies regarding the prevalent abuse of nyaope in South Africa, has shown 
that nyaope abuse has led to the growth of drug abuse and crimes statistics 
(Monyakane, 2018:2). 
The use of nyaope is reported to make the users feel ecstatic and excited. Continuous 
use is linked with the development of tolerance and dependence. Users will start to 
use increasingly greater and more frequent amounts of the drug to achieve the same 
effect. When nyaope users are dependent on nyaope, they will experience withdrawal 
syndrome in the form of physical pain if they do not use nyaope (Mokwena, 2016:138).  
Even though nyaope was known to be smoked, users are transitioning to injecting. 
This practice of injecting is likely to contribute to an increase in health cases including 
transmission of HIV and endocarditis. Endocarditis due to injecting drugs contributes 
to morbidity and mortality in young male population (Meel and Essop, 2018:585-588). 
This implies that females who inject nyaope have a likelihood of having heart attacks.  
Pregnant women who use nyaope compromise their health and that of their unborn 
babies. Using nyaope while pregnant has harmful effects to unborn babies (Mthembi 
et al, 2018:115-116). Drug use amongst pregnant females may add in numerous 
pregnancy complications, such as neonatal abstinence syndrome, low birth weight, 
and premature birth. Neonatal abstinence syndrome mainly refers to heroin withdrawal 
syndrome, which is experienced by infants born to females who continue to use 
heroine during pregnancy (UNODC, 2018:21). 
According to Dintwe (2017:162), nyaope is a multi-faceted challenge, its addiction is 
caused by a variety of factors. Nyaope addiction needs a multi-faceted approach; it 






therefore calls for an integrative approach to address nyaope challenges in the 
communities. The challenges cannot be addressed without engaging the users to shed 
light concerning their challenges, coping resources, experience, risks, needs and 
hopes.  
2.5 Risky behaviour of females drug injectors 
HIV amongst people who inject drugs is unjustly higher compared to the general 
population; sharing injecting equipment is one of the elements contributing to high HIV 
incidence. People who inject drugs are also at risk of HIV transmission through 
unprotected sex, which is predisposed by links to sex work, transactional sex and 
drug-related effects. Several social and structural factors contribute to the increased 
HIV burden amongst people who inject drugs. For example, the criminalisation of drug 
use contributes to stigmatisation of people who use drugs, which makes it difficult for 
people who inject drugs to access health services (Scheibe, Shelly, Lambert, 
Schneider, Basson, Medeiros, Padayachee, Savva and Hausler, 2017:2).  
2.5.1 Sexual risk by female nyaope injectors 
Female nyaope injectors engage in transactional sex, sex work, sharing of injections 
and poor condom use, increasing the risk of contracting HIV. If female nyaope injectors 
address their risky behaviour, it will reduce the risk of contracting HIV and reduce 
financial burden on the stat; which comes with supplying ARVs and related services 
to HIV positive people.  
 Transactional sex 
Females are more likely to engage in transactional sex and sex work as compared to 
their male counterparts (Scheibe, Howell, Muller, Katumba, Langen, Artz and Marks, 
2016a:113). Females who use drugs and engage in sex work are more likely to share 
used injections and other injecting equipment amongst themselves and their clients. 
(Azima et al (2015:17) further argue that females who use drugs engage in 
unprotected sex with their clients, as well as their intimate partners, and have higher 
rates of sexual transmitted infections (STI). They are also at risk of experiencing 






A study conducted in Tanzania, highlighted that female who use drugs have reported 
condom inconsistency and multiple sexual partners as compared to men (Asher et al, 
2013:6). Due to the significantly higher rates of transactional sex and sex work by 
females who inject drugs and coupled with poor condom use, HIV risks are higher for 
them as compared with their male counterparts. 
 Poor condom use 
Majority of the females who use drugs are often incapable of discussing safe sex with 
their intimate partners. Sexual risk-taking may be linked with the feelings of trust in a 
relationship, or they may be culturally entrenched in the gendered distribution of 
power. Endeavours to discuss condom use with an intimate partner can consequently 
result in violence, isolation and exclusion if taken as an unwanted challenge to fidelity 
and privilege within the relationship (GCWA, 2011:5). This implies that culture and 
believes have a negative impact in terms of intimate relationships between females 
who are using nyaope and their partners.  
There are different factors that contributes to poor condom use. Haddad, Tang, 
Krashin, Ng’ambi, Tweya, Samala, Chiwoko, Chaweza, Hosseinipour, Lathrop, 
Jamieson and Phiri4 (2018:44) argue that low utilisation of condoms has been 
associated with cost, religious ideology, alcohol or drug use, younger sexual debut, 
poor knowledge of HIV/AIDS, beliefs of diminished sexual pleasure and male 
emotional fulfilment, disbelief in prevention efficacy, distrust in relationships, and 
gender inequality.  
 Sex work 
It is reported that most female sex workers use drugs. For some of them, drug 
dependency has contributed in starting to work as sex workers. Others may have 
started to use drugs to cope or numb the challenging routines linked with sex work 
(Strathdee, West, Reed, Moazan, Azim and Dolan, 2015:2). Sex workers in South 
African have mostly been unnoticed and underserved by health and social services. 
From 2010, efforts have focused on improving health care services for sex workers. 
Studies in South Africa suggest that the prevalence rate among female sex workers 
varieties from 40–88%, considerably higher than the 14,4% prevalence among adult 






variety of factors that predispose them to HIV and other blood-borne infections 
(SANAC, 2016:13-18). More attention is required in order to address the challenges 
of female nyaope injectors who work as sex workers.  
2.5.2 Impact of sharing injection 
Females are also injecting drugs, it is reported that 87% of female started to inject with 
heroin (Scheibe, Makapela, Brown, dos Santos, Hariga, Virk, Bekker, Lyan, Fee, 
Molnar, Bocai, Eligh, and Lehtovuor, 2016b:110).HIV contact through using used 
injecting equipment is six times more probable to transmit infection than contact 
through unprotected vaginal intercourse (WHO, 2015:8). This implies that chances of 
contracting HIV through use of contaminated injecting equipment is very likely.  
Female nyaope injectors are vulnerable and are at high risk of contracting HIV. In 
South Africa, is it projected that HIV prevalence amongst people who inject drugs is 
12,4% (Scheibe et al, 2016b:108). People who inject drugs are severely affected by 
HIV. Prelude analyses of the 2013 Global AIDS Response Progress Reporting 
(GARPR) data projects that people who inject drugs account for 30% of new HIV 
infections outside of sub-Saharan Africa (UNAIDS, 2014:3).  
Neglecting people who inject drugs, especially female nyaope injectors, through HIV 
prevention programmes, is tantamount to wasting money through HIV promotions and 
compromising efforts toward vision 90-90-90 and ending HIV by 20130.  
2.6 Vulnerabilities of female nyaope injectors 
Females who use drugs, regardless of whether they are injecting or not, experience 
numerous issues which increases their vulnerability to HIV. These includes: 
concomitant sex work, STIs, viral hepatitis, mental health problems, reproductive 
health issues, stigma, child care, violence, and lack of access to health services; 
including for HIV prevention, care and treatment (Azima et al, 2015:17).  
2.6.1 Biological factors 
Females are more biologically susceptible to sexual transmission of HIV than males. 
Such vulnerabilities, when joint with the particular risks experienced by females who 
use drugs, worsen their risk of HIV infection even further (GCWA, 2011:3 & UNODC, 






transmission through vaginal or anal sex than a male insertive partner, although risk 
differs depending on the context and setting (Larney et al, 2015:7). 
The physiological risk of contracting HIV is higher for females than males because 
females have a more mucosal surface area exposed to pathogens and infectious fluids 
for longer periods during sexual intercourse, and they are likely to face increased 
tissue injury. Exposure of a larger area of vaginal epithelium during sex, transmission 
of a larger volume of genital fluids from male to female ,and a higher viral load in 
semen, are cited as possible reasons for this discrepancy (Ramjee and Daniels, 
2013:2). Female specific clinical manifestations, such as gynaecological infections 
and precancerous lesions in the vagina and cervix, places females at a biological 
disadvantage (Rodrigo and Rajapakse, 2010:9).  
2.6.2 Gender inequality 
The social construction of the purpose of gender, as it relates to social standards and 
disparities, describes and shapes risk in the context of relationships between men and 
women. Studies on HIV prevention has argued that gender inequality and the 
subsequent power differential found in relationships between males and females are 
contributing factors in heterosexual HIV transmission and unequal rates of HIV among 
females (Morrisa, Montgomery, Bricenoa, Evansa, Andrewc, Pagec and Hahna, 
2018:2). 
There is a consensus that females’ lower social status can leave them vulnerable to 
infections from males, due to principles of masculinity linked with risk-taking and 
sexual conquest (Turmen, 2003:412). Cultural norms and values disempower females 
to discuss safer sex with their intimate partners, which increases their vulnerability to 
contracting HIV. Females reported that the fear of losing their intimate partners affects 
their decision making as it relates to safe sex; leaving the decision to practice safe sex 
to their partners (Jamshidimanesh et al, 2016:163).  
2.6.3 Intimate partner violence 
Intimate partner violence (IPV)has been reported as a substantial facilitator to HIV 
transmission risk among females who use drugs, and is also more prevalent amongst 
female nyaope injectors compared with females in the general population (Stoicescu, 






It is further argued that females who use and inject drugs experience high proportion 
of IPV such as physical assaults, sexual coercion, and rape. Females who are 
exposed to IPV may be unwilling to refuse sex with a condom for fear of provoking 
further violence (Larney et al, 2015:8). A refusal to use a partner’s used injecting 
equipment can expose females at a higher risk of IPV, which will further increase their 
risk of HIV infection.  
Such violence is often supported by cultural concepts whereby the male partner is free 
to exert power and control. Sexual duress is one of the forms of IPV, most strongly 
associated with the risk of HIV transmission. The risk of HIV amongst females who 
have experienced violence may be up to three times higher than those who have not. 
Eventually, the helplessness effects of IPV can result in a greater struggle for females 
in discussing safer sex practices to reduce their risk of acquiring HIV (GCWA, 2011:6). 
In situations where intimate partner is responsible for buying drugs for the female, 
there is often the anticipation that the female will have sex with them in exchange, 
which points to a gender power inequality that is deepened by drug use and places 
the female drug user in high risk of contracting HIV infection. In these situations, a 
female’s denial to have sex, or her attempts to discuss condom use, may trigger further 
violence (UNODC, 2018:17). In order to protect female nyaope injectors, the South 
African government, through the parliamentary processes, has to create bills and laws 
that are aimed to protect the vulnerable females drug users. This is discusses further 
in Section 5.4. 
Females’ intimate relationships with their male partners who also use drugs are 
complex and lively. Females work to maintain their drug habits and that of their intimate 
partners. A study of female nyaope injectors who sell sex in Canada established that 
the males control females’ lives through a process of building trust, supplying and 
controlling the supply of drugs, gaining control of their sex work environment, and 
transactions with their clients. Sexual and physical violence against female nyaope 
injectors is prevalent and the experience and the threat of violence serves to subdue 
them further (Azima et al, 2015:17). IPV affects females’ influence and ability to 







2.6.4 Cultural factors 
Culturally entrenched power disparities that exist between men and women across the 
world often leaves women susceptible to increased stigma, abuse, violence and 
coercion (GCWA, 2011:3). Cultural expectations of masculinity applauds men to 
accept the patriarchal attitude that wives, partners and daughters are their belongings, 
and most husbands expect or demand their conjugal ‘rights’ (Ramjee and Daniels, 
2013:2).  
The stigma that is experienced by female nyaope users is intense as compared to that 
which is experienced by male counterparts because of gender-based stereotypes that 
hold females to different values. Drug use by females is seen as breaking their 
traditional role in society as mothers and caretakers. Increased stigma is also linked 
with homelessness to females who use drugs, which causes them to stay deep-rooted 
within drug-using networks. As a result, they spend less time with people who do not 
use drugs that could be potential sources of help for treatment and care (UNODC, 
2018:20). 
It is reported that women who use and inject drugs are fewer than men, and they 
account for 20% of the worldwide estimate of people who inject drugs. In terms of 
risks, females who use drugs are more vulnerable than males to HIV and other blood-
borne infections. This is not only for biological reasons, but also because of gender 
power disparities. For example, being incapable to discuss condom use, being injected 
after an intimate male partner has injected himself with the same needle, and being 
involved in sex work. (UNODC, 2018:20). 
Cultural customs make it tough for females to acknowledge their drug problem and 
leave their homes and families to undergo substance related treatment. Since many 
females who use drugs also live with a partner or other family members using drugs, 
relationship issues and the role of drug use within the relationship remain the key issue 
in females seeking support for drug treatment (UNODC, 2018:22). Societal customs 
that supress females and build imbalanced power relationships further strengthen 







2.6.5 Economic factor 
While financial deficiency does not contribute to drug use alone, various factors linked 
with family, interpersonal instability, high prevalence of mental health disorders and 
low school completion rates, result in a situation where a lack of social and economic 
resources make females more vulnerable to using drugs. (UNODC, 2018:20). 
Female nyaope injectors typically depend on male partners for drugs and injections, 
contributing to high drug and equipment sharing (Des Jarlais et al, 2012:2). Many 
females are forced to participate in sex work to finance their own or their partner’s drug 
use, which may put them at dual risk of HIV infection through unsafe sex as well as 
unsafe injections (Azima et al, 2015:17). 
Financial gender inequality stimulates IPV in relationships, lessens females’ power in 
sexual discussions with male partners, and intensify their susceptibility to HIV. 
Unfavourable socioeconomic conditions can lead females to practice sex work, 
consequently elevating their HIV risk (El-Bassel and Strathdee, 2016:6). Female 
nyaope injectors often face gender and power inequalities Mburu, Ayon, Tsai, Ndimbii, 
Wang, Strathdee and Seeley (2018:2). Poor socio-economic circumstance can limit 
development, educational opportunities, access to health care services and 
employment creating a favourable setting for HIV spread (Rodrigo and Rajapakse, 
2009:10). 
Globally, females who use drugs experience high unemployment rates due to the 
stigma and discrimination. These females have slight prospects of accessing the job 
market and become financially dependent. Most of the females continue to be poor 
and depend on their intimate partners for food and shelter. These financial limitations 
reduces their access to educational or occupational training, banking and asset 
accumulation, as well as property ownership. Financial gender inequality also 
promotes IPV in relationships, reducing females’ power in sexual discussions with 
male intimate partners, and ultimately elevates their susceptibility to HIV (El-Bassel 
and Strathdee, 2016:6).  
Poor economic position has been linked with earlier sexual debut, inconsistent 
condom use, having multiple sex partners, increased chances that the first sex act is 






forced sex. Many females opt to engage in transactional sex to finance their lives 
(Ramjee and Daniels, 2013:3). 
Poor economic standing predisposes females to multiple risk factors that increase their 
likelihood to contracting HIV. Efforts to empower females economically should be 
prioritised in order to address HIV infections especially among the younger females as 
they are the ones affected most by HIV. This is discusses further in Section 5.4. 
2.6.6 Social factors 
Significant others play a role in encouraging females to inject drugs. Females are more 
likely to start injecting drugs with an intimate partner and are likely to have that partner 
inject them (El-Bassel and Strathdee, 2016:5, Larney et al, 2015:7). Females who are 
in an intimate relationship with a drug user have been shown to be significantly linked 
with a female’s initiation and continuation of drug use. They are also likely to request 
the male partner to inject them, contributing to their higher susceptibility (UNODC, 
2018:18, & GCWA, 2011:6).  
Tuchman (2015:6) discovered in her study that most females were initiated into drug 
injecting by their fellow females, rather than a male sexual partner. This is contrary to 
most literature which states that male intimate partners initiate females to injecting 
drug use. Societal determinants of gender inequality such as socio-economic 
conditions, gender norms, ethnicity, and religion can increase the risk of HIV (GCWA, 
2011:3). 
Females who use drugs may be excluded from family support structures, and those 
who are not financially independent or lack employment prospects may be more 
probable to participate in sex work, elevating their sexual HIV risk and drawing extra 
stigma linked with sex work (Larney et al, 2015:7).  
Female nyaope injectors who try to care for their offspring, while living with the 
substance abuse related stigma, face another layer of complexity with their family 
members. Females who use drugs may also have responsibilities as caregivers; 
consequently, their drug use unpleasantly disturbs their families, in particular, children. 
Such adverse childhood experiences can be transgenerational and impart the risks of 






Children are emotionally and financially dependent on their parents, harmful parental 
drug use, especially by the mother in societies where they have the role of caregiver, 
can affect the children adversely in the long term (UNODC, 2018:22). 
2.6.7 Conduct of law enforcers  
El-Bassel and Strathdee (2016:6) suggest that females who use drugs may be ill-
treated by police officers. Police officers may use violent policing on female nyaope 
injectors; including arresting females for buying or carrying sterile injections, pestering 
at needle exchange programs or drug treatment clinics, soliciting bribes to avoid 
arrest, sexual abuse and violence, or planting drugs on females. Studies of females 
globally have established a strong association between substance use and police 
sexual misconduct, coercion, or rape. Females do not report police abuses due to 
fears of imprisonment or other punitive penalties for themselves and their families. 
Criminalisation of drug use increases the likelihood of police targeting drug injectors. 
This adds to increased rates of drug offence sentences amongst people who inject 
drugs. The criminalisation of drug use, mainly in public spaces, has also led to police 
targeting drug and HIV treatment locations for arrests and detention of people who 
inject drugs (Marottaa et al, 2018:97). Growing literature of research has proposed 
that violent policing, such as crackdowns, has not decreased drug use and has instead 
led to serious public health consequences, including high HIV infection epidemics 
amongst people who inject drugs. For example, the fear caused by intensive policing 
on people who inject drugs may cause people who inject drugs to hideaway into 
remote or hidden settings and avoid needle exchange services that can help protect 
them from HIV infection (Hayashi, Small, Csete, Hattirat and Kerr, 2013:1). 
Studies have further suggested that criminalisation of drug use pushes pregnant 
females to hide their drug use from healthcare providers, restricting them from 
accessing harm reduction and HIV prevention services (El-Bassel and Strathdee, 
2016:5).  
The percentage of females convicted for drug related crimes is high as compared with 
that of males. Once released from correctional centre, females experience the 
combined stigma of their gender and their status as ex-offenders. They continue to 






health care services. They also experience social isolation, leaving them to continue 
living in conditions of social and economic disadvantage and inequality (UNODC, 
2018:7). 
It is understood that injecting drugs in public spaces may lead to drug crime convictions 
for females who inject drugs. This is because law enforcement pays greater attention 
on drug user status for female nyaope injectors compared to male injectors. Injecting 
in public locations is also strongly linked with hasty injections due to fear of police 
contact and harassment. This then exuberates female nyaope injectors to ignore 
hygienic and safe injection practices (Marottaa et al, 2018:103). 
According to a research titled ‘Experiences with Policing among People Who Inject 
Drugs in Bangkok, Thailand’ (Hayashi et al, 2013:5-7), it was discovered that people 
who inject drugs experience abuse at the hands of the police. Police falsely accuse 
them, planted evidence on them, or coerced them into admitting to a crime that they 
did not commit. Despite having experienced abuse and corruption from the police, 
participants showed an unwillingness to open criminal cases against the police or seek 
justice. Some participants indicated that they felt helpless and were discouraged by 
the police officers’ disregard for their rights. The findings indicate that police 
exploitation and other police misconduct have further led to people who inject drugs’ 
vulnerability to drug-related harm.  
Some participants reported that they try to avoid police and do so by refraining from 
going into public spaces where they could be exposed to police scrutiny. This 
intervention by the police often obstructed females who inject drugs access to health 
care. The violent policing undermines justice and intrudes important health services. 
This is violating the right to the highest attainable standard of health enshrined in the 
International Covenant on Economic, Social and Cultural Rights (Article 12) (Hayashi 
et al, 2013:7). 
South African key populations indicated numerous types of abuse committed by police 
officers. Key populations were defined by the United Nations Joint Programme on HIV 
and AIDS as social groupings that are among the most likely to be exposed to HIV, 
and who are negatively affected by punitive laws and stigmatising policies which 






2.6.8 Mental health challenges 
People who inject drugs face elevated levels of mental health challenges such as 
depression, psychosis, as well as anxiety and personality disorders. It is understood 
that mental health conditions leads to drug use (UNODC, 2015a:13). Females are 
more likely, than males, to name trauma or stressors such as relationship problems, 
environmental stress and family problems as grounds for their initiation or continuation 
of substance use (UNODC, 2018:9). 
Increased vulnerability adds to a mix of mood and anxiety disorders, particularly post-
traumatic stress disorder, and is linked with substance use amongst females. Some 
studies suggest that females may be more likely to start using drug as a way of self-
medicating for mental health issues, such as depression, anxiety, and posttraumatic 
stress disorder. These are often a result of trauma, abuse, and violence (Pinkham, 
Myers and Stoicescu, 2012:3). 
2.6.9 Stigma and discrimination challenges  
Stigmatisation and discrimination on females who use drugs increases the probability 
of practicing high risk behaviours, which then increases chances of contracting HIV 
and other blood-borne virus (BBV) transmission. The stigma attached to females’ drug 
use can result in them being forcibly removed from their homes, ostracised by family, 
friends and the community large, and having their children removed from their custody. 
This happens regardless of whether or not their parenting skills are compromised by 
the use of drugs (GCWA, 2011:2-3). Females who use drugs are stigmatised worse 
than males due to traditional stereotypes that hold females to different expectations 
and roles of females as mothers, partners and caretakers (El-Bassel and Strathdee, 
2016:5 & Khuat et al, 2015:1).  
Current evidence suggests that female nyaope injectors construct self-stigmatised 
identities to an extant where it becomes difficult to have important relationships; 
assuming that they do not deserve to be loved. The internalisation of the stigma is 
associated with low self-esteem. Apart from being ashamed of themselves, female 
nyaope injectors consistently witness negative attitudes from their communities and 
families. This stigma is influenced by moral judgement. Apart from the stigma which is 






healthcare settings. Regardless of its source, stigmatisation of females who inject 
drugs seems to result in isolation and exclusion through prejudiced social processes 
and institutional practices. Different forms of stigmatisation of female nyaope injectors 
are an influential barrier to their access and utilisation of health care services (Mburu 
et al, 2018:3-5). Stigma perpetuated on females who inject drugs does more harm 
than the drug itself.  
Drug use and injecting practice attracts deep levels of stigma. People who use drugs 
may encounter condemnation by their families and communities and discrimination in 
a variety of settings such as health care settings. Social exclusion, stigmatisation, and 
discrimination may fuel HIV risk and dent HIV prevention and treatment (Larney et al, 
2015:6). Females who use drugs are deprived social support, such as child-care, due 
to stigma held by their families and friends (El-Bassel and Strathdee, 2016:5). 
In many communities, drug use, both in general and among females, is severely 
stigmatised. This results in females who use drugs hiding themselves more than males 
who use drugs (UNODC, 2018:22). 
2.7 HIV prevention strategies among female nyaope injectors: Harm reduction 
services  
Regardless of the acknowledgement of the effects of drug use on HIV transmission, 
there are inadequate HIV harm-reduction services in South African. Based on the 
connection between HIV risk behaviour and drug use, it can be justified that 
strengthening efforts to offer integrated HIV harm-reduction and substance abuse 
treatment services should be prioritised. Although the drafting of South Africa’s Third 
National Drug Master Plan (2013-2017) gave eminence to the necessity of addressing 
drug abuse as part of comprehensive HIV prevention efforts, programmes targeting 
people who use drugs, with a sole purpose of addressing drug use and sexual risk 
behaviour in South Africa, are scarce (Parry et al, 2017:112).  
Females experience substantial systemic, structural, social, cultural and personal 
obstacles in accessing treatment for drug use. At a structural level, the most important 
barriers include lack of child-care services and negative attitudes towards mothers and 






injectors are a subpopulation that is deserted from HIV prevention and substance 
abuse treatment strategies for people who inject drugs (Marottaa et al, 2018:102). 
Stigmatisation and discrimination perpetuated on people who inject drugs makes it 
hard for them to access health care services. Several studies indicates that, when 
female nyaope injectors are living with HIV and are pregnant, they face ample 
obstacles accessing services to assist their infants from acquiring HIV infection 
(UNAIDS, 2014:10). A comprehensive package of harm reduction was endorsed for 
all people who inject drugs in order to lessen social and health harms related to 
injecting drugs (Mburu et al, 2018:1).  
The Southern African HIV Clinicians Society (SAHCS) released a statement on the 
3rd of June 2019 pledging their support for harm reduction. In the statement, they 
reported that they supports evidence-based law and policy-making. They believe that 
South Africa will not reach its, nor international, HIV or viral hepatitis reduction and 
treatment targets or related public health goals if it does not decriminalise drug use 
(SAHCS, 2019). 
Intervention guidelines includes are discussed in the section that follows. 
2.7.1 Harm reduction services package  
A technical guide for people who inject drugs was designed by WHO, UNODC and 
UNAIDS; it was named harm reduction (UNDOC, 2017:63). Intervention guidelines 
contains, needle and syringe programmes (NSPs), opioid substitution therapy (OST), 
prevention, vaccination, diagnosis and treatment of viral hepatitis B and C, and 
community distribution of naloxone for prevention and treatment of opioid overdose to 
name the few. Implementation of a harm reduction approach is cost effective and 
beneficial for the health outcomes of people who use drugs, their families and the 
communities in which they live (UNAIDS, 2014:13). 
 Needle and syringe programmes (NSPs) 
The first needle exchange programme in South Africa was established in Cape Town 
in 2012, focusing on men who have sex with men. In 2015, this service was provided 






inject drugs. In the same year, needle and syringe services were established in Durban 
and Pretoria (Scheibe et al, 2019:2).  
The use of drugs in South Africa is criminalised, but no laws prohibit the acquisition or 
provision of injecting equipment, therefore, the provision of needle exchange 
programmes is not outlawed. HIV is efficiently spread through the use of contaminated 
injecting equipment and can spread rapidly within PWID networks. Provision of 
injecting equipment can reduce the HIV transmission among females who inject drugs 
drastically (Scheibe et al 2017:2) 
The facilitation of access to sterile needles and injecting equipment through NSPs has 
proven to be effectively in decreasing the risk of contracting HIV and other blood-borne 
infections. NSPs provide sterile needles in order to discourage the use of 
contaminated needles and injecting equipment. NSPs have confirmed to produce 
outcomes and are cost-effective, and have not been shown to promote drug use or 
injecting. 
NSPs should attract people who inject drugs to other crucial services like health and 
social services, which they might be unwilling to use. NSPs are implemented by people 
who have a history of injecting drugs. As peers, they are able to appeal to people who 
inject drugs to access harm reduction services.  
Characteristics of NSPs are that they:  
• are harm reduction-oriented, make minimal demands on the injector; 
• offer a range of free products; 
• are not punitive (do not adhere to strict exchange policy); 
• does not stop injectors from giving other injectors needles; 
• provide other services by qualified staff, for example, psychosocial service or 
medical services; 
• provide needle disposal services; 
• provide overdose management; 
• train drug injectors on safe injecting; and 






 Opioid substitution therapy (OST) and other evidence-based drug-
dependence treatment  
The first South African government-funded OST was implemented in Western Cape 
and has demonstrated modest success, in terms of completion and retention rates, 
and further argues for a move to increase availability of and accessibility to OSTs for 
management of opioid use disorder (Michie, Hoosain and Macharia. 2017:542).  
OST aims to alleviate the symptoms of opioid withdrawal, reduce cravings, and the 
opioid response through receptor coverage. Over 40 years of research has shown that 
OST saves lives, improves retention in healthcare and treatment, reduces illicit heroin 
use, reduces interactions with the criminal justice system reduces HIV risk, and 
improves health and quality of life. (Scheibe, Marks, Shelly, Gerardy, Domingo and 
Hugo, 2018:800). 
OST has shown to be the greatest effective drug-dependence treatment for preventing 
HIV among people who injecting drugs and are addicted to opioids. OST is a safe and 
cost effective medical opioids treatment. OST improves ARV and TB treatment 
adherence for diagnosed people (UNODC, 2017:66-72). 
 HIV testing services  
The HIV testing services (HTS) are initial entry into HIV prevention services. They are 
important to caring and sustaining treatment for people living with HIV. Integrating 
counselling with knowledge of one’s HIV status and HIV testing services can assist 
people with regards to harm reduction services in order to prevent HIV transmission.  
The HIV testing services must be part of a cohesive programme. This must address 
HIV prevention, care and treatment. The HIV testing services should adhere to the 
“Five C” principles namely; Consent, Confidentiality, Counselling, Correct test results 
and Connection to follow-up services (UNODC, 2017:72-74). 
 The antiretroviral therapy (ART) regarding people living with HIV  
Expanding accessibility to HIV testing and ART is critical, both to reducing levels of 
AIDS mortality, and to reducing HIV incidence. This is therefore the focus of the 






with HIV, a 90% rate of ART coverage in HIV-diagnosed individuals and a 90% rate of 
virological suppression in patients on ART (Johnson, Dorrington and Moolla, 2017:2). 
There is significant decrease of HIV related illness and death as a result to increased 
availability and access to ARV. Recent improvements in HIV treatment, combined with 
promotion for increased availability of cost-effective drugs, have resulted in massive 
enhancements in the value of life of people living with HIV globally. Conversely, global 
levels of treatment provision have improved significantly over the last years. The 
accessibility of ARV amongst people who inject drugs is still very poor, with a global 
average of less than 10%. South Africa has the largest ART program in the world, with 
more than 3,4 million HIV-infected individuals accessing ARV drugs. The ARV 
programme continues to grow with the removal of CD4+ count thresholds as a criterion 
for ART initiation (Moorhouse, Maartens, Venter, Moosa, Steegen, Jamaloodien, Fox 
and Conradie, 2018:73-74).  
According to WHO guidelines, it is recommended that people living with HIV must 
commence with ART regardless of their clinical stage and CD4 count. This must 
include people living with HIV who inject drugs. (UNODC, 2017: 75-76). 
 Treatment and prevention of sexually transmitted infections  
Sexually transmitted infections (STIs) are infections caused by bacteria, viruses and 
parasites that are transferred mainly via sexual contact, be it vaginal, anal, oral or in 
some instances via non-sexual means, that is, by means of blood or blood products. 
The high level of STIs in South Africa can be attributed to a large number of factors 
including low socio-economic conditions, social stigma, gender inequalities, inability 
to access adequate health care systems and lack of preventative programmes (Van 
Eyk, 2016:12). 
South Africa has some of the highest rates of STIs in the world, the government views 
them as a major public health problem. In 2007, the South African government 
introduced its first national strategic plan for HIV and STIs; its latest plan for 2017–
2022 includes STI interventions and targets (Kularatne, Niit, Rowley, Kufa-
ChakezhaID, PetersID, Taylor, Johnson and Korenromp, 2018:2). 
The delivery of elementary HIV and STI clinical services is a crucial part of a 






strategies should aim to improve STI care-seeking behaviour as a community 
standard. People who inject drugs, together with their intimate partners, should have 
knowledge of STI symptoms and be encouraged to undergo STI screening regularly 
(UNODC, 2017:76-77). 
 The reproductive and sexual health 
Women’s sexual and reproductive health and wellbeing is dependent on a complex 
factors of socioeconomic and healthcare. Two decades after the advent of democracy, 
South Africa remains a highly unequal society socio-economically. Black South 
Africans continue to be economically disadvantaged, with females most 
disadvantaged. On average, women are 30% poorer than men. South African 
women’s sexual and reproductive health and rights (SRHR) in the context of new 
legislation, policies and programmes in the second decade of democracy include; 
contraception and fertility planning, abortion, maternal health, HIV, cervical and breast 
cancer, and sexual violence (Cooper, Harries, Moodley, Constant, Hodes, Mathews, 
Morroni and Hoffman, 2016:79-80).  
People who inject drugs have similar needs for a variety of sexual and reproductive 
health services. These needs are often not available for females who inject drugs. 
Accessibility and availability of family planning and contraceptives for females who 
inject drugs is important and part of their basic rights. The right to access to health 
care services, which includes sexual and reproductive health care, is enshrined in 
South African Constitution. This implies that female nyaope injectors have equal rights 
to reproductive and sexual health as supported by the constitution (Constitution of SA, 
1996:11). 
Drug use may influence a female’s menstrual cycle. This may lead to irregular 
menstruation. Female nyaope injectors should be knowledgeable that this does not 
stop them from becoming pregnant. They need contraceptives if they do not wish to 
fall pregnant (UNODC, 2017:78-81). Intensified efforts are needed to reach and 
provide services to women who inject drugs, and to ensure that these services are 






 Effective condom distribution for people who inject drugs and their 
intimate partner 
Condom distribution, promotion and social marketing represent a highly cost-effective 
HIV prevention strategy; given the low cost of condoms and their strong prevention 
efficacy (Ashmore and Henwood, 2015:1). Condoms have been endorsed as an HIV 
prevention strategy. This has been effectively applied since the mid-1980s and remain 
a very effective tool in prevention of sexual transmission (UNODC, 2017:81-82). 
 Essential information, education and communication  
The harm reduction programme comprises change of knowledge, attitudes, beliefs 
and behaviour. It strives to establish community cohesion. The information, education 
and communication materials should enhance HIV infection services. The material 
should use easy to read information to prevent misinterpretation (UNODC, 2017:82-
84). 
 The prevention, vaccination, diagnosis and treatment of viral hepatitis 
B & C 
According to Scheibe et al (2019:2) viral hepatitis is accountable for the demises of 
about 1,34 million people every year globally. This is similar to the annual number of 
deaths from HIV/AIDS (1,3 million), malaria (0,9 million) and tuberculosis (1,3 million). 
This statistics are alarming and necessary programmes should be implemented to 
protect female nyaope injectors from contracting viral hepatitis B and C. HCV, and HIV 
are major health threats affecting PWID in South Africa. On-going high risk practices 
are influenced by limited access to OST and needle and syringe services, as well as 
the social and structural factors affecting PWID. High coverage of OST and needle 
and syringe services can reduce the risk of HCV infection by 74% (Scheibe et al, 
2019:8).  
Hepatitis B is avoidable through vaccination, and treatment is effective in retreating 
liver infection and preventing liver cancer. There is no vaccine for Hepatitis C. Sharing 
injecting equipment may contribute to Hepatitis C infection. Injecting equipment should 







 The prevention, diagnosis & treatment of Tuberculosis (TB)  
Tuberculosis (TB) remains an enormous public health concern globally. South Africa 
is ranked among the top 10 high TB burden countries with the highest absolute burden 
of TB, and the second highest rate of TB incidence, respectively. TB is one of the top 
10 causes of death worldwide, and has been the leading cause of death from a single 
infectious agent for the past 5 years, surpassing even that of HIV/AIDS. South Africa 
had the highest number of HIV-associated TB cases worldwide in 2017, with 59,9% of 
incident TB cases coinfected with HIV. HIV-positive TB mortality accounted for 71,8% 
of deaths among TB patients (Padayatchi, Daftary, Naidu, Naidoo and Pai, 2019:2 
&Mekebeb, Von Pressentin and Jenkins, 2019:1-2). 
There is increasing scientific data linking HIV, injecting drugs and multidrug resistant 
TB (MDR-TB), mostly in Eastern Europe. PWID diagnosed with MDR-TB, and in 
specifically HIV-associated MDR-TB, have poor treatment outcomes and high death 
rates. 
All female nyaope injectors who are living with HIV should be screened frequently. 
WHO four-symptom TB screening algorithm should be utilised. This screening helps 
establish suitability for treatment of latent TB infection. Programmes aimed at people 
who inject drugs can offer doorways to early TB detection and timely prevention and 
treatment of both TB and HIV (UNODC, 2017:86-90). Tuberculosis is curable and can 
be prevented, therefore all female nyaope injectors should be encouraged to be 
screened and take their treatment.  
 The distribution of naloxone for prevention and treatment of opioid 
overdose within the community  
With an increasing global problem of opioid use and dependence, the mortality rate 
from opioid overdose continues to rise; there are more than 100,000 deaths globally 
per annum. Heroin is the most common drug involved in opioid overdose in much of 
the world. Naloxone is a well-established essential medicine for the treatment of life-
threatening heroin/opioid overdose in emergency medicine. Naloxone administration 
reverses heroin/opioid overdose within minutes with rapid re-establishment of 
independent breathing and return of consciousness (Strang, McDonald, Campbell, 






Naloxone should be readily accessible as part of harm reduction services overdose 
prevention programme. The accessibility to naloxone must concentrate on: 
• Training and capacitation of community members on administration of 
naloxone. The training should be prioritised. Once community members are 
trained on the administration of naloxone, naloxone should be readily available 
in the communities, so as to enable the community to assist in reducing 
overdose when need arise.  
• Community health workers, emergency services, police and general health 
care practitioners should be equipped to administer naloxone. This is because 
they are usually the first respondents in health related fatalities.  
• Increased access through commercial points of sale, for example community 
pharmacy and medical general practitioners, will enable easy accessible to 
naloxone as over the counter medication (UNODC, 2017:91-93). 
 Implementation of psychosocial services  
The HIV care services and harm reduction sites must make provision for early 
detection and management of mental health challenges amongst female nyaope 
injectors. It is imperative that service providers should be aware of self-stigma which 
may contribute to social withdrawal, a poor sense of self-worth and an unwillingness 
to admit or adhere to treatment or other health and social services (UNODC, 2017:93). 
2.7.2 Additional services to strengthen components of comprehensive Harm 
reduction package for female nyaope injectors  
In addition to harm reduction interventions discussed in 2.7.1 from (UNODC, 2017:62-
93), services purposed to address the needs of female nyaope injectors will be 
discussed in detail. 
 The provision of reproductive and sexual health needs 
People who work with female nyaope injectors need to be knowledgeable about sexual 
and reproductive health needs of female nyaope injectors. Sexual and reproductive 
health needs of female nyaope injectors should be; pre-conception support, access to 
contraception, prevention of mother to child transmission, sexual transmitted infection 






reduction services and vice versa. Female nyaope injectors are also likely to profit 
from relaxed and reliable and discreet family planning services. This should include 
pregnancy tests, counselling support and termination services (UNODC, 2016:31). 
 Prenatal and postnatal care  
Harm reduction programme staff must provide support when they coach female 
nyaope injectors about the potential need for prenatal care and provide them with 
home pregnancy test kits if possible. It is common for female nyaope injectors to have 
abnormal periods. Female nyaope injectors may not be aware that they are heavily-
pregnant until late into their second or even third trimester. Female nyaope injectors 
should be empowered with accurate information pertaining to the risk and harms to 
pregnancies associated with continued drug use. This will improve their ability to take 
appropriate decisions. The staff should exhibit a non-judgmental attitude at all times 
to female nyaope injectors (UNODC, 2016:31-33). 
 Provision of gender-based violence and related services 
Female nyaope injectors are highly vulnerable to gender-based violence. Gender-
based violence refers to physical, mental, emotional and other forms of abuse and 
harassment. The harm reduction services should assist to identify and respond to 
Gender-based violence by providing direct support to female nyaope injectors 
(UNODC, 2016:33-34). 
 Services tailored for PWID who are engaged in sex work  
Female nyaope injectors that practice sex work are best aided when harm reduction 
and sex worker services are diligently connected. Services may be provided through 
referral or by offering them on-site. Such services can be provided at harm reduction 
service site, at sex worker project sites or through outreach. Harm reduction personnel 
should be fully supportive and recognise that sex work is a genuine profession and 
that it is not their role to critic the correctness of a client’s career choice. Information 
on safety intervention to avoid violence for sex workers is important and highly 






 Provision of parenting supports  
Most female nyaope injectors experience stigmatisation and marginalisation from their 
close and extended families as well as their communities. Female nyaope injectors 
might not have access to extended family networks where parenting skills can be 
learnt or where they can be supported. Issues concerning child custody, the law, and 
domestic violence might be more important for them. Harm reduction services can play 
an important role in assisting female nyaope injectors overcome many of these 
challenges. Female nyaope injectors who have limited family support may need 
additional aided referral to other groups or agencies (UNODC, 2016:35). 
 The benefits of child-care  
The provision of elementary child-care services is important in improving service 
access for female nyaope injectors who have main responsibilities for caring for young 
children. Trustworthy child-care can be useful in allowing female nyaope injectors to 
effectively utilise HIV Counselling and Testing (HCT) and other counselling and testing 
services. The Harm reduction services and community-based organisations can 
further support female nyaope injectors’ child-care needs by encouraging substance 
abuse service providers to offer ongoing child care and education at the site for the 
duration of the individual’s stay (UNODC, 2016:35). 
 Provision of couples counselling  
Couples counselling may capacitate female nyaope injectors to implement and follow 
safer-injecting and safer-sex practices. Couple counselling can also be directed to 
addressing tensions and imbalances in relationships. This will further assist female 
nyaope injectors to access harm reduction services if their intimate partner refuses 
them to participate (UNODC, 2016:36). 
 Legal aid services (relevant to female injector needs) 
The harm reduction services offer referrals to reliable and quality legal services.  
The legal support is provided by organisations, groups and individual persons who 
specialise in issues that have direct bearing on female nyaope injectors. 
The services should be integrated into a harm reduction site of service provision 






specific issues related to female nyaope injectors and females living with HIV 
(UNODC, 2016:36). 
 Provision of ancillary services and commodities 
Some ancillary services have been revealed to build conducive relationship between 
harm reduction services and female nyaope injectors. It is highly impossible for harm 
reduction programme to address all needs directly. It can still provide female nyaope 
injectors with reasonable options by establishing links with service providers which 
can assist with provisions of ancillary and commodities services.  
The following are among various commodities and ancillary services which can pull 
females to harm reduction services: 
• toiletries; 
• free washing facilities; 
• food parcels; 
• pregnancy test kits; 
• condoms (male and female); and 
• child-care necessities (UNODC, 2016:36-37). 
 Income generating strategies for female nyaope injectors 
Income-generating strategies can help female nyaope injectors achieve some degree 
of financial independence. Strategies in this area might focus on skill development, 
microfinance and access to employment, among other things (UNODC, 2016:37). 
2.8 Harm reduction services in South Africa 
In South Africa, programmes that integrate substance use and HIV prevention services 
for people who inject drugs are almost non-existence and are mainly offered by non-
profit organisation. Subsidised substance abuse treatment services are almost wholly 
for abstinence-based programmes (Scheibe et al, 2017:2). 
2.9 Theoretical framework 
The study will used the Social Ecological Model and Health Belief Mode. The models 
were used as a guide to understand experiences of female nyaope injectors. The 






female nyaope injectors’ health and wellbeing. The Health Belief Model focus on 
explaining and predicting the attitudes and beliefs of female nyaope injectors.  
2.9.1 Social Ecological Model 
Social Ecological Models classifies individuals as rooted within bigger social systems 
and gives detailed accounts of the interactive characteristics of individuals and 
environments that influence health outcomes. Social Ecological Models views that 
multiple levels of influence that exist on female nyaope injectors. It focuses on the 
social, physical, and cultural facets of an environment that have a collective effect on 
health. The environment itself is multi-layered, institutions and neighbourhoods are 
rooted in larger social and economic structures. Establishing sustainable health 
improvements, therefore, is most effective when all of these factors are targeted 
concurrently (Golden and Earp, 2012:364). 
The Social Ecological Model offers a holistic approach to understanding health-based 
choices and influences. It foscuses on in-depth examination of personal qualities and 
environmental situations that affect health and wellbeing of female nyaope injectors 
(Dunn, Kalich, Henning& Fedrizzi, 2015:7). The Social Ecological Model describes 
individuals’ behaviours using five concepts, namely; intrapersonal, 
networks/interpersonal, community, organisation and public policy (Baral, Logie, 
Grosso, Wirtz and Beyrer, 2013:2 & Kumar, Quinn, Kim, Musa, Hilyard and Freimuth. 
2012:1). Female nyaope injectors do not act in isolation; they are influenced by 
different factors. It is important to understand the way female nyaope injectors interact 
with their communities and environments in order to determine why they do what they 
do. 
 Intrapersonal factors 
The attitude and beliefs are the usual variables measured for the intrapersonal level 
of influence (Kumar et al, 2012:3). Intrapersonal factors are behavioural or biological 
features linked with susceptibility to acquire or transmit illness or infection (Baral et al, 
2013:2). These features have the ability to influence how female nyaope injectors 
behave. Age, education level, sexual orientation and economic status are some of the 






contribute to female nyaope injectors entering into sex work. This may increase the 
risk of contracting HIV (El-Bassel and Strathdee, 2016:6).  
The interpersonal factor will be expanded further by utilising health belief model in 
Section 2.9.2 Health belief model which attempts to explain and predict health 
behaviours by focusing on the attitudes and beliefs of female nyaope injectors.  
 Interpersonal factors 
The interpersonal level indicates social influence from significant others. The 
relationships and social networks that female nyaope injectors take part in have great 
potential to influence their behaviour. Families and friends are important influencers at 
the interpersonal stage of the model. Interactions with other people can offer social 
support or create obstacles to interpersonal growth that encourages healthy 
behaviour. Sexual networks are included in interpersonal relationships and have a 
direct impact on health and health behaviours in multiple ways (Baral et al, 2013:2). 
Interpersonal relationships have important influences on health behaviours, including 
consulting a healthcare provider or accessing substance use programme. Female 
nyaope injectors who believe that family and friends do not want them to access 
substance use programme or harm reduction services are unlikely to access such 
services (Kumar et al, 2012:3).  
Female nyaope injectors may be left out from family support structures. Those who 
lack financially, or have less prospects of employment opportunities, may be more 
likely to participate in sex work, which increases their HIV risk and attracts further 
stigma linked with sex work (Larney et al, 2015:7). Female nyaope injecting practice 
attracts extensive levels of stigmatisation. People who use drugs may experience 
denunciation by their families and communities, as well as discrimination in a variety 
of settings, including health care settings. Social exclusion, stigmatisation, and 
discrimination increases HIV risk and dents HIV prevention and treatment (Larney et 
al, 2015:6).  
 Community environments 
Community atmospheres may also encourage health and welfare. It can also be a 
foundation of stigmatisation for female nyaope injectors. The description of who or 






associations between organisations and group, and geographical regions (Baral et al, 
2013:3). Formal or informal social standards that occurs among individuals, groups, 
or organisations, can reduce or strengthen healthy behaviours. Female nyaope 
injectors are stigmatised worse than their male counterparts. This is influence by 
cultural stereotypes that hold females to higher expectations and roles (El-Bassel and 
Strathdee, 2016:5).  
Drug use by female nyaope injectors is perceived as infringing their traditional role in 
society as mothers and caretakers. Increased stigmatisation is also linked with 
homelessness of females who use drugs, which results in them to staying extremely 
deep-rooted within drug using networks and spend less of their time with people who 
do not use drugs (UNODC, 2018:20).  
 Institutions/Organisations 
Institutions include healthcare organisations, stretching from primary care physicians 
to community health centres. It offer female nyaope injectors substance related and 
harm reduction services. (Kumar et al, 2012:3). Institutions are influential in the 
development of behaviour as they often impose behaviour-determining guidelines and 
boundaries. The organisation have rules, regulations, policies, and informal structures 
that constrain or promote accessibility of services (Baral et al, 2013:2). The study has 
explored the role of health workers in creating barriers for female nyaope injectors not 
to access health services at community health centres.  
 Policy and laws 
Policies and laws are initiated at local, national and international levels. They makes 
up the widest level of the Social Ecological Model. The policies have the prospects to 
influence large numbers of female nyaope injectors. The policies implemented either 
promote or demote the community’s ability to provide preventive or harm reduction 
services. Laws make certain practices illegal or legal (Baral et al, 201:3). In this study, 
the researcher has looked into the conduct of the law enforcers in relation to the role 
they play in facilitating the high risk behaviour amongst female nyaope injectors.  
Nyaope was declared an illegal drug when the amendments (amendment of schedule 
1 and 2) to the Drug Trafficking Act of 1992 (Act 140/1992) were signed in 2014 






nyaope will be arrested. According to El-Bassel and Strathdee (2016:6) female nyaope 
injectors maybe be oppressed by police officers as justification for using drugs. Hostile 
policing includes arresting females for buying or carrying sterile syringes, harassment 
at needle exchange programs or drug treatment clinics, asking bribes to avoid arrest, 
sexual abuse and violence, or planting drugs on females. Studies of females 
worldwide have found a strong link between substance use and police sexual 
misconduct, coercion, or rape. Female nyaope injectors fail to report police abuses 
due to fears of imprisonment or other retaliatory consequences for themselves and 
their families. This study viewed the conduct of law enforcement officers when dealing 
with female nyaope injectors.  
2.9.2 Health Belief Model 
The Health Belief Model is one of the most effective health behaviour-change models 
that contains of six constructs: 
• perceived susceptibility; 
• severity; 
• benefits; 
• barriers,  
• cues to action; and  
• self-efficacy. 
These constructs predict why female nyaope injectors may or may not accept 
precautionary measures against the disease of interest (Kaba et al, 2017:797). 
Motivating people to avoid a negative health consequence is a key element. 
Perceived susceptibility is the individual’s awareness of the chance of contracting a 
health condition (Tarkang and Zotor, 2015:5). It is about contracting HIV through 
sharing injections, transactional sex and unprotected sex. The researcher explored 
why female nyaope injectors overlook the risk of contracting HIV when they share their 
needles, have unprotected sex, and engage in transactional sex. Essentially, whether 
female nyaope injectors see themselves as susceptible to contract HIV and other 






Perceived severity speaks to one’s belief of how serious contracting a health condition 
and its consequences are. The researcher explored how female nyaope injectors 
perceive the gravity of contracting HIV and its consequences on their lives (Tarkang 
and Zotor, 2015:5).  
Perceived benefits is about ones conviction to implement effective strategies to reduce 
the risk of contracting HIV or other blood-borne infections (Tarkang and Zotor, 2015:5). 
The researcher explored if the female nyaope injectors believe that there are benefits 
when they practice safer behavior. The safer behavior can be ensured by using a 
sterile needle every time they inject drugs, and using condoms consistently every time 
they engage in sex. It is within themselves to develop the strategies which will reduce 
risks of contracting health conditions.  
Female nyaope injectors should acknowledge that there are perceived barriers. 
Perceived barriers affect people’s decisions to take a particular action. The barriers 
might be societal or structural (Tarkang and Zotor, 2015:5). 
Female nyaope injectors should acknowledge that they have the ability to deal with 
the obstacles, and that they are able to take necessary actions to reduce the risk of 
contracting infections, despite challenges they encounter.  
Cues to action are experiences that inspire a person to take action. Self-efficacy refers 
to an individual’s self-belief in their aptitude to produce required behavioural change 
(Tarkang and Zotor, 2015:5). Female nyaope injectors should believe in themselves, 







3. CHAPTER THREE 
Research Design and Methodology 
3.1 Introduction 
This section will describe research method, research design, population and sample, 
data collection, data analysis, ethical considerations and actions used in the study. 
3.2 Research approach 
A qualitative research approach was utilised in this study. The aim of the study was to 
explore the experiences of female nyaope injectors. A qualitative research method 
was the most appropriate research paradigm. Qualitative approach methods permit 
the researcher to study designated issues authentically and in detail as they classify 
and try to understand the groups of information that arises from data (Blanche et al 
2006:46). Qualitative research emphases on describing and understanding the 
phenomenon rather than explanation or predicting female nyaope injectors’ behaviour 
(De Vos, 2011:64 & Babbie, 2012:53). It was considered appropriate because it 
affords the researcher an opportunity to explore the experiences of female nyaope 
injectors. Qualitative research attempts to view the experiences of female nyaope 
injectors through their own perspective (Babbie, 2012:271).  
3.2.1 Characteristics of qualitative research  
 Natural settings 
Qualitative researchers gather data in the field and site where participants lives. The 
participants are not carried into a laboratory, nor do researchers send questionnaires 
out for participants to complete. The interviews are conducted by means of face-to-
face communication. The researcher held the interviews at the Community Oriented 
Substance Use Programme (COSUP), where the participants are accessing 
substance abuse related services.  
 Researcher as key instrument 
Qualitative researchers gather data themselves by means of inspecting documents, 
observing behaviour or interviewing participants. In this study, the researcher only 






 Multiple sources of data 
Qualitative researchers collect numerous forms of data, such as interviews, 
observations, documents, and audio-visual information, without relying on a single 
data source. The researcher conducted interviews with 15 females who are current 
injectors and nine who were recovering from injecting nyaope.  
 Inductive and deductive analysis 
Qualitative researchers shape their designs, categories and themes from the bottom 
up by arranging the data into gradually more abstract units of information. Qualitative 
researchers keep an emphasis on learning the meanings as articulated by the 
participants, not the meaning the researcher brings to the research or expressed by 
literature.  
 Emergent design 
The course for qualitative research is developing. This means the beginning phase of 
the research process cannot be forcefully set. Some or all phases of the process may 
change after the researcher enters the field.  
 Reflexivity 
Qualitative researchers mirror on how their part in the study and their personal 
background, culture, and experience could possibly for shaping their interpretations. 
For example, the themes they advance and the meaning they subscribe to data. This 
will be discussed more in Section 3.9. 
 Holistic account 
Qualitative researchers attempt to establish multifaceted pictures of the problem or 
issue under study (Cresswell, 2014:186).  
3.3 Research design 
Kumar (2014:122) states that research design is a blueprint, arrangement and plan of 
enquiry so considered as to find answers to a research question or problem. In this 






“Exploratory research is implemented in order to gain awareness into a situation, 
phenomenon, community or individual” (De Vos et al, 2011:95). Kumar (2014:370) 
states that exploratory research is implemented when the objective of the study is to 
explore an area where little is known. The experiences of female nyaope injectors 
residing in City of Tshwane Municipality, Gauteng, will be explored in order to gain 
insight into the phenomenon in study. 
Descriptive research was also used in this study. According to De Vos et al (2011:97), 
descriptive research denotes to more rigorous examination of the phenomenon and 
their deeper meanings, as a result, leading to thicker description.  
3.4 Research methods 
3.4.1 Population 
Population is described as the entire quantity of cases to be studied (Walliman, 
2016:110). The population in this study were females, between the ages of 19–35 who 
reside in City of Tshwane Municipality, and have a history of injecting nyaope. 
3.4.2 Sampling 
Due to restricted time, money and human resources, a research sample was drawn 
from females with a history of injecting nyaope between the ages of 19–35 who reside 
in City of Tshwane Municipality. 
Sampling is described as the course of choosing a few representations from the 
population to become the basis for approximating or predicting the prevalence of an 
unknown piece of information, situation or outcome regarding the bigger group of 
female with history of injecting nyaope. A sample is a subgroup of the population the 
researcher is interested in (Kumar, 2011:229-230). The research sample was 15 
females who are currently injecting nyaope and nine females with a history of injecting 
nyaope who were between the ages of 19–35 and resided in City of Tshwane 
Municipality. The total participants which the researcher interviewed were 24. 
The researcher used purposive sampling in this study. Purposive sample is chosen 
based on what the researcher knows about the population and the aim of the study. 
The researcher exercises judgment or knowledge of a population, and the aims of the 






During recruitment, the researcher was guided by inclusion and exclusion criteria 
when selecting the research participants. The researcher considered recovering 
female nyaope injectors and current female nyaope injectors in this study. The 
researcher initially targeted current female nyaope injectors but included the 
recovering female nyaope injectors to balance the sample and to maintain high 
credibility of the results. 









1 Unemployed 23 Black 7 years Currently injecting 
2 Unemployed 32 Coloured 4 years Currently injecting 
3 Unemployed 34 Black 5 years Currently injecting 
4 Unemployed 22 Black 4 years Currently injecting 
5 Unemployed 31 Black 5 years Currently injecting 
6 Unemployed 27 Black 6 years Currently injecting 
7 Unemployed 24 Black 8 years Currently injecting 
8 Unemployed 35 Black 13 years Currently injecting 
9 Unemployed 31 Black 11 years Currently injecting 
10 Unemployed 32 Black 12 years Currently injecting 
11 Unemployed 35 Coloured 9 years Currently injecting 
12 Unemployed 32 Coloured 4 years  Currently injecting 
13 Unemployed 28 Coloured 1 year  Currently injecting 
14 Unemployed 23 Black 4 years Currently injecting 
15 Unemployed 27 Black 9 years Currently injecting 
16 Unemployed 31 Black 6 years 5 Months 
17 Unemployed 27 Black 10 years  1 year eight months 
18 Unemployed 32 Black 6 Years  8 Months 
19 Unemployed 30 Black 9 Years 4 Months 
20 Unemployed 35 Black 16 Years 5 Months 
21 Unemployed 26 Black 6 Years 6 Years 
22 Unemployed 32 Black 15 Years 9 Months 
23 Unemployed 31 Black 12 Years 5 Months 
24 Unemployed 29 Black 9 Years 11 Months 
 
Twenty-four research participants were considered for this study. All participants were 
active beneficiaries of COSUP, and they were recruited when they came to access 
their weekly services at different COSUP sites. The participants were prepared prior 
about possible inclusion into the study by their site social workers before the 
researcher recruited them for the study. Risks, benefits and their rights were discussed 
at length with the participants in the presence of a site social worker before they 






 Inclusion criteria 
3.4.2.1.1 Recovering female nyaope injectors. 
Recovering female nyaope injectors are females with a history of injecting nyaope, 
who are initiated on OST for two months or more.  
• The participant should be a female who has a history of injecting nyaope and 
has stopped injecting.  
• The participant should reside in City of Tshwane Municipality.  
• The participant must be in between the ages of 19–35 years.  
• The participant must be linked to an organisation.  
3.4.2.1.2 Current female nyaope injectors. 
Females who are currently injecting nyaope are those with history of injecting nyaope, 
who have not received medical treatment or been admitted at an inpatient treatment 
center, but are undergoing the process to be on treatment or to be referred to an 
inpatient treatment center. 
• The participant must be a female who has history of injecting nyaope. 
• The patient must reside in City of Tshwane Municipality.  
• The participant must be between the ages of 19–35 years.  
• The participants must be linked to an organisation.  
 Exclusion criteria  
3.4.2.2.1 Recovering female nyaope injectors. 
Recovering female nyaope injectors are females with a history of injecting nyaope, 
who are OST for more two months or more.  
• All male nyaope injectors are excluded from the study. 
• A participant who does not have a history of injecting nyaope. 
• Participants who have relapsed. 
• Participants who reside outside City of Tshwane Municipality.  
• Participant who are younger than 19 years or older than 35 years of age. 






3.4.2.2.2 Current female nyaope injectors 
Females who are currently injecting nyaope are females with history of injecting 
nyaope who have not received medical treatment or been admitted at an inpatient 
treatment center, but are undergoing the process to be on treatment or to be referred 
to an inpatient treatment center. 
• All male participants are excluded. 
• Females who does not inject nyaope.  
• Participants who reside outside City of Tshwane Municipality.  
• Participant who are younger than 19 years or older than 35 years of age. 
• Participant who are not linked to an organisation. 
• All participants who are under the influence of a substance during the time of 
the interview.  
3.5 Data collection process 
Bickman & Rog (2009:27) highlighted five issues which the researcher considered in 
planning for primary data collection: (1) site selection, (2) authorisation, (3) the data 
collection process, (4) accessibility and (5) other support needed.  
The researcher requested permission to conduct research at COSUP. COSUP was 
more suitable as it is a harm reduction based organisation and runs OST and NSPs 
across the City of Tshwane Municipality. 
After permission was granted to conduct the research within COSUP sites, the 
researcher liaised with COSUP Social Work Manager to facilitate entry at all COSUP 
Sites, namely; (1) Sunnyside, (2) Daspoort Poli Clinic, (3) Mamelodi Regional Hospital, 
(4) Eersterust Community Health Centre, (5) Laudium Community Health Centre, (6) 
Tshwane District Hospital, (7) Olievenhoutbosch Ext 23, (8) Sediba Hope Bosman, (9) 
AttMed Attridgeville, (10) Soshanguve Block V, (11) Block K, (12) M17, and (13) 
Reliable House Hatfield.  
The researcher telephonically contacted the social workers at the thirteen COSUP 
sites. The social workers agreed to inform potential participants about the study, 
therefore, the researcher shared informed consent for participants in the study with 






The researcher negotiated dates with the social workers for collection of data. The 
social workers gave the researcher days which the participants were coming for their 
weekly services.  
The researcher was able to interview 24 research participants, and data reached 
saturation point. As mentioned, nine recovered injectors and 15 current injectors were 
interviewed.  
Table 2: List of COSUP sites where data was collected and how many participants 
were interviewed 
COSUP Site Recovered injectors Current injectors 
Soshanguve Block H 2 0 
Soshanguve Block V 2 0 
Sediba Hope Bosman 0 6 
AttMed Attridgeville 1 4 
SunnySide  0 1 
Eersterust Community Health 
Centre 
0 4 
Mamelodi Regional Hospital 4 0 
 
The researcher did not collect data at Daspoort Poli Clinic, Laudium Community Health 
Centre, Tshwane District Hospital, Olievenhoutbosch Ext 23, Sediba Hope Bosman, 
Soshanguve M17 and Reliable House Hatfield. The researcher communicated with 
the social workers about reaching data saturation and apologised for the 
inconvenience.  
The interviews were conducted at COSUP site offices with strict supervision from a 
site social worker who set in during the data collection session. The participants 
consented to their site social worker sitting in during interview process.  
The researcher used purposive sampling in order to select participants from those 
identified at COSUP. The researcher was recruiting participants individually as they 
were coming at COSUP. The researcher gathered data from the 24 participants by 
means of semi-structured interviews. An interview is described as a verbal 






gain an understanding of another person (the interviewee). The interview is an 
effective tool for bringing about rich data on people’s views, attitudes and the 
meanings that support their lives and behaviour (Gray, 2014:382).  
The researcher used in depth, semi-structured interviews as a data gathering method. 
The in-depth interview is steered through the aid of an interview guide. An interview 
guide is a written list of questions and topics that need to be addressed in a particular 
order, but are open ended questions (Bernard, 2013:82-83). The in-depth interview 
permits for probing of views and opinions where it is required for respondents to 
expand on their answers (Gray, 2014:385-386). A semi-structured interview is 
regarded as an effective tool as far as interviewing is concerned. According to Thomas 
(2017:206), it offers a structure of a list of issues to be covered together with the 
freedom to follow up points as necessary. All the interview were audio recorded and 
the interviews were kept safe as to protect the information to maintain confidentiality.  
The researcher used qualitative observation. Qualitative observation involves taking 
field notes on the behaviour and non-verbal communication of the participants 
(Creswell, 2014:191).  
The researcher had initially planned to interview 15 recovering female nyaope injectors 
and 15 current female nyaope injectors, however, 15 current female nyaope injectors 
and nine recovered female nyaope injectors were interviewed as mentioned. The 
reason the researcher did not interview 15 recovering female nyaope injectors was 
due to data saturation. Kumar (2011:398) denotes that data saturation is the phase in 
data collection where a researcher is determining very little or no new information from 
the research participants. The research reached data saturation after the researcher 
interviewed 24 research participants and then researcher stopped. Saturation was 
reached after 19th interview, but the researcher continued until the 24th interview.  
There were a few challenges that were experienced during data collection. One 
participant requested money in order to participate in the study. She indicated that she 
did not have money for drugs and she must go look for money and participating in the 
study will waste her time, the researcher did not give her money and she left. Two 
participants were intoxicated during data collection, as a results, they were not 






The data collection period started on the 1st of July 2019 and came to completion on 
the 26 July 2019. The researcher interviewed the participants at an environment they 
were familiar with, and in the presence of their social worker. This was done to assist 
the participant be at ease since the researcher was a male interviewing vulnerable 
females. The researcher gave the participants an option to choose a language suitable 
to them. The participants chose English and Sotho/Sepetori.  
Establishing a conducive environment was imperative for the researcher before data 
collection. The provision of pre-counselling enabled the researcher to establish a 
rapport before collecting data. All the interviews were audio recorded and transcribed 
for data analysis 
The researcher collected data using Kvale’s interviewing guidelines: 
• Introduction questions 
The interview primarily centred around the experiences of female nyaope injectors. 
The experiences were explored with guidance by the theoretical framework. 
Constructs of the Social Ecological Model and Health Belief Models were used to 
explore the experiences of female nyaope injectors. The researcher used the semi-
structured interview guide to conduct the research (Berry,1999 & Krave 1994). 
• Follow-up questions 
The interview process started with questions aimed at exploring the factors 
contributing to female nyaope injecting, followed by exploring the experiences of 
female nyaope injectors and ways in which HIV can be curbed amongst them 
(Berry,1999 & Krave 1994). 
• Probing questions 
Using open-ended and probing questions, the researcher was able get the participants 
to elaborate more of their lived experiences and enable them not to answer ‘yes and 
no’. The researcher observed body language and recorded accordingly. This 







• Specifying questions and direct questions 
The researcher was guided by the interview guide; the questions the researcher asked 
were specific as per the interview guide. The researcher allowed flexibility and did not 
ask the questions as they appear on the interview guide (Berry,1999 & Krave 1994).  
• Indirect questions 
The researcher used indirect questions as they often take an open-ended form with 
the intention to open up the opportunity for the interviewees to elaborate on things that 
they see as important and meaningful to their life (Berry,1999 & Krave 1994).  
• Structuring questions 
The researcher used structuring questions. Structuring questions refer to the use of 
key questions to finish off one part of the interview after exhausting it and opening up 
another. For example, after exhausting “What influenced you to inject nyaope” the 
researcher introduced “How did your family react after they discovered you are 
injecting nyaope”. This enabled the researcher to ask all important questions and not 
to ask irrelevant questions (Berry,1999 & Krave 1994). 
• Silence 
The researcher was attentive to the research participant and was willing to tolerate 
silence when it happened. Silence allows pauses in the interview which can offer the 
interviewee ample time to reflect, gather their thoughts and energy for more disclosure. 
Throughout the interview process the, researcher carefully and attentively listened 
without interruption, allowing participants to express themselves freely (Berry,1999 & 
Krave 1994).  
• Interpreting questions 
The researcher used interpretation during data collection. Interpreting questions is 
similar to some forms of probing questions, to rephrase an interviewee’s answer in 
order to clarify and interpret rather than to explore new information. This line of 
questioning allowed the researcher to assist the participants explore more, especially 
when participants were asked about their risky behaviour as a result to nyaope 






• Throw away questions 
The researcher used throw away questions. Throw away questions serve different 
purposes, including to maintain conducive relationship, to assist with making the 
participants calm whenever the questions are sensitive. The study was sensitive, it 
was exploring the lived experience of female nyaope injectors (Berry,1999 & Krave 
1994).  
3.6 Data analysis 
Data analysis is the process of organising, structuring and giving meaning to bulk of 
collected data (De Vos, 2011:397). Data analysis consist of “reading through your data 
repeatedly and engaging in activities of breaking the data down (thematising and 
categorising) and building it up again in one novel way (elaborative and interpreting)” 
(Blanche et al, 2006:322). 
The researcher used six phases as identified by Braun and Clarks (2006) in Jensen 
and Laurie (2016:609-610) to analyse data.  
• Phase 1: The researcher acquainted himself with the data;  
 
All 24 audio interviews were transcribed, after transcribing, the researcher read 
through the transcripts to familiarised himself with the content of the transcripts. The 
process of transcribing started immediately after the first interview was conducted; the 
researcher did not wait until 24 interview were conducted before transcribing.  
 
• Phase 2: The researcher generated initial codes;  
 
The researcher started to generate initial codes. The researcher read through the 
transcript one-by-one, critically identifying initial codes. The transcripts were coded 
whilst the researcher was listening to the recording. This allowed the researcher to 
code many codes which had a potential to form different themes.  
 
• Phase 3: The researcher searched for themes; 
 
The researcher started organising codes linked to each other into potential themes 







• Phase 4: The researcher reviewed themes;  
 
The researcher reviewed and polished all the themes. Sub-themes were created to 
accommodate themes which are in alignment.  
 
• Phase 5: The researcher defined and named the themes; and  
 
This phase started when the researcher was satisfied with the themes and sub-themes 
identified. It was identified what each theme is about and what aspect of data each 
theme captures. 
 
• Phase 6: The researcher produced the report.  
 
The researcher started writing up the thematic analysis to be included in chapter four 
of the dissertation. The researcher strived to provide a concise, coherent, logical, non-
repetitive, and interesting account of the experiences of female nyaope injectors. The 
analysis went beyond description of data and was linked to the research questions.  
3.7 Ethical consideration 
Social researchers abide to ethical and professional responsibilities in order to conduct 
themselves in a principled manner (Neuman, 2014:69). According to De Vos et al 
(2011:115), ethics are described as a set of virtuous principles and values. The ethical 
procedures serve as principles which the researcher ought to assess their conduct. 
3.7.1 Voluntary participation 
According to Babbie (2012: 520), social research represents a meddling into people's 
lives, and it disrupts the subject’s steady activities. Researchers should acknowledge 
the intrusion, and provide all participants with an opportunity to be fully briefed of the 
study so that they can consent voluntarily knowing what the study entails. According 
to De Vos et al (2011:116), participation should at all times be voluntary; no one was 
forced to participate in the research project. The purpose of the research was been 
explained and all participants were allowed an opportunity to accept or decline 






participate in the research study. One participant did not want to participate and the 
researcher respected her decision.  
The researcher distributed consent forms to all participants. The consent forms were 
written in easy English, free of vocabularies, jargons, and legalese so that the 
participants can comprehend what was written before they consent to participate.  
3.7.2 Prevention of harm to the participants 
The social research should, under no circumstances, harm the research participants 
being studied; irrespective of whether they are volunteering for the study or not 
(Babbie, 2012:522). De Vos et al (2011:115) denotes that no harm to the participants 
is an important ethical rule. 
The study concentrated on personal experiences of female nyaope injectors, which 
increased the sensitivity of the study. There was no likelihood of physical harm that 
could occur to the participants as a direct result of the study. However, the sensitivity 
of the study on the emotional state of participants was foreseeable and recognised. 
The researcher prepared to mitigate the emotional harm by conducting pre-counselling 
with all participants before data was collected to minimise psychological harm. The 
fact that participants willingly consented to be interviewed minimised the probability of 
psychological harm. The researcher used social work counselling rooms to conduct 
the interviews. A debriefing interview followed up after completion of data collection 
session and participants who consented were referred to a site social worker for further 
intervention.  
3.7.3 Anonymity and confidentiality  
Protection of participant’s interest, welfare, and the protection of their identity is key in 
social research. A response may be regarded as unidentified when the researcher 
cannot identify a given respondent (Babbie, 2012:523). The research participants were 
provided with an opportunity to choose a nickname for themselves to protect their 
identity. The researcher also assigned participants numbers to the participants. All 
information regarding their address, and contact number has been safely stored. The 
data which was collected by the researcher is protected, only the researcher and 






3.7.4 Deceiving participants 
Deception is described as misleading participants, purposely misrepresenting facts 
and concealing information from the participants (De Vos et al, 2011:119). The 
researcher informed the participants that the study is for MA Social Behavioural 
Studies at UNISA. The researcher did not deceive the participants in any way or the 
other. The consent form provided all the information needed.  
3.7.5 Debriefing of participants 
Debriefings are psychosocial sessions in which participants have an opportunity, after 
the study, to work through their experiences and its aftermath in order to get their 
question answered and remove misconception (Babbie, 2012:123). The researcher 
afforded research participants opportunity to ask any questions they might have had 
after collection of data. The participants who consented for referral were referred to 
their site social workers for further counselling. 
3.8 Measures to ensure trustworthiness  
Polit & Beck (2011:584) denotes that the standard of respectable qualitative research 
is based on trustworthiness. The trustworthiness is discussed in details using five 
construct namely; credibility, transferability, dependability and confirm ability and 
authenticity. 
3.8.1 Credibility 
According to Kumar (2014:219), credibility contains confirming that the results of 
qualitative research are credible or authentic from the perspective of the participants 
in the research. The findings must reflect the experiences of females who are injecting 
nyaope and females who have recovered from injecting nyaope. This qualitative 
research has explored the experiences female nyaope injectors who reside in City of 
Tshwane in order to come up with the possible solutions. The researcher enhanced 
credibility by: 
• Building rapport with the participants: Pre-counselling was conducted with 
research participants before data collection in order to build rapport.  
• Transcript verification: Transcripts were taken to the participants to allow them to 






Sepedi (Sepitori) then translated to English. Transcripts were taken back so that 
the participants can establish if the interview transcript did not lose meaning during 
translation process.  
• Two participants who were under the influence of the substance(s) at the time of 
the interview were not be considered. 
3.8.2 Transferability 
Transferability is described as a level to which the results of qualitative research can 
be generalised or transferred to other contexts of setting (Kumar, 2014:219). The 
researcher has interviewed multiple participants from different areas within the City of 
Tshwane Municipality. The researcher has audio taped the interview, observed and 
explored nonverbal clues during the interview. 
3.8.3 Dependability 
Dependability is described as whether the same results will be achieved if the same 
phenomenon is observed twice. Qualitative research promotes flexibility and freedom 
(Kumar, 2014:219). To improve dependability, De Vos at all (2011:421) state that the 
researcher should ask whether the research process is logical, well documented and 
audited. Due to high cost of co-coder, the researcher could not appoint an independent 
co-coder, rather the supervisor, as an experienced qualitative and mix-method 
researcher, assisted with co-coding to ensure dependability.  
3.8.4 Confirmability 
Confirmability is described as the level to which the results can be confirmed or 
corroborated by other researchers (Kumar, 2014:219). De Vos et al (2011:421) report 
that confirmability captures the traditional concept of objectivity. Conformability was 
captured by audio recording the participants which was explored by following up on 
questions, probing, and not assuming to understand what the researcher did not 
understand. 
3.8.5 Authenticity 
Authenticity is described as the extent to which researchers honestly and authentically 
show a variety of realities. Authenticity emerges in a report when it carries the feeling 






residing in City of Tshwane Municipality will not be changed, it will be taken as the real 
truth of the problem under investigation (Polit & Beck 2011:585). 
3.9 Reflexivity 
Reflexivity is described as the capacity of the researcher to stand outside the research 
process and disapprovingly reflect on the process without influencing the direction of 
the study. It entails continuous reflection about the researcher’s role, personal 
background, culture and experience, as well as the integrity of the process. (O’Leary, 
2004:11& Cresswell, 2014:186). The researcher is passionate about the field of 
substance abuse and the human rights issues affecting people who use drugs. The 
researcher approached the study open-mindedly, with the intention to learn the lived 
experiences of female nyaope injectors.  
The researcher acknowledged the potential of influencing the study, however, the 
importance of objectivity and giving the female nyaope injectors a chance to represent 
themselves in the study assisted the researcher to be reflexive through the study. The 
researcher did not collect data at his COSUP site; none of the research participants 
knew the researcher. No participant knew that the researcher was an employed social 
worker within COSUP, which had a potential to compel participants to participate in 
the study. This was achieved by asking the social workers not to disclose information 
about the researcher.  
3.10 Conclusion 
This chapter provided an overview of the research approach, research design, 
population and sample, data collection, data analysis, ethical considerations and 
measures utilised in this study. The researcher presents and discusses the findings in 







4. CHAPTER FOUR 
Findings of the Study  
4.1 Introduction 
The purpose of the research was to explore the experiences of female nyaope 
injectors residing in City of Tshwane Municipality. Furthermore, it was to gain insight 
into, and understanding factors contributing to female nyaope users injecting, as well 
as how they can be assisted to reduce the risks associated with nyaope injecting. This 
chapter discusses the findings of the research. 13 themes, 46 sub-themes, 3 
categories and 3 sub-category were identified. These will be discussed fully in 4.3.  
4.2 Profile of participants 
Interviews were held with 24 participants accessing harm reduction services at 
COSUP sites. COSUP has sites across all regions in City of Tshwane Municipality. 
The researcher recruited and interviewed participants at different COSUP sites, 
namely; Soshanguve, Pretoria CBD, Sunny Side, Mamelodi, Eersterust, and 
Attridgeville. Fifteen current injectors and nine recovered injectors were interviewed. 
Fifteen current injectors were recruited from NSP database and nine recovered 
injectors were recruited from OST database. Participants chose pseudonyms for 
themselves. For the purposes of data analysis, a participant’s number is used rather 
than the pseudonyms. The numbers were allocated without following any arrangement 
or order.  










1 Unemployed 23 Black 7 years Currently injecting 
2 Unemployed 32 Coloured 4 years Currently injecting 
3 Unemployed 34 Black 5 years Currently injecting 
4 Unemployed 22 Black 4 years Currently injecting 
5 Unemployed 31 Black 5 years Currently injecting 
6 Unemployed 27 Black 6 years Currently injecting 
7 Unemployed 24 Black 8 years Currently injecting 
8 Unemployed 35 Black 13 years Currently injecting 
9 Unemployed 31 Black 11 years Currently injecting 
10 Unemployed 32 Black 12 years Currently injecting 
11 Unemployed 35 Coloured 9 years Currently injecting 






13 Unemployed 28 Coloured 1 year  Currently injecting 
14 Unemployed 23 Black 4 years Currently injecting 
15 Unemployed 27 Black 9 years Currently injecting 
16 Unemployed 31 Black 6 years 5 Months 
17 Unemployed 27 Black 10 years  1 year eight months 
18 Unemployed 32 Black 6 Years  8 Months 
19 Unemployed 30 Black 9 Years 4 Months 
20 Unemployed 35 Black 16 Years 5 Months 
21 Unemployed 26 Black 6 Years 6 Years 
22 Unemployed 32 Black 15 Years 9 Months 
23 Unemployed 31 Black 12 Years 5 Months 
24 Unemployed 29 Black 9 Years 11 Months 
 
The participants’ ages range from 19–35 years, which positions them in their youth. 
Four coloured and 20 black females were part of the research. All participants were 
females as the research was purposed to explore the experience of female nyaope 
injector. The participants were all unemployed at the time of data collection. Majority 
of them had more than 5 years’ history of using nyaope. Those who have recovered 
had 4 months or more since they have stopped using nyaope.  
4.4 Key findings 
The following themes were generated after the process of data analysis. The themes 
are arranged as per the objectives of the study.  
4.4.1 Objective 1: Factors contributing to injecting nyaope 
This section focuses on the factors contributing to the use and injection of nyaope. 
 Factors contributing to using nyaope 
4.4.1.1.1 Intimate partner influence 
The motives and underlying reasons that drive women to drug use and addiction are 
different from those of men. While men are mainly introduced to drug use through their 
peer and friendship networks, women may start using drugs due to family matters and 
the influence of their intimate relationships (Zolala, Mahdavian, Haghdoost and 
Karamouzian, 2016:1). An intimate partner who is using drugs can be influential to 
their female partner. Female nyaope injectors reported that they were influenced by 
their boyfriends to use nyaope. One participant indicated that her partner was always 
away and he did not give her the attention she desired, which led her to using nyaope 






The participants supported the narrative when they said:  
Participant 19 “I was trying to please my boyfriend. I loved him, and I wanted him to 
spend time with me”. 
Participant 13 “I was in a relationship with someone using nyaope. I was using Cat at 
that moment; from Cat he introduced me to nyaope”. 
Participant 12 “I first started using nyaope with my boyfriend, smoking zol”. 
Intimate male partner influenced the initiation of their female partners’ smoking 
nyaope. This finding is corroborated by UNODC (2018:18) & GCWA (2011:6) arguing 
that being in an intimate relationship with a partner who also uses drugs has been 
revealed to be considerably linked with a female’s commencement into and 
continuation of drug use. Females who use drugs are probable to have had a male 
intimate partner who introduce them into drug use. They are also probable to have 
asked the male partner to inject them. This occurs in a social setting where others are 
present, and it further contributes to their high vulnerability. 
4.4.1.1.2 Peer pressure 
Peer pressure and a sense of belonging contributes to nyaope use. A yearning to test 
and to be part of a social network adds to use of nyaope (Marks, Gumede and Shelly, 
2017:5). Peer pressure was quoted as one of the sturdiest predictors of youth 
behaviour; it influences experimentation of drugs. In a study by Gauteng Department 
of Community Safety (2014), participants reported that they used nyaope to impress 
their friends to avoid being stigmatised. However, they became habitual users and 
were eventually addicted (Charlton, Negota and Mistry, 2019:45). The participants felt 
they would not be part of the social network if they did not use nyaope. Findings of this 
research study corroborates with the Department of Community Safety findings. The 
participants reported that:  
Participant 10 “Truly speaking, I was involved [in drug use] because of peer pressure, 
having friends at school who are smoking and feeling like if you do not do what they 
do, you are not cool, that is how I got hooked”. 







Participant 23 “I was with my friends, we began by smoking dagga then this other day 
our friend came with nyaope for us to try out. That is how I was introduced to nyaope”. 
Participant 8 “I was smoking dagga before I got introduced to nyaope; then I had a 
friend that was smoking nyaope; then I was introduced to nyaope and that was it”. 
There is evidence that some of the nyaope users started and consequently became 
addicted as a result of following what their peers were doing. Dintwe (2017:115) 
argues that peer pressure is the sturdiest predictor of youth behaviour with enormous 
influence on young people’s experimentation in drugs during adolescence. One of the 
reasons is that young people would want to gain admiration and honors amongst their 
peers. The desire for approval and acceptance by peers and friends can easily 
influence an individual to be pressured into doing something that he or she would not 
normally do. This need for acceptance from peers increases the likelyhood of 
engaging in risky behaviour (Jacobs and Slabbert, 2019:228).  
The Department of Basic Education should introduce life-skills programme as part of 
their Life Orientation curriculum where learners will be capacitated and empowered to 
handle peer pressure. Implementing such a programme from Grade 7 will enable the 
learners to handle peer pressure well.  
The researcher further observed that the use of dagga amongst friends raises the 
likelihood of using nyaope. Participants highlighted that they were using dagga before 
they started using nyaope; it can be assumed that if they were not smoking dagga, 
chances of using nyaope were less. 
4.4.1.1.3 Tricked by friends  
Participants indicated that they smoked nyaope without their knowledge. They were 
tricked by their friends into smoking nyaope because they assumed they were smoking 
dagga. They only knew they were smoking nyaope when they started experiencing 
withdrawal syndromes and by then it was too late. They sought-out how to get nyaope 
on their own to satisfy their withdrawals. This is supported by the following narratives: 
Participant 3 “I lived with this guy (who is my neighbour) in a two room [house]. I had 
borrowed [rented] him the other room so that when I am not there he can guard for 
me. That guy was smoking nyaope. One day told the guy to prepare the dagga since 






paying attention when he was doing it as I was busy. While he was preparing he added 
nyaope. I am used to preparing mine with a paper from yellow pages book; that guy 
was preparing it with rizla. I went to his room to smoke; I felt that this dagga is different 
from the one that I am smoking [on regular occasions] then I asked him why is dagga 
it tasted different and it made me dizzy. He said this is the one that is good. Then I 
started to like that one that he prepared instead of the one I prepare myself because 
but the other one I feel the high same time [compared to the other one which tales 
time]. By then I was not aware that it is that thing [nyaope]”. 
Participant 9 “I was associating with people who were attending school, studying 
together. We competed with one another in terms of academic performance, and I met 
a wrong turn [bad] friend. This friend was smoking and doing lot of things. They would 
give me to smoke, indicating that it is only dagga. I was surprised this other morning 
when I woke up, I started to feel stomach pains, but I did not understand until she 
came and told me to give her money so that she can buy [nyaope]. After smoking, the 
pains disappears”. 
Marks, Gumede and Shelly (2017:5) discovered in their study that some of the nyaope 
users were uninformed of what drug was being used. A fewer of the users assumed 
they were smoking dagga, when in fact they were smoking nyaope. They only became 
conscious when they started experiencing physical withdrawals after stopping their 
day-to-day use of the drug. This happened after a period of time sufficient to develop 
a physical dependence. Smoking nyaope turns into a way to cope the pain and 
discomfort of the withdrawals.  
Smoking dagga increases the likelihood of being tricked by friends to smoke nyaope 
without ones knowledge. The participants could not have been tricked into smoking 
nyaope by their friends if they were not smoking dagga. 
4.4.1.1.4 Losing weight 
Participants indicated that they were gaining excessive weight which they were not 
happy and comfortable with. They started smoking dagga to lose weight but when the 
progress was not speedily, they started using nyaope. The effects of acute marijuana 
use on appetite and snacking behaviour are well-known and colloquially described as, 






to have lower body mass indices than nonusers (Sansone, R. A and Sansone, L. A. 
2014:50). This is expressed through the following statements: 
Participant 18 “For me to start using nyaope was because I wanted to lose weight”. 
Participant 16 “I started smoking nyaope because I want to slim, to lose weight”. 
Carra and Jaffeb (2012:3) argue that overweight persons are more likely than their 
slimmer age group to face teasing, discrimination and tense relationships with family. 
This contributes to an unstable psychological well-being, including depressed moods 
and poor self-esteem. It can be concluded that the participants did not desire to 
experience discrimination, as a result, they found themselves applying mechanisms 
which would enable them to lose weight and keep to their body image.  
4.4.1.1.5 Mental health 
Participants reported that they started using nyaope due to issues they were facing in 
life. Some studies propose that females are more likely to indulge in substance use as 
a way of coping with mental health issues, such as depression, anxiety, and 
posttraumatic stress disorder that are often the result of trauma, abuse, and violence 
(Pinkham et al, 2012:3). Females who use drugs reported to have high rates of post-
traumatic stress disorder and may also have encountered childhood difficulties such 
as physical neglect, abuse or sexual abuse (UNDOC. 2018:6). The participants 
reported that:  
Participant 20 “It was when my brother killed my father, it [the murder] has affected 
me a lot. When I tried to reflect on what happened, it was just too much”. 
Participant 21 “My brother had just passed away; I was stressed and I could not sleep. 
I had a friend that was smoking nyaope; she told me that if I can smoke this (nyaope), 
I can be able to sleep”. 
Participant 15 “I can say that I started to smoke nyaope because of the things that 
happened in my life. I was adopted and [through that] adoption, my father turned me 
into his sexual slave. When I spoke with my adoptive mother, she told me that I was 
lying about it. That is when I was told how they did a favour for me; how they picked 
me from gutters; how I should be grateful. So they ended up kicking me out, and I 






Participant 5 “For me to begin using nyaope was [because of] the situation at home, 
after my mother passed away”. 
Participant 22 “I told him that I am struggling with sleep, it just after my mother passed 
away. I was struggling with sleep, he then told me that there is a drug called nyaope”. 
Different emotional stressors, like the death of a parent and incest by family members 
has driven the participants to smoke nyaope to ease the pain. There is solid evidence 
for the role of mental health, particularly depression and post-traumatic stress 
disorder, in both conserving and enabling associations between substance use, IPV 
and HIV. Mental health experiences can also play a role in raising females’ drug use, 
and in constraining their ability to distinguish and navigate risky circumstances 
(Stoicescu et al, 2018:3326-3328). The experiences of trauma can lead to the 
development of mental health issues and further increase the risk of drug use (Arpa, 
2017:6). 
4.4.1.1.6 Counteracting other drugs 
The participants started using nyaope to counteract other drugs. Participants were 
using cocaine, which is a stimulant. The participants reported that they struggled with 
sleep when they have used the cocaine and they used nyaope to relax their nervous 
system since nyaope is a downer. Masombuka (2013:44) reports that cocaine can 
provisionally reduce the need for food and sleep, so users struggle with sleep after 
using it. Angarita, Emadi, Hodges and Morgan (2016:9) reports that wooziness and 
tiredness are common side effects of opioid. This is confirmed by the following 
narratives: 
Participant 4 “I was using uppers; I was using cocaine. You know with cocaine, it is 
like when you want to sleep it is a problem; so I knew that this thing [nyaope], it will 
down me and help me sleep”. 
Participant 2 “I met some people who were smoking that also, but, they told me about 
the downer. The downer is heroine, it pins you down when you too up [too high]”. 
The participants started using nyaope to address restlessness which was prompted 
by use of stimulant drugs. It was never their intention to be regular users, but to the 







Curiosity has influenced a participant to smoke nyaope. The participant had a history 
of using dagga so when people she knew were using nyaope, which she did not have 
any idea what it was so she was curious. The participant asked to try it and she was 
hooked. For adolescents, substance use tends to be acquired through 
experimentation and curiosity, particularly through peers (El Kazdouh, El-Ammari, 
Bouftini, El Fakir and El Achhab, 2018:1). This is supported by the following narrative: 
Participant 1 “The very first time I tried nyaope, I did not know that it was nyaope. I 
came across some boys from where I come from back at home, they were smoking 
and I wanted to try what they were smoking, then I tried it”. 
 Factors contributing to injecting nyaope 
4.4.1.2.1 Need for intense high 
The need to experience an intense high which lasts longer has influenced females to 
transition from smoking nyaope to injecting it. The transition from smoking dagga to 
their injecting initiation was centred on their need to increase the effect of the drug and 
their desire to fit in with the injecting drug use social network (Tuchman, 2015:3). 
Guise, Horyniak, Melo, McNeill and Werb (2017:8) suggest that many studies 
described the search for a greater ‘high’ or ‘rush’, potentially available through 
injecting, as the primary reason linked to injection initiation. An increased high 
associated with drug injecting was described as developing from engagement in social 
networks that include people who already inject drugs, where the high is witnessed or 
encouraged and curiosity generated.  
Participants reported that when they inject nyaope, they experience an intense high 
which lasts for longer as compared to when they have smoked. Smoking nyaope was 
considered a waste by the participants as it could not give them a desired high and it 
wears off easily, forcing them to use nyaope too often. The participants alluded that:  
Participant 15 “I felt that smoking dagga was not strong like it used to be and when I 
injected, it stayed longer in the body but zolo was not”. 
Participant 8 “I was smoking, but [after] realising that I do not feel that kick that I want, 






Participant 4 “Started injecting because smoking it did not do anything anymore”. 
Participant 13 “Injecting goes straight to the blood, gives much more high than 
smoking; after [realising] that I started to inject”. 
Participant 2 “You get more high same time you inject it, but to smoke, you have to 
wait to feel it and you do not feel it more”. 
Participant 22 “In my township they give us free packets, so everyone in my township 
was using a syringe. I was not using a syringe by then, so Makwera (dealer) gives us 
free two packets every Tuesdays. So the one I… there was two of us, they pair us. 
The one who I was paired with injects and he forgot that I smoke with dagga. He mixed 
all of it in water, I told him that today am withdrawing, he is taking chances, I am going 
to use syringe. That is how I started, I felt the high the whole day, I realised that it 
saves money, I will not be going back to smoking it; I started using a syringe”. 
Participant 10 “When I started to injecting, smoking dagga was not giving me a 
desired high. I did not feel it after smoking; so a friend told me about the injecting 
practice. I was told if I inject it remains longer in my body and I will achieve the desired 
high”. 
Participant 18 “The high is fast because it goes straight to the blood, it is not like the 
one of dagga”. 
Participant 24 “The high that I was experiencing was more intense than that of dagga, 
when injected I got more high”. 
Participants indicated that when nyaope is injected, it gives a high faster as compared 
to smoking. The injector experiences the high immediately after injecting. Drug 
injecting is regarded as easily to use and an effective manner to use low-purity heroin. 
The injecting of heroin produces near-rapid analgesic and etatic effects. When heroin 
is injected, it lasts more hours as compared to when is smoked (Masumbuka, 
2013:44). 
4.4.1.2.2 Intimate partner 
Female nyaope injectors were predisposed by their intimate partners to inject nyaope. 
Female nyaope injectors are more likely to be in an intimate relationship with a 






also use drugs are complex and lively (Azima et al, 2015:17). The relationship between 
female nyaope injectors and their male intimate partners is characterised by violence. 
Rejection to use a partner’s used injecting equipment can position females at a higher 
risk of IPV, as a result, further increasing their risk of HIV infection (GCWA, 2011:6). 
The participants reported:  
Participant 17 “Because the father of my child, the person I was dating was smoking 
with zol and ended up injecting, I also ended up injecting”. 
Participant 1 “My boyfriend influenced me [to inject], sometimes when we do not have 
money, he was injecting and I was not [injecting]. This other time he said let me allow 
you to try. Mostly he would say that but I would refuse [to inject] but on that day 
because we only had one bag, he mixed then that is how I started”. 
The influence of intimate partners on initiating injecting nyaope should be 
acknowledged. Such an influence increases the risk of female nyaope injectors 
contracting HIV and other blood-borne infections. The way the participants reported it 
reflects powerlessness from the females as the initiator is an intimate partner. 
4.4.1.2.3 Curiosity  
Female nyaope injectors are not on all occasions inactive in transitioning from smoking 
to injecting drugs. Often, they have an active role in transitioning. Some participants 
reported that the transition was their own idea. The participants were curious about 
injecting but incapable to inject themselves, Tuchman (2015:3). For the participants, 
as highlighted, curiosity was a contributing factor which influenced them to inject 
nyaope. The participants reported that:  
Participant 23: “I saw people injecting so I became curious”. 
Participant 16 “I was smoking at Block R and some boys were injecting with one girl 
but they got the intense high more than us who are smoking with cocktail, then I got 
curious”. 
Participant 7 “I was dating my boyfriend who was also a smoker. It happened that this 
other day we found new needles and we used to see people injecting and we were 
smoking cocktail. He said to me let us sell this needles then I was like no! Let us not 






It is not always males who influence females to inject. Participant 7 influenced her 
intimate partner to inject nyaope while Participant 23 and Participant 16 injected 
because of curiosity after they saw other people injecting. 
4.4.1.2.4 Cost effective 
Nyaope does not come cheap. Participants indicated that injecting nyaope reduces 
the cost as you achieve intense highs and it remain in the body for longer. Injection 
initiation involved crossing boundaries of morality, stigma or risk, where fears or 
negative social norms are displaced or replaced. Accounts of managing increasing 
tolerance, economic efficiency and seeking a better high were frequently linked. A 
recognition of the increased efficiency of injection drug use can occur within social 
networks of people already injecting. They can encourage this understanding or be a 
rationale for coercing others into injecting, and thereby, reflect economic pressures 
generated by poverty, marginalisation, and shifts in drug supply (Guise et al, 2017:8). 
The participants reported that:  
Participant 16 “The problem of cocktail is that, I would smoke the whole day because 
after an hour I withdraw, then I have to smoke and it becomes costly. But with injecting 
you can smoke two packets, you can stay the whole day with the desired high until 
late at night”. 
Participant 24 “It was going to be too much costly for me, the more I buy the more 
money I need to have. It is better for me to inject so that I can have the satisfying high”. 
Nyaope costs between R25–R35 per fix. However, it is an increasing cost. Even in the 
short term, it is high because of the strength of the addiction and the resultant frequent 
use (Mokwena and Morojele, 2014:376). Injecting nyaope reduces the cost as an 
injector is able to get an intense high using low quantity of nyaope.  
4.4.2 Objective 2: Experiences of female nyaope injectors 
 Risky behaviour 
Injecting drug use (IDU) is associated with high sexual risk, linking people who inject 
drugs to the well-established HIV epidemic in Africa. Although most HIV infections in 
the region occur as a result of unprotected heterosexual sex and mother-to-child 






positions this mode of transmission to become a significant threat in a region that is 
over burdened by HIV. While data available on IDU is scarce, evidence has suggested 
that PWID engage in high-risk injection and sexual exposures, and have high rates of 
HIV infection. Low HIV testing uptake and lack of knowledge of the risks associated 
with injecting drugs may also contribute to the emerging problem (Asher et al, 2013:2). 
Female nyaope injectors engage in transactional sex, injection sharing and poor 
condom use which escalate the risk of contracting HIV. 
Multiple and concurrent partnerships, low and inconsistent condom use and low levels 
of male circumcision have been shown to be the key drivers of the epidemic. While 
HIV risky behaviours are known to be drivers of the spread of HIV, cognitive factors 
including perceived susceptibility to HIV, perceived monetary or material benefits of 
having sex for material gain, self-efficacy, and attitudes play a significant role in 
influencing risky sexual behaviours. Based on the health belief model, an individual’s 
personal belief influences their behaviour (Manjengwa, Mangold, Musekiwa and 
Kuonza, 2018:2).  
4.4.2.1.1 Sexual risk  
Females who use drugs are barred from family support structures. Those who lack 
financially or have poor employment prospects are more likely to be involved in sex 
work, which increases HIV risk and draws the additional stigma linked with sex work 
(Larney et al, 2015:6). 
4.4.2.1.1.1 Sex work 
Females who participate in both the sex work and use of drugs are more likely to share 
needles and other injection equipment among themselves and their clients, as well as 
have unprotected sex with their clients and their intimate partners. Many females are 
pressured to sell sex to finance their own or their partner’s drug use, which may put 
them at dual risk of HIV infection through unsafe sex as well as unsafe injections 
(Azima et al, 2015:17). Adverse socioeconomic conditions may contribute to females 
engaging in sex work (El-Bassel and Strathdee, 2016:6). The participants raise money 
through sex work; which increase their risk of contracting HIV infection. This is 






“I sell my body - Participant 2”. Another one said: “I am hustling through sex work – 
Participant 6”. Recovered participant shared that “At times my boyfriends would give 
me but they began to complain, so I looked for other options then I became a sex 
worker, so that I can be able to buy myself drugs - Participant 24”. 
The participants found themselves becoming sex workers to make money for their 
next fix, they did not entirely want to depend on their boyfriends for money. 
4.4.2.1.1.2 Transactional sex 
Female nyaope injectors are more likely to participate in transactional sex compared 
to their male counterparts (Scheibe et al, 2016b:113). Poor economic standing has 
been linked with earlier sexual involvement, inconsistent condom use, having multiple 
intimate partners, increased chances that the first sex act is non-consensual, and a 
greater likelihood of having had transactional or physically forced sex. Many females 
choose to engage in transactional sex to finance their live (Ramjee and Daniels, 
2013:3). Transactional sex increases the risk of female nyaope injectors to contract 
HIV. Participating in transactional sex is significantly linked with increased HIV 
prevalence in females. In a review of this association, across eligible studies, females 
who have history of participating in transactional sex were, on average, 50% more 
probable to be living with HIV than females who had never participated in transactional 
sex (UNAIDS 2018b:7). The participants reported that they participate in transactional 
sex in order to raise money for their drug use.  
The participants reported that: 
Participant 10 “Sometimes I sleep with someone for money”. 
Participant 15 “Truly speaking even my boyfriend does not know. I have people who 
I meet secretively and I would give them sex in exchange of money”. 
Participant 20 “… like to have a mutual agreement that he would give me money and 
I have sex with them”. 
Participant 8 “Since I started using nyaope I do not have feelings, I do not like to be 
intimate with men but I do it, even if a man can come with R300 and say sleep with 






The need to get the next fix influences female nyaope injectors to engage in 
transactional sex to raise money when they do not have other options of raising 
money. This practice increase their risk of contracting HIV and other blood-borne 
infections. This practice increases the likelihood of female nyaope injectors 
contractring HIV.  
4.4.2.1.1.2.1 Factors contributing to transactional sex 
Formson and Hilhorst (2016:8-9) contend that there are three elements that jointly 
contribute to transactional sex. Firstly, the fortunate economic position of men. It is 
rooted in their access to well-paid sections of the formal and informal economy, as 
well as to resources such as housing. The second is masculine dissertations. It places 
a high worth on men having multiple sexual partners. The third, by contrast, relates to 
an expression of females’ agency: females engaging in transactional sexual 
relationships not as inert victims but rather in order ‘to access power and resources in 
ways that can both challenge and reproduce patriarchal structures’. Participants 
reported that: 
Participant 1 “I did not have money to buy nyaope so he said you are not fine, you 
look sick; he knows that I am smoking because he used to see me. Then he said 
escort me I want to take something in my room then we will come back. I said if you 
can give me at least R20.00 I will escort you. He then said let us go I will give you, 
when we got there he said I will give you R100 if you sleep with me, and at that time, 
I was desperate, so I took it then I slept with him”. 
Participant 22 “Sleeping with a person whom you do not love, just because you want 
him to give you money so that you can smoke nyaope. You just tell yourself that you 
will sleep with him and no one will see us. When you sleep with him, no one will see 
you, and you sleep with him and he gives you money for nyaope, then it ends there. 
Even if you do not love that person, you sleep with him so that he can give you money”. 
Financial factors influence female nyaope injectors to participate in transactional sex. 
A lack of stable income contributes to females having to resort to begging or other 
forms of income generation, such as sex work or crime, in order to pay for their daily 
needs (UNODC, 2017b:32). Transactional sex is a way for drug users to earn an 






transactional sex among IDUs; this behaviour is strongly associated with HIV infection 
in these populations. In this respect, transactional sex among IDUs increases the risk 
of spreading HIV to their social networks and the general population (Guimarães, 
Rodovalho, Fernandes, Silva, de Felipe, Vera, Gregório and Lucchese, 2016:1).  
4.4.2.1.1.2.2 Feeling associated with transactional sex 
It is not all female nyaope injectors who are proud of engaging in transactional sex. A 
participant indicated that she resented herself after practicing transactional sex for the 
first time, however, due to the demand of money to be able to maintain the using habit, 
she felt powerless and found herself engaging further in transactional sex. Participant 
1, with tears in her eyes, reported that “I resented myself afterwards, but then I still did 
it again”. She was not proud of engaging in transactional sex but she kept on engaging 
in it as she struggled for money through socially moral ways.  
4.4.2.1.1.2.3 How females are approached for transactional sex 
Men are taking advantage of female nyaope injectors. Men are aware that female 
nyaope injectors are financially struggling and need money to buy nyaope. Some 
females reported that they are used by men for sex, and are targets of sexual favours, 
in return for a small amount of money. This further breaks down the psyche of these 
females, as their bodies are equated to nothing more than a few Rands (UNODC, 
2017b:19-21). The Participants reported that:  
Participant 16 “… they take advantage to us”. 
Participant 15 “… they approach me as sex object and ask how much do you sell”. 
Participant 10 “They had advantage [over me] because I am using drugs, they know 
that if I give her R50, I will be able to sleep with her”. 
Participant 12 “Many times guys approach me to have sex with them and I … I do not 
know if it is in me, I cannot say yes or no. Then they will tell me they will pay me R50 
just to sleep with me”. 
Participant 22 “Some are upfront with you because they know you use nyaope. They 
will tell you that if you satisfy me, I satisfy you. I give you money and you satisfy me. 






does not lie to you. He will tell you that I give you R30; their price is R30. He will tell 
you I give you R30 so that you can buy packet and it ends there”. 
Participant 19 “When a person comes and offer me money, I would say I do not want 
that amount; you see how I look, if you can give me at least R300 then I can give you 
what you want with a condom, then we would have sex”. 
Some participants like Participant 19 and Participant 1 exploited the opportunity by 
demanding higher amount of money which was able to sustain them for longer. This 
means some female nyaope injectors decide to be taken advantage of, or rather, they 
use the unpleasant circumstances for their advantage. 
4.4.2.1.1.3 Inconsistent condom use 
Females who use drugs are frequently disempowered to discuss safe sex with their 
intimate partners. Sexual risk-taking may be associated to feelings of trust in a 
relationship, or they may be culturally entrenched in the gendered distribution of 
power. Efforts to discuss condom use with an intimate partner can therefore result in 
violence, isolation, and exclusion if taken as an unwelcome challenge to fidelity and 
privilege within the relationship (GCWA, 2011:5). Gendered cultural beliefs place an 
intimate partner above oneself, avoiding conflict, and conserving accord in 
relationships may add to females’ powerlessness to discuss safer sex, even in 
situations when they feel they are at risk (Stoicescu et al, 2018:3316). The participants 
reported that: 
Participant 16 “We often use it [condom] when I am on my periods… I usually do not 
tell him to use a condom, he is used to the fact that he is my partner”. 
Participant 20 “He is positive I never contracted HIV, seems like my blood is strong, 
and I do not contact HIV”. 
Participant 6 “Yes we do [have sex] but there were times when we did not use a 
condom and also sometimes it burst”. 
Participant 7 “After we went to test and then it came (and found out) we were both 
clean [HIV negative], we never used a condom and we always go and test like last 
week when I came from my medical certificate we both got tested again and then I 






Participant 10 “The first time when we slept together, we used a condom but as time 
goes we stopped because we were used to each other”. 
Participant 17 “I did think of it [using a condom] but we had been in the relationship 
for a while now and before I started to inject, we tested on the gazebos that are placed 
on the streets; we were both negative since then”. 
The participants are not consistently using condoms with their intimate partners. The 
attitude of not using condoms by partners of female nyaope injectors is increasing their 
risk of contracting HIV. The risk is higher as most of the boyfriends are injecting nyaope 
themselves, and might be sharing injections with other drug users.  
Female nyaope injectors in developing countries have shared that females were more 
probable to participate in high risk activities in the context of a sexual relationship with 
an intimate partner (Rahman, Iqbal and Vicknasingam, 2015: 2). This was supported 
by the following narratives of participants:  
Participant 12 “He does not like to use a condom, but it is a long time we have not 
been sleeping together, (intimate) he is not a person of [not much into] sex”. 
Participant 19 “He did not want to use condom. Eish! I loved him; I do not know how 
to explain this, I loved him”. 
Participant 24 “You know when you talk to males about using condoms they do not 
understand, at times they want to have unprotected sex. I think that we were going to 
fight maybe he was going to hit me”. 
Participant 20 “It is hard to refuse my partner as he would accuse me that I have been 
sleeping around, why I am refusing? It is difficult because I do refuse at times and 
suggest condom use, but he does not want to”. 
The participants reflected helplessness in negotiating condoms use with their intimate 
partners. They feel powerless and have left their health in the hands of their intimate 
partners. Women gave many reasons for not using condoms. Amongst others, it was 
reported that condoms were perceived to be something that was used at the beginning 
of a relationship when there was still a lack of trust and commitment. The need to 
continue using a condom could be seen as a sign of distrust or a lack of real love. 
Women also wanted to preserve their relationship by pleasing their partner or making 






4.4.2.1.2 Sharing needles 
Societal customs that supress females and generate imbalanced power relationships 
further strengthen injection sharing in intimate partnerships (Marottaa et al, 2018:103). 
The participants reported to having injected with a used injection with their intimate 
partners. Reasons for sharing needles and injecting equipment are complex. Individual 
factors like knowledge, perceived risk, and perceived sense of control indisputably 
influences injecting and sharing behaviours (Morris, Andrew, Tan, Maher, Hoff, Darbes 
and Page, 2019:2). The participants reported that: 
Participant 1 “He did not have an injection, actually we had but it blocked, so he asked 
if he can use mine”. 
Participant 10 “I just said because is my boyfriend, I only shared with my boyfriend”. 
Females tend to ignore risks in the context of injecting intimate relationship (Morris et 
al, 2019:5). It is easy for female nyaope injectors to inject with their partners as they 
perceive sharing with their partner as not risky.  
Participants reported to have shared injections within the network of people who inject 
drugs, especially with intimate partners. They explained that a lack of access to clean 
injections has contributed to them sharing injections because the withdrawals are 
unbearable, and at the time when they have to inject, they do not think of the 
consequences of sharing injection. At that point they indicate that injecting the drug is 
more important than anything. The participants reported that: 
Participant 19 “At that time where was I going to get the injection? Because when I 
withdraw I get alostro [withdrawals]; it is a very painful thing, it is like having cramps, I 
cannot do anything by that time. I am experiencing withdrawal, there is nothing else 
that I can do”. 
Participant 21 “My needle was broken and I was experiencing withdrawals, that 
feeling is unexplainable”. 
Participant 23 “Mine was blocked, I was with this other guy who is my ex, he gave me 
his and he injected me because at that time I was not able to inject myself. I could not 






Participant 2 “Because you cannot wait when you withdraw, you do not think about 
it”. 
Participant 6 “Eish! I was sick and cracking (withdrawing) and I did not have an 
injection, and also, I did not have money to buy it. I had to borrow”. 
Participant 21“It is because when you are experiencing withdrawals you become 
impatient, for me to go to Dischem and come back and smoke [inject] was too much 
of administration. So if I can ask from my associate I would ask just to inject then I will 
go later”. 
Participant 5 “Eish! I never thought of that because I was withdrawing, you know when 
down, eish!” 
Participant 5 “When you experience withdrawal you lose your mind, you forget about 
everything, you forget about sickness, you forget that what you doing will get you in 
trouble and you will remember after. At that point, you are looking for that high, you 
inject and get high, then after you realise that sharing a needle increase chances of 
having AIDS”. 
Participant 7 “I will not lie, the first time I was starting to inject, I used to [share 
needles]; sometimes in location is hard to find a needle. I used to ask if I have alostro 
and I do not have it [own needle]. Someone borrows me and I give them something 
then I inject”. 
Participant 9 “I was withdrawing and I wanted to inject badly, and this thing that I 
know this person, I have lived with him for a longer period, and he is safe, he does not 
have HIV. That is what I was telling myself but I knew I cannot be 100%, because what 
if he also borrows other injectors”. 
Participant 4 “It was difficult to find a needle because when you are going to a 
pharmacy they would ask do you have a prescription to buy needles”. 
Participant 22 “Where I stay needles are scarce and we can use one needle with 10–
20 people because they are scarce where I stay”. 
Participant 17 “I did not think because I did not know anything about a syringe. I told 






Participant 24 “I was not thinking about all that, my main concern was to smoke {to 
inject] and relieve myself from the withdrawal symptoms and be high”. 
Participant 19 “Yes, when desperate, one would share and the person giving you a 
needle wants some remains. He or she is also desperate and experiencing 
withdrawals, that person would give you a needle (also)”. 
Participant 16 “It did happen [sharing needles] that they were scarce. The ones that 
had it they would borrow; we were not thinking about being sick so we diagnosed a 
person by looking at him if he is sick or not for as long as we did not see the symptoms. 
But a coughing person who looks discoloured and sick I would not allow them to 
borrow me the gun [syringe]”. 
Participant 12 “I had to get that nyaope in my system for me not to get sick and where 
am I going to get a needle now? It was at late night and he is the only one who has a 
needle. But I had to share that packet with him if I had to use that person’s needle”. 
Participant 11 “Eish! I wanted to get something from my friend, because I had nothing 
to smoke that time, after she injected, she left something for me to inject as well. So 
when you borrow someone your needle, they must leave something for you”. 
Participant 19 “You cannot think about it because I was eager to feel what he or she 
was feeling and wanted to be high at that moment; nothing goes to mind”. 
Participant 7 “You when you have alostro you do not make sense of those things, 
unless after when you are fine then you get to think about those things like, what if I 
get sick? What if this?, but it is already done”. 
Participant 8 “You know when you are addicted you do not really care, you just want 
the kick of nyaope, it is because you are already addicted. If you can inject once, 
tomorrow’s alostro, will only be taken out by injecting so if you do not have an injection 
you do not really care”. 
When female nyaope injectors start experience physical withdraws, their need for the 
drug surpasses all other concerns, even as they may have knowledge of infection risks 
(Chakrapani, Newman, Shunmugam and Robert Dubrow, 2011:7). It is key that female 
nyaope injectors should never run out of needles. Importantly, they have a habit of 






(Horitavorn, 2008:13). From a moral perspective, giving people needles might seem 
like promoting needle using practice, but from what the participants have indicated, 
lack of needles influences sharing and availability of needles will reduce sharing 
amongst female nyaope injectors.  
 Social interaction 
4.4.2.2.1 Family  
When most participants start engaging in substance use, they live with their families. 
When their families learn about their drug use, they react. It is reported that families 
experience traumatic experiences. Families experience mix feelings which includes 
fear that their child might die, feeling of disappointment or accountability for the drug 
dependence, and shame as a result of being stigmatised by the community as a parent 
who cannot control their children (Masombuka, 2013:99).  
4.4.2.2.1.1 Family reaction when they discovered that participants are 
using nyaope 
The families were not happy with the participants when they learnt that they are using 
nyaope. The families experienced lots of unpleasant emotions; they were shocked, 
angry, surprised and disappointed when they learnt that participants are using nyaope. 
Schultz and Alpaslan (2016:100) argue that the initial reaction of the family involves 
shock when they learn about the drug use of their family member. The shock is joined 
with feelings of dismayed, rage, frustration, sorrow, disorientation, helplessness, as 
well as pity and disbelief. The initial shock reaction experienced is not unusual, for 
when a family discover about the drug use of one of its family members, the family is 
“thrown into shocked disarray”. The participants reported that: 
Participant 17 “Yoh! They were angry. It was bad because when they found out that 
I am smoking and everything I needed, I depended on them, that changed and the 
way the treated me, was not [it was no longer] the same”. 
Participant 22 “They would have taken me for an animal. I am forward, or am not 
scared of things, maybe they would think I want to kill myself or something like that 






and she is not scared of things, I hear when they talk about others. I was afraid to tell 
them that I am injecting”. 
Participant 18 “They were really disappointed, shocked, because I was the brilliant 
child in the family”. 
Participant 16 “They were not happy at home, there is no mother that would be happy, 
there is no parent that can be happy that their children are smoking nyaope”. 
Participant 13 “Yoh! They disowned me, totally. But from his family I get support and 
they always encourage me to stop and stuff like that because they knew I never 
smoked before, and he was the reason that I started to smoke”. 
Participant 18 “They did not trust me, no one was trusting. Everybody, even my 
mother; her money … she would always make sure she puts it safe. Everyone who 
would come home would hold on to their bags, phones are kept safe; like, you are not 
trusted at home”. 
Participant 14 “Yoh! They were very angry with me”. 
Participant 11“They were shocked because I was a sports girl and playing soccer, 
also running; now I am using drugs. Every time they watch the friends I used to play 
sports with see what they have become in the media it hurts them, they are sore”. 
Participant 10 “I have broken their hearts; especially that I am a mother; I have kids. 
My mother just prayed to God, waiting for a day where I would change my life”. 
Participant 5 “They were in disbelief, saying no one has smoked nyaope in the family. 
The people who claim I am using nyaope are crazy, they talk bad things about their 
children. I always made sure when I was on the streets. I would not be untidy; I would 
be clean, my partner would give me money and I would buy groceries whenever I am 
going home. They would be shocked as I do not look like someone who is smoking 
nyaope. I always make sure I look beautiful, my hair is proper, am wearing proper, 
plus I like good things”. 
Participant 7 “They are not feeling good actually, at first I could not even communicate 
with them, it was like… I do not know how to even explain. It was like I am out of their 
lives forever, like I do not have a mother, I do not have a brother, I do not have a 






Participant 9 “They were so angry and their hearts were broken, it contributed to 
conflicts in the family, it was not nice”. 
The families did not expect to see their children using nyaope. When they learnt that 
they are using, they did not believe it. They got the shock the lives. The family did not 
only go through shock and disappointment, they tried to show support to some 
participants. The participants reported that their families reacted by offering support 
and taking them to centres where they could be rehabilitated when they learnt that 
they are using nyaope. This is supported by the following narratives: 
Participant 14 “They tried everything, first they took me to places where they thought 
they will help me to stop, even to church and then I came to COSUP. They even came 
with me here for me not to run. I tell them there by the house that I am coming to 
COSUP then I first go there” [to use nyaope]. 
Participant 4 “Oh! My mother was crying and said that I must go to a rehab or she is 
going to disown me and all those things. Then I went to rehab but I went to rehab to 
please them, it was not for me. I think that is why it never worked out”. 
Participant 19 “She is a parent, no parent wants their child to do wrong things. She 
tried to take me to rehab and took me to another doctor, they inserted another pill”. 
Participant 22 “My mother tried to help me, even before she passed away she went 
some place for me to get help but before she could, she passed away” 
The family extended their hand to help participants when they learnt that they use 
drugs. This reflects that family is supportive. They sought help for the participants at 
different institutions.  
4.4.2.2.1.2 Family reaction when they discovered participants are 
injecting nyaope 
The families were disappointed at the conduct of the female nyaope injectors when 
they learnt that they have transitioned from smoking to injecting. The families confuse 
pure injecting practice with bluetooth practice where drug injectors share blood among 
themselves. The families further associated drug injecting with committing suicide. The 
practice of sharing blood among drug injectors was first reported in Tanzania in 2005, 






much as 3 cc of blood into a syringe, and passing the syringe filled with blood to 
another injector for injecting (Asher et al, 2013:2). This practice is called bluetooth by 
South Africans (www.timeslive.co.za) and flashblood by Tanzanians. The participants 
reported that: 
Participant 24 “My mother was worried thinking that I am killing myself saying that I 
will die very young”. 
Participant 16 “Ehh! the one of injecting was the one that made them more furious 
because I had once missed [injected wrongly] and they saw that I missed and they 
have heard how many people have died because of the needle they tried to reprimand 
me about it”. 
Participant 14 “Like I told you, the trust in the house and things like that. They did not 
trust me; if I turn my back they are there, if I do, they are there. When I see their 
phones, they are gone already because of they are scared of me, they take it”. 
Participant 4 “She said I am killing myself and I am so clever, why am I throwing my 
life away and all those things”. 
Participant 21 “Yoh! It became worse, very worse because my mother does not like 
and does not even want the injection”. 
Participant 12 “Like my mother does not treat me like she treats my other brothers 
and sisters. She treats me far different from the others, like if something is getting lost 
in the house or something is not there, then they would always say ‘but why must she 
take things in the house that does not belong to her’. So always when things go 
missing they say it’s me. Sometimes they will not dish food for me out. 
Participant 11 “They are disappointed, I am disappointing them, and they want me to 
come out the drug”. 
Participant 1 “She expressed a lot of concerns; that means you cannot stop because 
you are even worse than before”. 
Participant 7 “Yes, they reacted but not badly they just told me you going to die, we 
hear now that you are even injecting, do you know that injecting is more dangerous 






Participant 10 “They are not proud about it [the injecting], they said what I am doing 
now is killing myself. Sometimes when things are lost, I am the first suspect. They 
undermine me because I am a drug addict”. 
Drug use and injection invites extensive stigmatisation. Females who use drugs may 
encounter rejection from their relations and communities. Female will further face 
discrimination in a variety of contexts, including health care settings. As a result, 
females who use and inject drugs may be unwilling to divulge their drug use and be 
reluctant to access health services, including drug treatment, for fear of stigmatisation. 
Social barring, stigma, and discrimination contribute to increased HIV risk and weaken 
HIV prevention and treatment (Larney et al, 2015:6).  
4.4.2.2.1.3 Perception of how families would have acted when if 
discovered the participants inject nyaope 
Some of the participants hid their nyaope injecting from their families so their families 
did not know they transitioned. Due to stigma associated with injecting nyaope, the 
participants are of the assumption that if their families knew they were injecting 
nyaope, they would be disappointed at them and might disown them. This is supported 
by the following statement of the participants:  
Participant 5 “Yoh! Yoh! Yoh! Eish, I think that they will give up on me and will tell me 
that they are paying burial society and they are waiting to collect my dead body. You 
know how the words of the parents are, once they can tell you to stop they reach a 
point where they give up”. 
Participant 18 “Yoh! They will go crazy. Yoh! You know my mother does not tolerate 
the injection at all more than dagga, she can even tell me that I should not inject I 
would rather dagga than injection. Because there has been this misconception of 
bluetooth they think like that we are experiencing that, a lot of people are saying a lot 
of things about the injections”. 
Participant 7 “They think people who are smoking drugs are not good at all, they are 
stealers, they are not supposed to be around people, like … I do not think they will 
ever like me or they will ever feel safe around me. They are going to think maybe I am 






4.4.2.2.1.4 Feelings associated with being home 
The reaction of family members toward female nyaope injectors often has an 
emotional effect on them. Female nyaope injectors feel unwanted and not accepted 
by family members due to drug use. Their “good daughter” image is substituted by the 
junkie image which they have seen in the media (Horitavorn, 2008:20). The 
participants did not feel welcomed and comfortable at their homes.  
Participant 2 “I do not feel like I am welcomed, that is why I just go because they are 
always talking about me”. 
Participant 14 “I feel like I am a stranger in my own house [home] and now that my 
mother is not there, and my father is also using but he is not doing it in front of people. 
People know that he is also smoking, but not nyaope, he is smoking mandrax … so 
like ... he swears at me [say things like] ‘you nyaope what what, go to the hostel. I 
never taught you smoke this thing, I told you before spiking and all those things.’ He 
is always talking like he prevented me from stopping to do this but he never”. 
4.4.2.2.1.5 Relationship with children 
 The participants reported that due to drug use, they were not involved, the way they 
wished to be, in their children’s lives. They believe their drug use affected their 
involvement in their children’s lives. Kontautaite, Matyushina-Ocheret, Plotko, 
Golichenko, Kalvet and Antonova (2018:4) reported that 25 females in their study 
described the restriction of parental rights because they were drug users or drug 
dependents. Mothers were not permitted to contribute in any decision-making related 
to the child’s health and were poorly involved in the life of the child. The findings of the 
study corroborate the findings of Kontautaite (2018) and partners. The family has 
taken some responsibilities from female nyaope injectors due to using nyaope. The 
families are now managing social grants and welfare of the children. The participants 
reported: 
Participant 11 “It was because I was on alcohol and I started using drugs; that is the 
reason she took her [family took her child away]”. 







Participant 18 “He did stop, but now he is doing everything. Like paying for the child’s 
school fees, the transport, buying the child’s groceries, everything that has to do with 
the child, he takes care of it”. 
Participants are not happy with the state of relationship they have with their children. 
They expressed that their children do not want to see them using drugs and it is 
unpleasant for them. 
The participants reported that:  
Participant 23 “At times I would chase him away, you understand me? But there was 
a time when he asked me why am I injecting, then I made a promise that I will stop. 
He found me again injecting and asked if I am still injecting, then I promised him again 
that I will stop. That is when that thing made me feel bad because this was hurting my 
child, because when he would find me injecting, he would walk away same time; he 
would no longer entertain what I am doing, turning away from the things that I am 
doing”. 
Participant 10 “He knows and it affects him because he is old enough, and he 
understands. He asks my mother, when I am going to stop smoking. It makes feel 
bad”. 
Participant 2 “We do not have a good relationship but he knows I am his mother, he 
is five years [old] but I do not see him much”. 
4.4.2.2.2 Community 
4.4.2.2.2.1 Reaction by the community when they learnt that females use 
nyaope 
When families try to tolerate drug-using behaviour, the community makes things worst 
with their gossip. Gossiping by neighbours about females who use drugs makes family 
members feel uncomfortable and humiliated. Using drugs brings shame and lost face 
in the community and among relatives (Horitavorn, 2008:24). Participants reported 
that:  
Participant 23 “They started acting up, others would distance themselves from me, 






to ask me to run their errands, it becomes difficult because of they might think that I 
will run away with their money”. 
Participant 1 “The community, to be honest, once they know you smoke or injection 
nyaope they start to look down upon you. They do not take you as a person anymore, 
to them you are just a thing”. 
Participant 8 “Like everyone sees their child better and I am seen like the worst 
person”. 
Participant 4 “They have this perception that if you are using nyaope you are dirty 
and you will do this thing of recycling and you steal, and so, they are judgmental. That 
stand-offish thing comes and they are, like no we do not want you here”. 
Participant 17 “They treated me badly because they were talking behind my back. If 
anything got lost they would point at me saying I am brining people to come and steal; 
it was bad”. 
Participant 9 “Some treat us badly, sometimes when things get stolen, you are the 
suspect. They look down on you, they treat you badly and when they look at you, they 
see rubbish”. 
Participant 15 “They tell their children that they must not come near me or my 
associates, then there are some whose children are also smoking. When they see me, 
they wish that I can change and leave the drug and also to becomes a better person”. 
Some participants reported that instead of the normal discrimination which is 
perpetuated on females who smoke and inject nyaope, some community members 
expressed love and encouragement. The participants reported that:  
Participant 9 “Some treat me well and others discriminate against me, and undermine 
me. Others changed, sometimes they treat you well, sometimes they stigmatise”. 
Participant 3 “They did not discriminate against me that I am smoking nyaope; they 
were supporting me, they would give me advice, they even offered to buy me drugs 
when I did not have money because they wanted to be free when I am around them. 
They did not want to hide their phones when I am around them. They would tell me 






have a problem as such, they only emphasised that they do not want me to steal 
because of nyaope”. 
Awareness campaigns should also be directed to the community with the aim of 
educating them about the effect of their stigmatisation which is perpetuated on female 
nyaope injectors. It can also help teach them how they can assist females to mitigate 
risk of contracting HIV and other blood-borne infections.  
4.4.2.2.2.2 Community reactions to injecting practice by female nyaope 
injectors 
Female nyaope injectors experience intensive stigma than their male counterparts 
because their drug use is perceived as breaking the natural roles of females in society, 
that is, as “mothers, the anchors of their families, and caretakers” (Rahman, Iqbal and 
Vicknasingam, 2015:1). Once the community learns that particular females have 
transitioned from smoking to injecting, they increase the level of stigma and 
discrimination. Studies from India, Mexico, Vietnam, and the UK on stigmatisation 
within social and healthcare settings have revealed that female nyaope injectors often 
experience intense stigma and social barring from their communities due to social 
condemnation of females injecting drug use (Mburu et al, 2018:5). The participants 
have reported that: 
Participant 20 “When I was smoking dagga it was better [the stigma], but after using 
injection, it became worse”. 
Participant 24 “Yoh! They treated me badly, very bad. When I was passing by they 
would say it is that girl who injects nyaope, what kind of a girl is that; people would talk 
behind and I hear them”. 
Participant 11 “They have changed and they kept on saying that now I have taken it 
far and that I will get sick”. 
Furthermore, like the families of female nyaope injectors, the community equates the 
practice of injecting nyaope to self-destruction. Participant 9 reported that “they are 
saying now they are killing themselves, this is the end, and some are happy, someone 
said few weeks back, “to inject is better why does she not sniff it”. This was 
corroborated by Participant 22 when she reported that “when they pass us on the 






ourselves, and things like that. But they would not tell us, they would gossip as they 
walk away”. 
The stigma has contributed to female nyaope injectors hiding their injecting and 
exposing themselves to high risk behaviour and lack of access to harm reduction 
services. Participant 2 reported that “… it was not easy, because I would go far from 
the people who really know me, I would smoke where people do not know me”. Fear 
of the community knowing that she injects nyaope drove her away from her 
community, around people she knows, places she knows, to where she is not known. 
This could make her meet different drug networks which engage in riskier behaviours 
than the ones which are in her community.  
4.4.2.2.3 Health care institutions 
Female nyaope injectors have different experiences regarding health care institutions, 
which are mostly unpleasant, making it challenging for them to seek health care 
services when they are in need. Participants shared about the stigma and 
discrimination they experienced from health practitioners. Stigma and discrimination 
influences how health practitioners relate with, and spoke to people who inject drugs 
when they learn about their drug use (Carusone, Guta, Robinson, Tan, Cooper, 
O’Leary, de Prinse, Cobb, Upshur and Strike, 2019:4).  
The intense stigma directed to female nyaope injectors can present an overwhelming 
obstacle to the opportunity of approaching harm reduction services, drug treatment, 
HIV treatment, sexual and reproductive health care. More, especially in culturally 
conventional societies (Pinkham et al, 2012.126). Many females unavoidably found 
themselves forced by conditions to seek health services, and in those conditions, they 
tried to hide their identities, so as to avoid being stigmatised or discriminated against 
by health workers (Mburu et al, 2018:5). Stigma adds to poor mental and physical 
health and hinders with drug treatment and recovery (El-Bassel, 2015:5). 
4.4.2.2.3.1 Barriers accessing health care services 
Participants highlighted stigmatisation, withdrawal and poor services at local health 
institution as a barrier to assessing health care services. They reported that: 






Participant 8 “You do not feel welcomed as long as it is about withdrawals or if the 
nurses can find out that you are an addict, they do not treat you nice”. 
Participant 4 “Some of them become very rude and very stand-offish. Some of them 
are very judgmental and at times they say things like ‘why must you be even be here 
because this thing that you are using kills everything, so do not come here to waste 
our time’. Sometimes they have that attitude, but not everyone”. 
Participant 3 “They treat us good at the clinic [Sediba], they are not like our clinics 
(ordinary clinic) they would insult us. It happens that you arrive at 7.00am, you will 
leave at 4.00pm or 4.30pm. Since I have been attending the clinic from town [Sediba] 
I never spent more than 3 hours, even an hour”. 
Participant 22 “I feel, if I go to the clinic, people who are at the clinic will look at me, 
all the attention will come to me, saying there comes nyaopes [nyaope user], what is 
she doing at the clinic, things like that”. 
Participant 5 “Let me tell you, the first time they turned me away for proof of address. 
I stayed the first day, then the second day, I looked for the proof of address and I did 
not find it. Third day I went and asked for help, I was fine, then they refused saying I 
should find proof of address looking at me”. 
Female injectors who are vagrant or lack proper documents may face extra difficulties 
in accessing harm reduction or HIV treatment (El-Bassel, 2015:4). Participant 5 was 
turned away several times from the community health centre because she did not have 
proof of address.  
Participants highlighted that stigmatisation by health care practitioners makes them 
unwelcomed at the clinic. They further alluded that due to time spent at the clinic, it is 
unbearable to deal with withdrawals. The participants shared the following narratives: 
Participant 8 “Yoh! When you smoke and you do not have money you will compromise 
your appointment. Like you must first hustle before going to the clinic”. 







Participant 24 “It was not easy because every day I had to look for money to be able 
to smoke. The time I spent going to the clinic was the time that I was supposed to 
make money in the streets while I am sitting in the clinic”. 
Participant 17 “I would smoke first, it would not have been easy because I would be 
going up and down”. 
Stigma has been identified as an essential barrier to care for people who inject drugs, 
leading to poor health outcomes. PWID were less likely to receive a routine physical 
examination than the general population (Lan, Lin, Thanh, and Li, 2018:2). 
4.4.2.2.3.2 Attending antennal classes  
The participants did not visit their clinic in time when they were pregnant. Factors which 
influenced the participants not to access their health care services disadvantaged 
them as they did not attend antenatal classes. Females who use drugs normally do 
not take the non-appearance of menstruation as a sign of pregnancy; other signs of 
pregnancy had to be seen before they would begin to suspect that they were pregnant. 
Most females’ pregnancies were accidental because of their irregular periods while 
taking drugs (Horitavorn, 2008:39). The participants reported that:  
Participant 17 “I did not attend to the clinic until the child came. The child came before 
time but he is fine, healthy and well. I was scared that the child can be disabled or 
come deformed but I was unable to stop”. 
Mokwena (2016:138) argues that health issues pertaining to nyaope use are not 
extensively known, however, Thomas and Velaphi (2014) reported cases of two 
neonates who were born to mothers dependent to nyaope. The children presented 
with growth restriction and other signs of neonatal abstinence syndrome, which the 
authors attribute to nyaope use. Drug use among females may also result in some 
pregnancy difficulties, such as neonatal abstinence syndrome, low birth weight and 
premature birth. Neonatal abstinence syndrome mainly refers to opioid withdrawal 
experienced by infants born to females who continue to use opioids during pregnancy 
(UNDOC. 2018:16) 
Some female nyaope injectors did not know they were pregnant until quite late, making 






care, harm reduction services, drug treatment and other support, or to terminate their 
pregnancies safely if they so choose (Pinkham et al, 2012:127). This was confirmed 
by Participant 19 when she reported that she “was 7 months pregnant” when she 
discovered her pregnancy. The participants did not know they were pregnant until it is 
too late to attend antenatal classes at their local clinic. Participant 10 reported about 
her child that “she is also infected with HIV... I went late to the clinic”. If she had known 
in time and attended antenatal classes, the health care practitioners would have 
assisted the participants to be on medication which would have enabled the child to 
be born HIV negative. 
It is also reported by literature that most health practitioners are not skilled to handle 
the unique needs of females who use drugs. The unfriendly attitude towards females 
who use drugs poses a substantial deterrent for females to pursue treatment (Azim et 
al. 2015:519). It is therefore of importance that health service providers are trained 
and capacitated to handle the unique needs of female nyaope injectors so that they 
know what to do when they encounter female nyaope injectors. A study by Mburu and 
colleagues (2018) has shown that different forms of stigmatisation of female nyaope 
injectors are an obstacle to their access and use of health services. Facing shame 
related to one’s drug use can contribute to dodging of harm reduction and general 
healthcare services. Further, the study revealed that poor access to services was 
facilitated by poor interactions with, or obvious discrimination by health providers 
(Mburu et al, 2018:5) 
4.4.2.2.3.3 Treatment of abscess by female nyaope injectors 
Participants have experienced abscess and they treat it differently. Some participants 
reported that they go to community health care centres while others indicated that they 
treat them themselves and others do not treat them.  
Participant 3 reported that she does not experience abscess even when she has 
missed, she reported that “I would be surprised when I have missed, you see my hand 
(showing) I had missed but I cannot show you the wound because I do not see it. This 
are the marks of injecting. I cannot really show you because when I have missed, I get 
swollen then it disappears just like that. I do not get open and get discharges like it 






my hand will get normal”. This was corroborated by Participant 5 who said “I do miss 
at times. But I do not get abscess, you see here and here (showing). I have missed 
yesterday but it is not even painful”. 
Participant 9, who went to the community health care centre, reported that “I missed 
on Monday and I immediately went to the hospital following day. That is where I was 
told that the reason they dealt with it easy was because I came for treatment early. 
They also showed me an example of a person who does not go to hospital early”. 
Participant 18 reported that it was embarrassing to go to the clinic but she went and 
“(the nurse) just looked at me, he was a male nurse. He just looked at me, clicked his 
tongue and cleaned me then gave me pills. I am sure that he was able to conclude 
that I am injecting and it was embarrassing”. Participant 12 reported that “when I was 
using a needle, old needle at that time, I did not know about COSUP, I was using one 
needle for two weeks because I was using it alone, so I started getting abscess in my 
hand then my hand started to get dirt, stinking; then I went to Steve Biko (hospital)”. 
The participants, despite the stigmatisation perpetuated on them for injecting drugs, 
drew courage and visited their community health centres when they experienced 
abscess.  
Some participants indicated that they treated themselves. Participant 7 reported that 
“I used to leave it until it becomes yellow itself then, I bust it, then after that I put a 
Betadine then I bandage it. I have to clean it first then my husband advised me to drink 
Stameta”. Participant 11 reported that she “was treating it with an olive leaf and 
bandages”.  
The stigma perpetuated against female nyaope injectors is doing more damage that 
the drug itself. Judgmental and moralising views towards drug users are regularly 
spoken within South African communities, more specifically by health practitioners. 
This demands specific attention as health care service providers are required to attend 
medical needs of female nyaope injectors. The attention can be through training health 
care workers to handle female nyaope injectors. Sensitisation training for health 
practitioners about key populations has been endorsed to reduce stigmatising 
attitudes and behaviours towards clients, and therefore reduce HIV transmission and 
prevalence rates in South Africa. The training is in line with The South African National 






expanding training and sensitisation programmes to reduce stigma: Programmes to 
protect those affected by HIV against discrimination and violence and to support 
access to HIV prevention, treatment, care and support” (Duby, Fong-Jaen, Nkosi, 
Brown and Scheibe, 2019:2).  
Through the sensitisation training, the health workers will be able to handle female 
nyaope injectors, which will make female nyaope injectors to feel welcomed at the 
health care centres and not to delay when they experience health issues.  
4.4.2.2.4 Police 
The police, as law enforcers, are caught violating the law with regards to female 
nyaope injectors. Instead of protecting the rights of female nyaope injectors, the police 
are leading in violating their rights. The police indirectly contribute to needle sharing. 
Carrying clean needles for fear of arrest contributes to needle sharing, which increases 
the risk of contracting HIV (Chakrapani et al, 2011:4). Scheibe et al (2017:2) reports 
that drug use is criminalised in South Africa, but no laws ban the buying or providing 
injecting equipment. The participants reported that police broke and confiscated their 
needles, and arrested them without charging them in court.  
4.4.2.2.4.1 Breaking injections 
In order to curb HIV incidence amongst female nyaope injectors, it is important that 
they should have access to sterile injecting equipment at all time in order to discourage 
injecting sharing. Females who use drugs report high rates of police abuse (UNAIDS, 
2019:14). Appropriating injecting equipment, even in places where needle-syringes 
are not legally restricted, contributes to female nyaope injectors not carrying their 
injections (UNAIDS, 2019:36).  
Police confiscate and break female nyaope injectors’ injections, exposing them to a 
situation where they must share injections with other injectors. It is extreme 
disappointing when police confiscate injections which are provided by harm reductions 
programmes like COSUP with an aim of reducing infections among people who use 
drugs. Participant 11 reported that “they did not arrest me, they took my needles and 
broke them”. This was supported by Participant 10 who reported that “they break 






further added that “they took all of them [the needles], like, I just came from COSUP 
to exchange and they took all of them”. Police are fighting and unfairly treating female 
nyaope injectors. Confiscating female nyaope injectors’ needles fuels the sharing of 
needles among females and the network of people who inject nyaope. 
4.4.2.2.4.2 Police arrests 
The participants have been arrested by the police without being charged in court. The 
participants have identified this type of arrest as white door arrest. The researcher is 
of the view that the police arrest female nyaope injectors as punishment for injecting 
nyaope. Such a practice violates the rights of female nyaope injectors and destroys 
the trust and faith the females have in the justice system.  
The participants reported that:  
Participant 22 “Sometimes the police, when we are at station, when they find us 
smoking, they take us to holding cells and we remain in the police cell for 48 hours. 
After 48 hours, we are released through a white door. We do not go to court or 
magistrate, they just punish us”. 
Participant 7 “I was charged but I was out with white door [not charged], it is like you 
do not get to go to court; they keep you in police station. The day you have to go to 
court, you stay there in court until people get to court and they are finished after lunch. 
Mostly they call you guys the ones arrested for drugs and then they make you sign 
and take finger prints then you can go”. 
Participant 10 “They arrested me but later I was out and never went to appear at 
court, I only got out with a white door. I do not know whether it was a warning or what”.  
When the police are dealing with female nyaope injectors, they do not excise respect 
and do not protect their rights. Participant 3 recalled the ordeal she suffered when the 
police arrested her for the second time. She reported that “police approached us, 
people ran away and I fell down, then I was arrested. The police said I have something 
stashed down there, I said I do not have anything hidden on me. I tried to explain that 
I fell as other guys were running away. The female police searched me and stripped 
me but they did not get anything. They discussed among themselves to take me or 






better if they took me inside the van but they insisted that I undress in public they said 
that they want see, I really did not feel well”. 
Due to violation of human rights perpetuated by the police on female nyaope injectors, 
female nyaope injectors do not trust the police. Female nyaope injectors do not report 
police abuses due to fears of incarceration or other retaliatory penalties for themselves 
and their families (El-Bassel, 2015:6 & UNDOC, 2017b:23). Participant 2 reported 
that “we do not go there, because if we go to the police station, for someone who is 
injecting drugs, they are not going to take you serious”. The treatment female nyaope 
injectors receive from the police has created an impression on female nyaope injectors 
that the police are not for them, and they do not deserve justice.  
Police are another factor that drives drug users out of their community. The “War on 
Drugs” brands injecting drug users as criminals characterised by deviance, lack of 
control, violence, and moral depravity. This eventually builds an environment of 
violence and discrimination against anyone who uses drugs (Horitavorn, 2008:25). 
There is cumulative acknowledgement that the criminalisation of people who use 
drugs is destructive to human rights and public health objectives. The decriminalisation 
of drug use and possession has the prospect to lessen obstacles to providing harm 
reduction services. UNODC is conducting sensitisation training for police officers to 
assist in addressing the harms that often rise when people who use drugs interacts 
with the police (Southwella et al, 2019:4). 
Dintwe (2017:162) contends that the availability and distribution of nyaope is openly 
visible and the failure by law enforcement agencies to close ranks with the pushers 
and drug lords provides a mystery as far as the willingness of law enforcement 
agencies to deal with nyaope.  
The author further argues that law enforcement need to approach nyaope differently 
because:  
• Nyaope is a multi-faceted challenge;  
• Nyaope addiction is caused by a variety of factors;  
• Nyaope addiction needs a multi-faceted approach; and  






 Raising money 
Female nyaope injectors engage in different means to raise money to feed their habit. 
They do not engage only in sex related risk as highlighted at the sexual risk section.  
4.4.2.3.1 Having multiple partners 
The participants have highlighted that they are able to generate money through 
multiple partners. Some of the partners are aware that they are not in normal 
relationship, rather they are in a transactional sex relationship. Others are of the 
assumption that they are in relationships, without knowing they are used as cash cows. 
Multiple partners increase risk of contracting HIV infection.  
Participant 10 reported that “I have my people whom I engage in transactional sex 
with, but he does not know”. Participant 24 “only one was good to me but the other 
two, they were not so good to me but I was with them because I wanted money”.  
Participant 7 reported that “I used to, because you know, sometimes the other one 
does not have money, the other one has it, so it is like when that one does not have 
that one has; they cannot all not have it at the same time. So that was one (way) of 
finding myself, control my habit because if one did not have I would go to another one; 
apparently he would have money, then I would smoke and feed my habit”.  
Participant 23 said “I used to do it because there was this guy that loved me but he 
knew that I have a problem of smoking. He used to come to me wanting to have sex 
with me then I would tell him I cannot, I want money first so that I can be fine because 
you will also be fine with whatever you want so I also want to be fine, I want money”.  
The participants, while having their intimate relationships, established a network of 
sexual partners whom they slept with for money.  
4.4.2.3.2 Stealing 
Charlton, Negota and Mistry (2019:47) argue that most of the time nyaope users are 
unemployed and do not have sufficient resources to maintain their drug using 
lifestyles. Due to their circumstances, many admit to engaging in crime to feed their 
habit. The common crimes that were identified include housebreakings, theft, stealing 






utensils. Nyaope users further confirm that they would steal whatever they can get 
their hands on like water faucets, electric cables, copper and aluminium wires. Once 
they have obtained these items, they will sell them at scrap yards for cash and use the 
money for their next “hit”. Most participants stated that they prefer to commit minor 
crimes as these types of crimes require less energy. Participants acknowledge that at 
times they are involved in criminal activities to raise money to buy drugs. Participants 
reported that:  
Participant 22 “When I did not have money, the first thing that came to my mind was 
shoplifting so that I can make money to buy nyaope”. 
Participant 1 “Eish! You [when I was still back at home] I used to steal from my 
parents”.  
Participant 19 “Searching my mother; I used to search her with the mentality of I took 
it and there is nothing she can do. But I did not steal from people in the streets”. 
Participant 24 “At times we would steal the purses of the clients and phones”. 
Participant 2 “Sometimes if have a customer/client I would steal money or phone just 
to get extra”. 
Participant 5 “Currently I sometimes go to the white neighbourhood and ask, others 
would give me. When they do not give me, I [would] jump the fence, pick up something 
very fast then run away”. 
Participant 7 “I used to do shoplifting, so I used to go to Jubili Mall, that was the time 
I was in the location”. 
Participant 8 “I do shoplifting, and I steal at home”. 
Participant 10 “Sometime I make plans. Sometimes I will do things against my values, 
like stealing, but most of the time I do odds jobs; I do washing for people. That is how 
I raise money”. 
Participant 14 “I remember with my friend we risked. He wanted to steal something 
from some people, but if they can realise that we are here, it was either one of us will 






the territory, and you know what, the way we planned it, the getaway is quick, here is 
the house and there is the bush [showing with hands]. It was not a house but a place 
where they fix cars, so he gave me the one battery and he also took one battery. That 
was risky, if they catch you, they will hit you badly. Remember the last one they hit so 
bad that he did not make it after four days in the hospital; he died. They call those 
people the Maries. All of them they are like this [huge] but they are using cars, you can 
ask anyone about the Maries”. 
Participant 15 “House breaking and stealing things like irons. I did that because of 
my boyfriend. Personally, I have a fear for stealing from someone”. 
Participant 6 “Searching and stealing from my clients”. 
The mixture of poor financial backgrounds, joblessness and the addictive nature of 
nyaope sways drug users to commit crime, mostly petty theft, to finance their habits. 
The criminal element is influenced by the intense physical withdrawals for nyaope 
(Mokwena and Huma 2014:358). Communities distressed by nyaope use report crime 
mostly in the form of stealing of various items, including food, and household items 
like pots, cutlery and clothes, committed by the users, as they sell the stolen items to 
obtain money to sustain their habit (Mokwena and Morojele, 2014:380). 
4.4.2.3.3 Depending on boyfriend for money  
Drug-using females encounter high levels of unemployment due to the discrimination 
and stigma. Females who inject drugs have insignificant prospects of finding 
employment and become financially dependent. Many of the females remain poor and 
depend on their intimate partners for food, shelter and basic necessities (El-Bassel, 
2015:6). This is confirmed by the following statements:  
Participant 23 “Hmm… mostly things to smoke I would find them from my boyfriend, 
because my boyfriend is selling nyaope and at times I would get money from my 
parents”. 
Participant 1 “I was mostly dependent on him [my boyfriend], he used to be the one 
who provided most. If he does not have, I would have to go out and make a plan. If I 
go home, I would beg, and if I do not get anything, I would steal. Sometimes I would 






Participant 5 “Since he [boyfriend] was arrested, I am unable to hustle for myself, so 
I meet with people who have intentions of making me their girlfriend, but I am not 
interested in relationships. I get easily irritated since I began injecting, I tend not to 
have [sexual] feelings for the next person if he tries his luck. I use such for my 
advantage, he would be surprised next time when he comes to me I would dismiss 
him, telling him not to even touch me”. 
Participants are seen to be dependent on their intimate partner for maintaining of their 
nyaope use, the dependence fuels the risk of contracting HIV and other blood-borne. 
In circumstances where females’ intimate partners supply them with drugs, there is 
often the anticipation that they will have sex in return, which points to a gender power 
inequality that is strengthened by substance use. In these circumstances, a female’s 
refutation to have sex or her efforts to discuss condom use may trigger further violence 
(UNODC, 2018:17). In order to protect female nyaope injectors, the South African 
government, through the parliamentary processes, have to create bills and laws that 
are aimed at protecting the vulnerable females.  
4.4.2.3.4 Selling personal belongings  
Participant 18 shared that she sold her belongings to raise money. She reported that 
“other things like sex work I do not do, I would rather sell my own belongings”. The 
deprived socioeconomic environment results in street trading of a variety of items, 
which is a platform that nyaope users make use of in order to quickly and easily sell 
items to support their habit (Mokwena and Morojele, 2014:376).  
4.4.2.3.5 Working petty jobs 
The participants are involved in different petty jobs to raise money to buy their nyaope. 
Participants reported that: 
Participant 3 “I hustle by pushing people’s trollies, the ones who cook mielies”. 
Participant 16 “I do go to people’s houses, I am a woman; ‘do not you not have 
blankets that are dirty?’ So that I can wash them at a negotiable price”. 






Some of the participants use their hands to raise money for drugs. Participant 3 
further alluded that she stopped engaging in sex work to push trollies. This shows that 
female nyaope injectors can be self-sufficient in their pursuit to make money when 
their heart is at it.  
 Nature of intimate relationship 
As discussed above, female nyaope injectors are more likely to be in an intimate 
relationship with a male sex partners who injects drugs. Females’ relationships with 
their intimate partners who also use drugs are multifaceted and lively. Females work 
to finance their drug habits and that of their intimate partners. A study of female nyaope 
injectors who practice as sex workers in Canada established that the males take 
control of the females’ lives through a course of building trust, supplying and 
monitoring the supply of drugs, gaining control of their sex work environment and 
transactions with their clients. Sexual and physical aggression against female nyaope 
injectors is common. The experience and the threat of aggression serves to oppress 
females further. Intimate partners often control decisions on condom use. Poor 
condom use has been reported by females who use drugs with both clients and their 
intimate partners (Azima et al, 2015:17). IPV affects females’ power and capability to 
discuss the conditions of sexual intercourse, especially condom use (Turmen, 
2003:413).  
Some studies have projected that the occurrence of physical and sexual IPV is 3–5 
times higher amongst females who use drugs as compared to community-based 
samples of nondrug-using females (Pinkham et al, 2012:3). Violence has significant 
negative consequences on physical, mental and behavioural health, as well as sexual 
and reproductive health and chronic disease. Females who use drugs experience 
violence at far higher levels than the general population, and from multiple sources 
(UNODC, 2017b:6). 
Physical violence may build an environment of fear and submission that makes it 
challenging for females who use drugs to discuss safer sex, and for HIV-positive 
females to reveal their serostatus (El-Bassel and Strathdee, 2016:5). The participants 







4.4.2.4.1 What participants dislike about their intimate relations with 
boyfriends 
It is widely agreed that injecting drugs is a key driver of the HIV epidemic through risky 
sexual behaviour and use of contaminated injection tools. A majority of an estimated 
3,8 million women and girls who inject drugs globally are at risk of contracting HIV. 
Among these women who inject drugs, certain psychosocial conditions, including IPV 
and depression, co-occur within them leading to increased rates of risky sexual 
behaviour and subsequent HIV transmission (Mwangi, Karanja, Gachohi, Wanjihia, 
and Ngang’a, 2019:2). The relationships between female nyaope injectors with their 
boyfriends are not perfect; there are things which participants have highlighted with 
regards to what they do not like. 
The participants said: 
Participant 1 “Sometimes he would tell me ‘go and steal at your home, your mother 
has a lot of money’, such things”. 
Participant 2 “That he is smoking, I hope he was not smoking to help me to stop”. 
Participant 12 “I do not like it when he is stealing from me; that is what I do not like. I 
do not like a person that steals my things, he must rather ask then I will give because 
I cannot say no to a person”. 
Participant 15 “I am staying at his home and he will tell me that I must not forget that 
without him I am nothing. If it was not for him, I would be on the street. When he does 
not have anything, I must go and make a plan so that he can smoke; I end up selling 
my body”. 
Participant 4 “The fact that we are both using drugs and we have a child on the way”. 
Participant 24 “The fact that he allows me to go and be a sex worker; he is supposed 
to protect me. The other thing is that I used to give him money that I get from being a 
sex worker. He was not giving me good encouragement, all he wanted was money”. 
The relationship between female nyaope injectors and their boyfriends is complex. 
The participants have highlighted that they desire support, protection and 






researcher has observed that female nyaope injectors are negatively influenced by 
their intimate partners. Participants are not happy with dating intimate partners who 
are using drugs, they wish their intimate partner could stop using so that they can 
support them stop using drugs. Participant 24 and Participant 15 do not enjoy 
participating in sex work and t wish their intimate partners could assist them financially 
so that they can stop engaging in sex work. 
4.4.2.4.1.1 Emotional abuse  
Participant 3 shared that she experiences emotional abuse at the hands of her 
intimate partners. She reported that “the way he is so impatient, the way he does not 
trust me because I was a sex worker, he is controlling. Even now that I am here, you 
might find that he was following me, maybe if I get out I can find him at the gate”. The 
participant is being stalked and her freedom of movement is restricted by her intimate 
partner.  
Participant 5 reported that “after 6 months of injecting, I began to change, I did not 
take any medication. He would tell me that when he was touching me, he would feel 
flesh, but since I started to inject, he feels bones, and that I appear sick”.  
The intimate partners were insensitive of the emotional needs of their partners. It 
appears that they did not care how their partners felt. The emotional abuse inflicted on 
female nyaope injectors increases their vulnerability as they start to question their self-
worth, which then disturbs communication between the partners. Emotional abuse 
may generate a similar context of supremacy, which fuels females’ likelihood of 
participating in high risk sexual behaviour. Developing research suggests that 
emotional violence has comparable damaging impact on females’ health outcomes as 
physical and sexual forms of IPV (Stoicescu et al, 2018:3308). 
The anxiety of others finding out about the diagnosis also depresses people from 
making contact with health services, community, and family (Horitavorn, 2008:55). HIV 
positive females who experience IPV are less probable to access HIV care, comply 
with ART, and engage in HIV prevention and drug treatment services (El-Bassel, 
2015:5). Participant 5 shared that she “did not want him (boyfriend) to know my HIV 







4.4.2.4.1.2 Physical abuse  
IPV and HIV infection are key interrelated public health problems worldwide, 
disproportionately impacting sub-Saharan Africa. Sexual IPV may directly lead to HIV 
acquisition by forced sex without a condom or an inability to negotiate condom use 
with an infected, violent partner. Further evidence suggests that men who use violence 
against their partners are more likely to engage in a range of high risk sexual 
behaviours, relative to men who are non-violent (Sabri, Wirtz, Ssekasanvu , Nonyane, 
Nalugoda, Kagaayi, Ssekubugu and Wagman, 2019:1).  
Physical abuse is effected with the aim to capture control of female nyaope injectors 
by their intimate partner. Participants shared how their intimate partners are physical 
with them. Participant 6 shared this about her partner: “he assaults me at times”. 
Participant 5 said that “my boyfriend would beat me”. 
Participant 5 was abducted by her ex-boyfriend after their break up and knowing the 
she uses nyaope; he did not permit her to smoke dagga, but rather that she can use 
his nyaope only if she injects it. Participant 5 reported that “things did not go well for 
him with his new girlfriend and when he realised my new relationship was going well, 
he was jealous. He came with his friends and took me by force to Stinkwater… When 
we got there, I started to withdraw, he told me that if am withdrawing, I will not smoke 
his money, if I want to use his drugs, I will have to inject. I resisted at first because I 
did not want to inject because of him, but in the morning, around 3am, I decided that 
he can inject me because the withdrawals were getting severe”. 
4.4.2.4.2 What participants like about their relationships with their boyfriend 
Despite the negative experiences female nyaope injectors go through at the hands of 
their boyfriends, the participants have indicated what they like about their relationship 
with their intimate partner. The researcher has observed that participants are in an 
intimate relationship with people who are using drugs. The participants reported: 
Participant 12 “We are open with each other and we do things together, there is no 
hiding things, no! That is what I like about it, we are honest with each other”. 
Participant 13 “We have an open relationship; we are like friends, we trust each other 






there and I will not smoke if he is not there, so we always do things together we are 
like Bonny and Clyde (laughing)”. 
Participant 2 “Like, he would give me money to buy stuff, then I do not have to go to 
the streets”. 
Participant 4 “We are open with each other, we have an open communication and we 
trust each other”. 
Participant 3 “In our relationship, I love that my partner is considerate. This is because 
since I started dating him, I can see that I can stop using drugs because he gives me 
advice and he is not impatient with me. He gives me advice and the reason I go home 
constantly is because of him. To be honest, for me to go home it is because of him; I 
go home to see the children then he encourage me to stop smoking and to also come 
here”. 
Participant 5 “What I loved about my boyfriend is that he took care of me; people 
used to tell him that your girl is injecting behind your back but he did not take rumours. 
As long as he has not seen me, he would have never come to me and fight over 
something that he did not see. He also trusted me even though people were telling 
him that I am injecting, he would give me about R2 000 for clothes, and what we need 
in the house. He has a place in Hercules, it is his own place, now it is me who is in 
charge because he is not there”. 
Participant 10 “In the beginning, I used to struggle when I had to smoke; I had to go 
out and engage in bad things. Now he takes the responsibility that I should not lack”. 
Intimate partners are helpful in the lives of the female nyaope injectors as the 
responsibility of provision is relegated to them. The participants shared how the burden 
to hustle was offloaded from them as a result of the presence of their intimate partner 
in their lives.  
 Value of NSPs 
There is evidence that NSPs lessen the possibility of transmitting HIV and other blood-






people who inject drugs. WHO endorses distribution of two hundred needles and 
syringes per person who injects drugs each year (UNAIDS, 2019:19). 
4.4.2.5.1 Access to clean injections 
People who inject drugs who cannot access harm reduction services, specifically 
needle and syringe programmes, are at high risk of contracting HIV and other blood-
borne infections. People who use drugs struggle financially, and buying injecting 
equipment can be a daunting exercise for them. This will contribute to the increased 
probability of reusing, and sharing contaminated injecting equipment (Scheibe et al, 
2019:2-4). The participants have reported that accessibility to clean inject it is a huge 
challenge for them. They reported that before COSUP was established, they had to 
buy injections at pharmacies, which was not easy for them as they were discriminated 
against. Participants further indicated that they used to get injections from those who 
have been diagnosed with sugar diabetes. Participants reported that:  
Participant 1 “He [boyfriend] bought them, he used to go to town to buy rock [cocaine], 
when he goes to town, he would buy injections”. 
Participant 21 “I was buying them”. 
Participant 13 “We bought needles at first, but it was still sealed with the water and 
all and then after that I started to register myself for NSP by COSUP, now I am getting 
my own NSPs”. 
Participant 10 “There was also a place where there was some females who were 
sugar diabetic, and she was injecting herself. I would always ask from her when I did 
not have injections”. 
Participant 23 “I was buying them, because they sell them, so I was buying them. 
After that I had the information that at COSUP they distribute injections, I came and 
took injections”. 
Before the participants had access to NSP, participants used to buy needles. A critical 
question which this study did not ask would have been “Where were you disposing the 
used needles?” In terms of reducing the risk for people who inject and general 






4.4.2.5.2 Safe injection training  
Harm reduction services which teach safe injecting have benefitted the participants 
who have access to their services. The programme provides clean needles and 
teaches female nyaope injectors on how to inject, where to inject, and where not to 
inject. People who inject drugs are linked to increased risk of local soft tissue bacterial 
infections, with subsequent serious risk for aggressive sepsis, pneumonia, and 
infective endocarditis. Inappropriate cleaning of the skin before injecting has been 
linked with increased risk of skin abscess leading to severe systemic sepsis (Islam, 
Piggott, Moriggia, Astemborski, Mehta, Thomas and Kirk, 2019:2). High intensity 
injection drug use behaviour is a disposing factor for bacterial infections. Reducing 
injection occurrence had a rapid and substantial benefit in reducing risk for serious 
bacterial infections even in the absence of complete cessation (Islam et al, 2019:6).  
Through harm reduction, participants were empowered to reduce the risk associated 
with injecting. Peer educators teach safer injecting and refers people with injection-
related injuries for treatment (Southwella, Shelly, MacDonald, Verster and Maherd, 
2019:3). Participant 4 reported that “at COSUP they gave us some classes, how to 
do it the right way, and how to clean the needles the right way as well”. Participant 2, 
who does not have a history of sharing needles and abscess, reported that NSP “is 
very important, it also help not to miss yourself or to overdose”. Participant 14, who 
reported that she never shared needles accessing harm reduction services from 
COSUP, said that she “came to COSUP and they told me all about (it) so I started to. 
Obviously they told me and showed me pictures, and I just told myself the way I started 
it was wrong because the other person’s needle is not the way to do, it was wrong”. 
 Needs of female nyaope injectors 
4.4.2.6.1 Basic needs 
The participants desire to have access to basic commodities which are necessary for 
survival. Participants reflects the challenges female nyaope injectors face when they 
must buy necessities like toiletries versus buying drugs. Participant 23 reported that 
“there were times were I was not able to do what I want at the time I wanted, if I want 
to get my hair fixed or I want toiletries or pads, it becomes difficult to get those things 






not have pads at that time”. Participant 17 reported that she “needed food, needed to 
bath, needed clothes, I needed to live normal”. Participant 2 agrees with Participant 
17, she added that “maybe sometimes they can give us food, to get healthy food, 
medication maybe if we are sick”.  
Participants highlighted food, medication, toiletries, clothes and taking a bath as their 
basic needs. These needs can be addressed through establishing drop-in centres. A 
drop-in centre offers a chance to provide services that address the broader physical 
and social needs of people who use drugs, beyond harm reduction. This is important 
because these needs normally go unserved when people who inject drugs face 
stigmatisation and isolation. People who inject drugs who do not have anywhere to 
stay are often malnourished. This can seriously worsen any health condition they may 
have. Where possible, drop-in centre may provide nutrition, showers where vagrant 
people will maintain their hygiene, comfortable seating area where people who inject 
drugs can meet, talk and relax in safe environment. Seating areas can also be used 
for support group sessions, and sleeping space where homeless people who do not 
have anywhere to go can rest. Where possible, a residence with camp-beds for short 
sleeps or longer periods of sleep should be made available (UNODC, 2017:123).  
People with a history of injecting drug stated that health was not of a concern during 
periods of active drug injecting, despite a high level of need due to negative attitude 
of health care practitioner, high demand of their addiction, and fear of potential 
consequences (Tweed et al, 2018:3). It is important for government to establish health 
outreach teams that will go to hotspots, and where female nyaope injectors spend their 
time, in order to reach the females who are greatly in need of health services.  
4.4.2.6.2 Financial independence and financial stability 
The participants reported that they have dreams. Drug use might have delayed and 
wasted their time, but they are determined to stop using drugs so that they can focus 
on improving their lives and that of their families. The participants indicated the need 
to be financially stable and independent. Injecting drugs has significant health, social, 
economic and environmental costs on individuals and society. One of the most 
imperative costs is lost productivity and social functioning. This includes the looking 






indicated the need to be financially stable and independent. Social function-ability will 
enable them to regain self-worth, as it will allow them to contribute positively in their 
lives and that of their significant others. Having a secure living environment and being 
financially independent also plays important roles in the ability of people with history 
of using drugs to sustain their recovery (Stokes et al, 2018:10). The participants 
reported that:  
Participant 21 “It is for me to go to school, to take care of my child, all that he needs 
to be right”. 
Participant 9 “To go back to school and upgrade my studies, get the job and also take 
care of my kids and family”. 
Participant 10 “I want to live them a legacy; I want to be an example to them and even 
when I see children in the community or a person smoking, I will help. I will also give 
testimonies about my experiences and I will not allow them to pass where I have 
passed, for I understand the pain”. 
Participant 15 “I am now old and it has been years I have been smoking. If I get help 
[I will] then find a job and quit this because I am no longer young, I have grown now”. 
Participant 5 “What I need is to get help so that I can stop smoking and to get a job”. 
Participant 12 “It is that it is so hard to live this drug but my need is to be a mother to 
my child you understand”. 
Participant 9 “To go back to school and upgrade my studies, get the job and also take 
care of my kids and family”. 
Participant 10 “Eish! I am tired to tell the truth, and because I have kids, and my 
mother is also aging up”. 
Participant 18 “To get a job, look after my child, for God to bless me and get married 
get my own home and my own car”. 
Participant 17 “A job and to be able to take care of my child and stop depending [on 






Participant 23 “Now my need is to get a job and do things for myself and to go back 
to school”. 
One participant indicated that employers should understand that she is injecting 
nyaope and they should not use her drug use as a factor not to give her a job. This 
view will be embraced by females who wish to inject drugs. Participant 2 reported 
that “I need a job, which can understand [the place of employment] that I am using 
nyaope and that I am injecting, because I need to come off the streets; that will help 
me”. 
4.4.2.6.3 Affordable drugs 
Nyaope does not come cheap; when tolerance increase, the budget increases. 
Participant 1 indicated the need to have affordable drugs. She reported that her need 
is “to have access to drugs or maybe to have them at the cheaper price. We can buy 
them for R10, it would be better and to have access to needles. I would really want to 
have access to drugs”. The affordability of drugs can reduce the economic hardship 
female nyaope injectors face on daily basis.  
4.4.2.6.4 Access to needles 
Female nyaope injectors desire access to clean needles, they do not share needles 
so accessibility to clean needles will assist them. Participant 8 reported that “my 
needs are to get needles, at times I do not get them here, and you find that they are 
out of stock”. Participant 1 added that “access to clean needles and not be seen as 
nyaope”. No participant would like to contract HIV or other blood-borne infections. 
Accessibility of needles will enable participants not to share, use old needles and to 
assist those who do not have sterile needles.  
 Personal experience  
4.4.2.7.1 Initiation to injecting 
Significant others plays a role in encouraging females to inject drugs. As mentioned, 
females are more probable to have their first drug injecting experience with an intimate 
partner and to have that partner inject them (El-Bassel and Strathdee, 2016:5, Larney 






borne infection transmission during injection initiation, as they are more probable to 
be introduced by a male intimate partner, share drug injecting equipment, and be 
injected after their initiator (Meyers, Scheim, Jain, Sun, Milloy, DeBeck, Hayashi, 
Garfein and Werb, 2018:1). 
Studies suggested that people who already inject may encourage injection initiation 
and excite none injectors about the benefits of drug injection which is linked to pleasure 
or cost-efficiency. This advocacy is then linked to providing injection initiation 
assistance, including administering an individual’s first injection. This encouragement 
by people who already inject could extend to peer pressure and more direct coercion 
(Guise et al, 2017:5).  
Being in an intimate relationship with a drug user has been shown to be considerably 
linked with a female’s commencement into and continuation of drug use. Females who 
use drugs are more probable to have had a male intimate partner who started them 
into drug use; they are also likely to ask the male partner to inject them, including in a 
social setting where others are present, contributing to their elevated vulnerability 
(UNODC, 2018:18, & GCWA, 2011:6). The participants were initiated to injecting 
practice by their friends and intimate partners.  
The participants reported that:  
Participant 11 “I met this other guy who was injecting. He taught to me inject. He just 
said it is nice, you will enjoy. He even told me that it stays longer in the blood than zolo 
[dagga]. I just said that spike me and then it continued and it was like that since”. 
Participant 2 “It was a friend I got to know, I moved to Cape Town and met this friend. 
He was a white guy; he was injecting and I was smoking so he told me I am going to 
feel it more. I can feel the nyaope more if I inject because I was complaining to get 
more high. He injected me, he taught me how to inject”. 
Females are more probable than males to begin injecting drugs in social setting and 
sexual relationships. Female nyaope injectors are more likely to have another person 
inject them, and to be “second on the needle”. Because some female nyaope injectors 
do not know how to self-inject; they rely on someone else to prevent withdrawal 
(National Institute on Drug Abuse, 2019:3). Guise et al. (2017:5) argue that social 






Friends, family, intimate partners, acquaintances, gang members, elders and drug 
dealers were all described as influential. 
It is not always where females are injected as if they are completely powerless when 
it comes to drug injecting. Participant 15 reported that “I injected myself while I was 
hiding, I stole my boyfriend’s injection for I always saw him injecting himself and how 
he does it. He was doing it in front of me. One day, while he was not there, I stole his 
injection and I got addicted to using injection”. This reflects that some females use 
their autonomy, and the decision to inject drugs is entirely theirs.  
4.4.2.7.2 Period before self-injecting 
The participants took different periods of time to inject themselves. With other 
participants taking only one week and others having taken more than a year without 
injecting themselves.  
The participants reported that: 
Participant 2 “Like two months”. 
Participant 5 “It took me three weeks”. 
Participant 11 “It was about a month”. 
Participant 14 “Close to 8 months”. 
Participant 21 Three to six months”  
Participant 17 “One week”. 
The participants conveyed a sturdy sense of individuality and self-sufficiency of their 
capability to learn how to self-inject. The capability to self-inject also imparted feelings 
of know-how, independence, self-control, and prevention of harmful, visible scars on 
her body (Tuchman, 2015:4). It gives females an opportunity to be in charge of when, 
where and how to inject. The participants preferred someone they trust to inject them 
instead of self-injecting: “I am frightened of needles, me putting a needle inside myself, 
but with someone else putting it, is almost like going to a doctor, a doctor putting a 
needle inside of you it is different than you putting a needle inside yourself - 
Participant 13 ”. Participant 14 corroborated this when she said “I was afraid of miss 






knows how to do it”. The feeling of self-injecting is frightening and prevents some 
female nyaope injectors from injecting themselves, which puts them at risk of being 
second on the needle as they depend on other injectors to inject them. Females need 
help injecting because of their lack of knowledge or deference to an injector due to 
anxiety or withdrawal (Tuchman, 2015:6). 
4.4.2.7.3 Feelings of injecting first time 
Female nyaope injectors reported that injecting for the first time was not comfortable. 
The reasons for injecting outweighed the discomfort of injecting. This is supported by 
the following narratives: 
Participant 1 “From a scale of 1–10 (laughing), I was not comfortable at all [with 
injecting] because eish! You know when you are not used to needles, it is 
uncomfortable but as you go along…” 
Participant 2 “I was scared (laughing) I was very scared, but the people from needle 
exchange came, they asked how do I spike; I told them and they said I am doing it 
wrong so they taught me how to do it and gave us needles”. 
Participant 4 “It was not very comfortable because of why? It was like yoh! Really? 
Am I really doing this? [injecting].” 
4.4.2.7.4 Self-perception 
Female nyaope injectors create self-stigmatised identities in such a manner as to 
make it difficult to have valuable relationships, accepting that they do not deserve to 
be loved. The internalisation of the stigma is associated with low self-esteem. Apart 
from being ashamed of themselves, female nyaope injectors consistently witness 
negative attitudes from their communities and families. This stigma is influenced by 
moral judgement. Besides experiencing the stigma in communities, the stigma of 
injecting drugs was regularly experienced in health-care sites. Regardless of where 
the stigma comes from, stigmatisation of female nyaope injectors seems to results in 
separation and exclusion through biased social processes and institutional practices. 
Self-stigma is steady with other studies which have defined internalised self-stigma 
among female nyaope injectors, which in turn leads to feelings of embarrassment, low 







Participant 8 “I feel like a failure but I do not want to put that mind of a failure to me, I 
want to fight this thing”. 
Participant 11 “I just need to get out of this thing of drugs, it is not nice for a woman 
to smoke”. 
Participant 9 “If I still smoke I can achieve half or few of them. If I must achieve a 
100% and am still smoking, I know I will only achieve 15%. But if I stop using drugs, I 
will be able to achieve 100%”. 
Participant 6 “When I look at my life, it is ruined because of the drugs; they have taken 
over too much in my life that I live under their control now”. 
Participant 5 “I notice that people would take advantage, they would judge me saying 
I am in a line of people who are taking medication (HIV supplements); ‘she is also 
sick’; it is like people would be scared at me”. 
Participant 7 “I was always in the streets smoking, never had time to eat, never had 
time to bath, like, I was always where smokers are. I was there, not going home 
sometimes. My parents would even stay months and months not knowing where I was; 
I was not talking to them; so that was bad”. 
4.4.2.7.5 Sexual reproductive health 
Female nyaope injectors have rights to be intimate and to sexual reproductive health 
services. Substance abuse/use service programmes should empower females with 
knowledge of their sexual reproductive health. This research has shown that some of 
the participants do not understand issues pertaining to their menstrual cycle; which 
then disadvantages them. Harm reduction comprehensive packages could help 
female nyaope injectors improve their sexual and reproductive health, which will end 
in preventing unintended pregnancies and improving pregnancy outcomes (Pinkham 
et al, 2012:128). The participants reported that:  
Participant 12 “When I use drugs, I do not fall pregnant. I am telling you, but when I 






Participant 16 “I have inserted a misconception in my mind that the ladies that smoke 
nyaope hardly get pregnant; we do not know what nyaope does to their system, you 
understand me?” 
Participant 17 “When smoking, the chances of getting pregnant are slim,because one 
does not go to periods [menstruation cycle]. I did not even know that I was pregnant, 
I found out when I was 5 months, and on the 7th month I delivered”. 
Participant 23 “I did not have a regular menstrual period. Even now I have not gone 
on the periods. What I know is that when smoking nyaope as a woman, it becomes 
difficult to go on the menstrual cycle. Even when you get clean, it takes time for the 
system to go back to normal and be on periods; it can take close to 4–5 months to be 
on periods”. 
Participant 6 “I lastly saw them (period) last year”. 
Sexual and reproductive health care services, which encompasses contraception, 
should be looked at as a vital part of harm reduction, comprehensive prevention, and 
care for HIV among female nyaope injectors. For the programmes to make a desired 
impact, they should offer free, integrated needle exchange, drug treatment and non-
stigmatising sexual and reproductive health advice, and parenting assistance 
(Uuskülal et al, 2018:7). These programmes will be able to attract and reach out to 
female nyaope injectors (Azim et al. 2015:518). Harm reduction services have 
established individualised services for females which offer a conducive space and 
specialised services, such as sexual and reproductive health and pregnancy, neonatal 
and child-care support (Southwella et al, 2019:4).  
 Life after stopping drug use 
4.4.2.8.1 Feeling associated with stopping drug use 
Participants reported the use of nyaope as stressful; since they have stopped using 
drugs they have peace. The participants reported that:  
Participant 16 “I do not wake up with stress. I wake up free and normal like other 






Participant 23 “One does not have stress about to get money to smoke; life of 
smoking nyaope is very problematic. Like, it is very stressful, you can be afraid to wake 
up in the morning when you think that where are you going to get money to smoke; 
while others sell their body to in order to get money to smoke, others steal. Life as a 
nyaope addict is hard, it is not fun at all”. 
Participant 20 “It is good, I even gained weight now. I like the fact that I can be home 
for the whole day and watch TV. The other thing that I want is to work and have my 
own properties”. 
Participant 24 “I’m no longer smoking, I am clean now. I also keep myself busy by 
getting skills from POPUP. I am staying at home now, I do not go out a lot, I no longer 
smoke”. 
Participant 17 “I no longer ask for R1 from people. I am leaving like a normal person, 
even people from the community praise me. My child is also happy even at home”. 
Participant 19 “It is nice, I would ask for money, she gives me. All my requests … 
‘mom can you please come with pizza’, then she comes with it. She no longer locks 
the bedrooms, now I do not have problems. I no longer wake up in the morning thinking 
what am I going to smoke, no longer bother me because I do not feel anything, no 
cramps, nothing”. 
The participants concur that life of using nyaope is a life of slavery; it is a life no one 
can live intentionally. The participants report that their lives have improved since they 
stopped using drugs. They are more in control of their lives than before, and they enjoy 
their current life of no drugs.  
4.4.2.8.2 Desire to be treated well by family  
Participants indicated that after they have stopped using drugs, they wish for their 
families to treat them with respect and afford them trust which they had before they 
started using drugs. The participant reported that: 
Participant 16 “She can see the difference but she says I must stay clean; she will be 
satisfied if after a year I am still clean. That is when she can be assured”. 






Participant 17 “My mother is happy and the community is happy, things are back to 
normal. I live like a person that is not smoking”. 
A family member’s nyaope addiction has a negative emotional impact on the entire 
family. It disturbs the functionality of the family. The family, as a unit, becomes tangled 
in a course of physical and emotional disinterest, and individual members become 
socially detached from each other (Schultz and Alpaslan 2016:90). When a member 
of a substance-using family stops using drugs, the family reorganises and restores its 
peace.  
4.4.2.8.3 Treatment by community 
Community members have mixed emotions and do not treat females who have 
stopped injecting nyaope the same. Some wish them luck on their new journey, while 
other are counting the days for before they relapse. 
The participants reported that: 
Participant 23 “Now it is fine because they can see there are changes and like … 
They support me and tell me to be how I am now [clean], they will say ‘the participant 
23 that we know is now back so please keep doing that and keep it up”. 
Participant 20 “They are wishing me well, telling me to take care of my mother’s 
house. Others are telling me they are proud of me because people who smoke nyaope 
sell their belongings”. 
Participant 22 “Now they are trying to accept me, they do not treat me like nyaopes 
(nyaope user), they talk to me nicely. They say I have done well by stopping what I 
was doing and they treat me well”. 
Participant 19 “They would usually say there is no way I am going to last, I am going 
to go back”. 
Participant 17 “I could say fine, but I can also say they are jealous. They would say 
we only give her a month, soon she will be back to smoking things like that. But it is 







4.4.2.8.4 Managing intimate partner relationships 
Intimate relationship influenced some of the participants to start using and injecting 
nyaope. Participants adjusted their relationships with their partners. One participant 
has terminated the relationship, while another one changed where she spends time 
with her intimate partner. The participants acknowledge that their partners have 
influence and they can trigger them to use again. 
The participants reported that:  
Participant 23 “Currently, no, I do not have a boyfriend because I realised that 
continuing a relationship with him will take me back because I went to rehab then came 
back to him. I went to rehab again then came back to him, I tried being clean and when 
he is my life; it becomes hard to be clean because there is too much temptations”. 
Participant 16 “Now that he is still smoking, I made a decision not to go to his home 
anymore, if he wants to come, he has to come at home to see us”. 
Self-control, which extends to avoiding triggers such as friends who use drugs, places 
where drugs are sold, are some of the strategies important for maintaining abstinence 
throughout the recovery journey (Stokes et al, 2018:9). The participants identified their 
intimate partners as triggers and have instituted plans by separating in the case of 
Participant 23 and avoiding to see visit the partner at his place in the case of 
Participant 16. It is not easy for Participant 16 to separate from her partner as 
children are involved. 
4.4.3 Objective 3: Strategies aimed at curbing HIV prevalence among female 
Injector 
 Health intervention 
A health intervention is an act performed for, with or on behalf of a person or a 
population, whose purpose is to assess, improve, maintain, promote or modify health, 
functioning or health conditions. (www.who.int/classifications/ichi/en/). The 
participants identified NSP, condom distribution, accessibility to PrEP, and HIV testing 
and counselling as health interventions which can be used to curb HIV among female 






4.4.3.1.1 Needle and exchange programme 
Female nyaope injectors are pressured by lack of accessibility to sterile injections to 
engage in sharing injections. This fuels their vulnerability of contracting HIV and other 
blood-borne infections. Programmes that offer disinfected injecting equipment through 
NSPs are highly effective in decreasing transmissions of HIV and other blood-borne 
infections (UNODC, 2017:62). Females who are recovering from injecting nyaope 
acknowledge the worth of NSP in their lives. The following statements support the 
augment:  
Participant 10 “The service of providing injections is a good programme, it must 
continue”. 
Participant 18 “The idea for them to come here and give needles, I think it was a 
brilliant idea”. 
Participant 13 “NSP is important for the people that are smoking. I think the NSP is 
very important and now that COSUP is offering it, it is something good because some 
people really struggle to get NSPs”. 
Lack of accessibility to injections can influence females who are injecting nyaope to 
share among themselves or with other injectors.  
Barbour, McQuade and Brown (2017:2-3) argue that needle exchange programme 
has been shown to decrease risky behaviour and to provide a critical link to care for 
PWID, who may receive all or most of their services through their needle exchange 
programme. These valuable benefits occur without any known downsides, as NSPs 
often reduce syringe waste found in the community, decrease needle stick injuries, 
and have no negative impacts on crime or amount of drug use. Despite these 
impressive outcomes, NSPs remain politically contentious, largely due to significant 
social stigma against injection drug use and fears about legitimising drug injection or 
generating syringe waste. This is supported by the following narratives: 
Participant 1 “Actually, to prevent the spread of HIV I would suggest maybe giving 
them needles”. 






Participant 12 “What I would like to say is that they must not use these needles 
together because many of my friends passed on using needles together and did not 
know if the person is HIV [positive] and so on”. 
The participants further empathised that NSPs should be accessible to people who 
need it the most. Instead of providing the programme in offices, the programme should 
go to where female nyaope injectors are. Participant 3 highlighted that service 
providers should follow the footprint of condom distribution service providers.  
The participants reported that: 
Participant 4 “There should be more places that provide clean needles”. 
Participant 2 “People [female nyaope injectors] cannot always go there at the place 
where the needle exchange is, then they [NSP service providers] should go to more 
places”. 
Participant 19 “I would suggest that the needles be distributed to them. The same 
way they distribute condoms, they should give needles the same way”. 
NSPs should provide enough injections to enable users so that they do not borrow 
from other users. The programme can use vending machines, outreach teams, and 
pharmacies to guarantee that injecting equipment is easily reached and accessible in 
satisfactory amounts to prevent the need to share and reuse needles and syringes 
(Southwella et al, 2019:3). This is supported by the following narratives: 
Participant 3 “What I think we really need is the accessibility of injections and quantity, 
because most of us do not use the injections the same way. Some use less, others 
use more”.  
Since female nyaope injectors inject every day, it is important that the NSP is available 
daily. The participants reported that: 
Participant 23 “Injections to be available to everyone at whatever time, there should 
not be a particular day that a person gets injections, like, when a person needs an 
injection, they must get it”. 






Participant 24 “To give them the injections … giving them needles. Everyone should 
use their syringe. I think that to be helpful to reduce HIV”. 
NSPs come with controversy; mainly fuelled by the notion of whether a person who 
uses drugs should be seen as a criminal or a patient, and whether it is ethical or lawful 
to provide a person using drugs the means to inject. This assumption is usually held 
by opponents of NSPs who greatly support drug treatment programmes that are based 
on abstinence and ‘‘drug-free’’ treatment for addiction. NSPs have demonstrated to be 
a cost effective way of curbing HIV in other low income settings (Derrick and Clark, 
2013:139-140). The researcher argues that NSPs are necessary to curb HIV 
prevalence and other blood-borne infections, its accessibility will benefit the health 
state of female nyaope injectors.  
4.4.3.1.2 Condom distribution 
Females who inject drugs are more probable to practice transactional sex and sex 
work as compared to males who inject drugs (Scheibe et al, 2016b:113). Most of 
participants who engage in transactional sex, do not use condoms consistently with 
their intimate partners. Female nyaope injectors are more probable to practice high 
sexual risk as a result of the severe discrimination and cultural stigmatisation attached 
to injecting drug use (Marottaa et al, 2018:97). The participants reported that:  
Participant 17 “She must not be shot [lack] of condoms”. 
Participant 24 “They can be helped with condoms”. 
Participant 15 “Help them by giving them condoms”. 
Participant 21 “By giving them condoms”. 
Irrespective of a person's HIV status knowledge or ART compliance level, it is 
projected that the accurate and constant use of condoms decreases the risk of sexual 
transmission of HIV infection by seventy percent in heterosexual couples. Condom 
supply interventions have, for many years, been a backbone of public health HIV 
prevention efforts (Malekinejad, Parriott, Blodgett, Horvath, Shrestha, Hutchinson, 
Volberding and Kahn, 2017:2). 
The participants acknowledge the self-determination of female nyaope injectors to 






transactional sex can be lowered or reduced by the introduction and correct use of 
condoms during sexual intercourse. Distribution of condoms goes with the use of the 
condom. The participants said: 
Participant 24 “We can distribute condoms to them, and encourage condom use”. 
Participant 16 “Those who hustle by going to Rooival [informal brothel], at least they 
should have condoms”. 
Participant 2 “Sometimes girls come to me and ask for condoms; there is not always 
condoms everywhere. They want to use condoms but they are not everywhere like in 
the shops. They should put condoms more around the place”. 
Participant 9 “Let them be advised to always have condoms for safety. I cannot say 
let them be stopped because that is how they are able to get money to buy drugs. All 
in all, let them be advised to always have condoms with them in order to prevent 
themselves from getting sickness”. 
Participant 6 “They must bring them to us, we always have them”. 
Condom distribution should be intensified, and female nyaope injectors should have 
access to condoms. The distribution should reach female nyaope injectors where they 
are.  
4.4.3.1.3 Pre-exposure prophylaxis (PrEP) 
PrEP is a biomedical strategy, which offers supplementary HIV prevention options 
beyond traditional programmes like condoms for individuals at risk. PrEP comes in 
form of a pill that is taken daily to prevent HIV infection (Walters, Reilly, Neaigus and 
Braunstein, 2017:2). PrEP was made available only to people who are HIV negative, 
who are at a higher risk of contracting HIV (DOH, 2016:4).  
The price of PrEP is substantially lower than offering antiretroviral therapy to an 
infected person for the period of their lifetime. In countries where HIV PrEP is available, 
including South Africa, awareness of and access to it is low among female nyaope 
injectors. (National Institute on Drug Abuse, 2019:3). In South Africa, sex workers were 
amongst the first group of people to be eligible for PrEP initiation in June 2016. They 
were followed by men who have sex with other men in April 2018. The implementation 






(EHPSA, 2018:3). PrEP is imperative for female nyaope injectors because it has the 
ability to empower them to protect themselves from HIV infection (Walters, Reilly, 
Neaigus and Braunstein, 2017:2). 
The participants highlighted that the introduction of PrEP to female nyaope injectors 
is long overdue and its accessibility to them will assist in curbing HIV. Participants 
report that: 
Participant 23 “Like, this injection should be available to everyone, for as long as you 
are negative, it should be available. The one that helps you not to be positive when 
you are negative at all even if you are being intimate. I do not know what they call it 
(referring to PrEP)”. 
Participant 19 “Is there no pill that they get, like, when a person is raped which they 
provide in hospital for one not to be infected?” 
The researcher argues that female nyaope injectors should have been afforded an 
opportunity to be initiated on PrEP in 2016 when PrEP was made available to sex 
workers. Female nyaope injectors are vulnerable. Firstly, they are females; secondly 
they engage in risky sexual behaviour; thirdly they inject nyaope. Fourthly, due to 
inaccessibility of injections, female nyaope injectors find themselves in a very dire 
situation where no one is willing to understand and assist them. Female nyaope 
injectors should have been prioritised with sex workers by the Department of Health.  
PrEP has conceivable worth in the social and sexual networks of people who inject 
drugs where the prevalence of HIV is high. PrEP will escalate its HIV prevention 
prospects when it is introduced in a way that supplements and reinforces existing harm 
reduction and health promotion activities (Coleman and McLean, 2016:2-4). 
4.4.3.1.4 HIV Counselling and Testing  
HCT is the first step for multiple interventions for HIV prevention and care. HCT serves 
as an entry point for HIV prevention services that include prevention; such as access 
to condoms, and prevention counselling for HIV-positives. In addition, HCT links HIV 
diagnosed people into care and ART. At an individual level, it is associated with 
reduced mortality and extended life expectancy. At a population level, it is associated 
with reduced HIV incidence. Ensuring universal and equitable access to HCT services 






South Africa, HCT usage is lower among adolescents, the elderly, and men. 
Furthermore, some groups at higher risk for HIV infection, including men who have 
sex with men, young women, and possibly other groups, may be less likely to receive 
HCT (Mabuto, Latka, Kuwane, Churchyard, Charalambous and Hoffmann, 2014:1). 
Risks encountered by PWID are compounded by a lack of HIV testing uptake. HIV 
testing not only informs serostatus, letting individuals make conscious choices to 
protect themselves, their partners, and their children, pre- and post-test counselling, it 
also provides HIV education and individualised risk reduction counselling; even for 
people who are not infected with HIV(Asher et al, 2013:2). 
Female nyaope injectors are active members of the community. They are active in 
transmitting and also contracting HIV. Overlooking them might make 90-90-90 plan 
only a dream which will never be realised. Instantaneous HIV diagnosis, proper link to 
care, early treatment, retention in care, and sustained viral suppression are all 
important in reducing morbidity and mortality from HIV, (Mburu et al, 2018:2). 
This is supported by the following participant:  
Participant 13 “I think by going out to the community doing all this, like open the test 
[centres] where everyone is free; like where they smoke, like smoking zone or 
something like that, maybe to go there and to offer them for test”. 
When female nyaope injectors are diagnosed, retained in ART and a have suppressed 
viral load, it motivate them to protect themselves against re-infection. People who test 
for HIV must go to substance abuse hotspots where they will recruit female nyaope 
injectors to test. 
HIV testing in City of Tshwane needs to be extensively promoted more and made 
available in places accessed by vulnerable people, like female nyaope injectors. HIV 
testing services must go to where to people are, rather than for people to come to 
where services are (Dos Santos, Trautmann and Kools, 2011:10). 
 Economic Intervention 
4.4.3.2.1 Employment opportunities 
South African National Treasury (2019:3) reports that South Africa’s current economic 






and inequality remains high. The government should urgently implement a series of 
reforms that can boost South Africa’s growth in the short term, while also creating the 
conditions for higher long-term sustainable growth. These growth reforms should 
promote economic transformation, support labour-intensive growth, and create a 
globally competitive economy. 
Female nyaope injectors are not immune to the lack of employment as they are part 
of the society in general. According to Stats, SA (2019:7) there are 6,7 million 
unemployed persons in South Africa. Female nyaope injectors are affected by 
unemployment. This facilitates their dependence on their intimate partners which fuels 
injecting equipment sharing (Des Jarlais et al, 2012:2). 
This is supported by the following narrative statements  
Participant 3 “As females, we are unemployed, if we can get the opportunity to work 
for ourselves, I believe HIV among females who inject will decrease, because some 
of us when we are broke we depend on other users. For example, someone can come 
without an injection and ask you for your injection; knowing that she or he will leave 
something for you, you will give them an injection. At that point, I do not know if the 
person is sick or not. That is how we get infected”. 
Many females who inject drugs are pressured to sell sex to finance their own and their 
partner’s drug use. Poor prospects of unemployment add to dual risk of contracting 
HIV infection, through unprotected sex and engaging in sharing needles (Azima et al, 
2015:17).  
Participant 5 “It is painful to think that, if now you want R100, you need to sleep with 
five people. But if one has a part time job that would give them R100 in a day it would 
be much better”. 
Participant 9 “Females should be hired for part time jobs, it is painful to stay the whole 
day without using”. 
Poor socioeconomic status can act as an obstacle to educational prospects, 
opportunity to approach health care and employment, generating conducive 






Participant 20 “At times, people who smoke should be kept busy; maybe if they can 
find work and do odd jobs, even if it is domestic work”. 
Participants are of the view that if they are able to find work, working will disturb their 
routine of using drugs which will decrease the risk of contracting HIV and other blood-
borne infections.  
 Educational intervention 
The females reported support groups and awareness education as key interventions 
that can assist in empowering female nyaope injectors to take informed decision which 
will influence their decisions to protect themselves against HIV infection.  
4.4.3.3.1 Support groups 
Forming peer support groups of female nyaope injectors is critical to neutralise the 
self-stigma. It can also reinforce females’ communication skills which assist them in 
their relationships. This will help them to access social and health services (Mburu et 
al, 2018:6). HIV programs use support groups as an opportunity for health care 
workers to provide information to people living with HIV. Both WHO and the US 
President’s Emergency Plan for AIDS Relief promote peer support groups facilitated 
by trained people living with HIV to address the special needs of fellow people living 
with HIV and their partners. Such groups serve the purpose of sharing experiences, 
encouraging disclosure, reducing stigma and discrimination, improving self-esteem, 
enhancing patients’ coping skills and psychosocial functioning, and supporting 
medication adherence and improved retention in HIV care (Bateganya, Amanyeiwe, 
Roxo and Dong, 2015:368). 
The participants acknowledge that support groups will empower them to engage in 
safe injecting and other behaviours which will reduce their risk of contracting HIV. They 
further emphasised that the support groups must be conducted within communities. 
This means they must be assessable to all the female nyaope injectors.  
The participants reported that: 
Participant 10 “There must be programmes, were females will come together and be 
taught about the dangers of using drugs, sexual abstinence, and encourage those who 






Participant 14 “Get the ladies together and let us talk and listen to each other”. 
Participant 13 “Support groups so that they can lean more because other people do 
not really understand what HIV is. I think through support groups, which must be within 
the community, we will learn”. 
Participant 8 “They can have lessons every month, which will remind them now and 
then about safe injecting”. 
Participant 4 “There should be more support groups”. 
Support groups for women who use drugs were also brought forward by participants 
in the UNODC (2017b) study, with an excessive of importance placed on the 
importance of these groups being for WWUD. The environment of these support 
groups should promote relationship-building amongst the participants, as well as 
provide tools on how best to better one’s view of self and one’s surroundings (UNODC, 
2017b:47). 
Support groups are a vital service and resource that brings together people affected 
by a related issues so they can discover solutions to overcome shared issues. It 
provides space where members will feel supported by others who have related 
understandings. By joining support groups, people appreciate that they are not alone 
in their condition (Fanelli and Moyo, 2008:1& WHO, 2017:9). Price and Davey (2008:4) 
argue that a support group is a safe place to discuss topics that can assist group 
members to function better. 
4.4.3.3.2 Awareness presentations 
It is critical for mass media to play a positive role in preventing substance abuse 
amongst the communities by ensuring that appropriate messages are communicated. 
This can be done by educating the communities about the risks of sharing needles 
and safe injecting. It can further share with the communities about available substance 
abuse intervention programs that are found within different cities or areas (Charlton, 
Negota and Mistry, 2019:52). This statement is supported by the narrative of 
participants:  







Participant 23 “Go to the people who are smoking and educate them about 
possibilities of contacting infections when sharing needles”. 
Participant 9 “There should be campaigns to the hot spots where they meet to smoke. 
Maybe the campaigns must be once or twice in a week and give people who inject the 
injections”. 
Participant 18 “Even on the television, if they can make a programme or something 
or documentary to show the risk of woman to be easily infected from HIV when coming 
to using injections”. 
The participants alluded that hope is not lost and efforts must be strengthened to curb 
HIV prevalence. The participants indicated that awareness campaigns should be 
conducted and they should go to the hotspots. They should go where female nyaope 
injectors meet to use their drugs. They further indicated that as campaigns are 
presented, service providers should take injections with them to give females who are 
injecting nyaope. The awareness should use all sorts of platforms; including television. 
Television programmes can target audiences. They can target people who are 
injecting and teach them about safe injecting and help the community understand 
complexities of injecting and aim at reducing the stigmatisation against female nyaope 
injectors.  
To eradicate social stigma within our different communities, awareness programmes 
on stigma must teach the community about the harmful effects of stigmatising attitudes 
towards female nyaope injectors. The media must teach about the benefits of harm 
reduction in improving social functioning and health of female nyaope injectors. Media 
must educate the community and local leadership to understand that drug use is an 
indication of social glitches that confront female nyaope injectors, rather than an issue 
of simple individual choice that abstinence and prohibition can solve (Mburu et al, 
2018:6). 
Harm reduction capacitation for media personnel, police officers, wider community, 
and policy makers will help establish supportive setting for harm reduction 
programmes (UNODC, 2017:108). 
The researcher’s recommendations will be discussed in Chapter 5 where key findings 







This chapter presented profile of participants, table of research participants and key 
findings which are categorised using the three research objectives. Participants’ views 
where expressed regarding what influences them to inject nyaope, their experiences, 
and the strategies to curb HIV incident among female nyaope injectors. The next 







5. CHAPTER FIVE 
Conclusions and Recommendations  
5.1 Introduction 
The purpose of this study was to explore the experiences of female nyaope injectors 
residing in City of Tshwane Municipality. Furthermore, it was to gain insight into, and 
understanding, factors contributing to females injecting nyaope, and how they can be 
assisted to reduce the risks associated with nyaope injection. 
To realise this purpose, a qualitative research methodology was chosen based on the 
literature and the applicability of Social Ecological Model and Health Belief Model. This 
chapter provides a summary of key findings, limitations, formulated recommendations, 
and possible future research. 
5.2 Summary of key findings 
The findings were presented based on the formulated research objectives. The goal 
of formulating the research objectives was to enable the researcher to address the 
research purpose fully.  
The objectives of the study were:  
• To identify factors contributing to females injecting nyaope; 
• To explore the experiences of female nyaope injectors; and 
• To develop strategies to mitigate or reduce the HIV prevalence amongst female 
nyaope injectors 
5.2.1 Objective 1: Factors contributing to females injecting nyaope 
Two themes; namely factors contributing to use and injecting of nyaope, and 
experiences of female nyaope injectors, were identified. It was imperative to 
understand factors that contribute to the use of nyaope before understanding the 
factors that contribute to injecting transition.  
 Factors contributing to using nyaope 
The participants reported multiple factors that have contributed to them using nyaope. 






mental health issues, curiosity and counteracting other drugs contributed towards their 
drugs use.  
Firstly, an intimate partner who is using drugs can be influential to their female partner. 
Female nyaope injectors reported that they were influenced by their boyfriends to use 
nyaope. One participant indicated that her partner was always away and he did not 
give her the attention she desired; which led her to using nyaope so that she can spend 
time with him.  
Secondly, peer pressure and a sense of belonging contributes to nyaope use. Peer 
pressure is mentioned as one of the strongest predictors of youth behaviour, and 
influences experimentation of drugs. Using dagga increased the likelihood for female 
nyaope injectors to succumb to peer pressure. Participants have highlighted that they 
were using dagga before they started using nyaope. It can therefore be assumed that 
if they were not smoking dagga, chances of using nyaope would have been less.  
The Department of Basic Education should introduce life-skills programmes as part of 
their Life Orientation curriculum where learners will be capacitated and empowered to 
handle peer pressure. Implementing such a programme from Grade 7 will enable the 
learners to handle peer pressure well.  
Thirdly, participants indicated that they used nyaope without their knowledge. They 
were tricked by their friends into smoking nyaope; they assumed they were smoking 
dagga. They only knew they were smoking nyaope when they started to experience 
withdrawal syndrome. By the time they experienced withdrawals, it was too late; they 
sought out how to get nyaope on their own to satisfy their withdrawals.  
Fourthly, some participants indicated they were gaining excessive weight which they 
were not happy and comfortable with. They started smoking dagga to lose weight but 
when the progress was not speedily, they started using nyaope.  
Fifthly, participants reported that they started using nyaope due to unpleasant issues 
they were facing in life. Different emotional stresses like the death of a parent and 
incest by family member has driven the participants to smoke nyaope to ease the pain 
Sixthly, participants started using nyaope to counteract other drugs. Participants were 
using cocaine, which is a stimulant. The participants reported that they struggled with 






system since nyaope is a downer. Masombuka (2013:44) reports that cocaine can 
provisionally reduce the need for food and sleep, so users struggle with sleep after 
using it. Angarita, Emadi, Hodges and Morgan (2016:9) reports that wooziness and 
tiredness are common side effects of opioid. 
Seventhly, curiosity influenced participants to smoke nyaope. Participant 1 had 
history of using dagga, and when people she knew were using nyaope (which she did 
not have an idea about), she was curious. The participant asked to try it and she was 
hooked. 
 Factors contributing to injecting nyaope 
Firstly, participants highlighted the need for intense highs, influence of intimate partner 
and curiosity as factors which contributed to injecting nyaope. This study has shown 
that some of female nyaope injectors are actively involved in the decision to transition 
from smoking nyaope to injecting. Some participants reported that their initiation to 
injecting was their own choice due to curiosity of injecting nyaope, but not knowing 
how to self-inject (Tuchman, 2015:3). 
Secondly, curiosity had its way with the participants. Participants indicated that when 
nyaope is injected, it gives a high faster as compared to the cocktail route of smoking. 
The injector experiences the high immediately after injecting. Drug injecting is 
considered as the easy to use and potent manner to use low-purity heroin. Injecting 
nyaope lasts more hours as compared to traditional route of smoking it (Masumbuka, 
2013:44).  
Participant 7 influenced her male intimate partner to inject due to curiosity. This 
statement goes contrary with the literature highlighted that female nyaope injectors 
were influenced by their partners to inject drugs. Some participants like Participant 1, 
Participant 17 and Participant 5 shared how their intimate partners influenced them 
to inject nyaope. 
5.2.2 Objective 2: Experiences of female nyaope injectors 
 Risky behaviour  
Female nyaope injectors engage in risky behaviour which increases their chances of 






norm which must be addressed in order to help female nyaope injectors. They may be 
barred from family support structures. Those who struggle financially or have low 
prospects of employment, are probable to participate in sex work, which increases HIV 
risk and draws the additional stigma linked with sex work (Larney et al, 2015:6). 
Females practicing sex work and use of drugs are more probable to share needles 
and other injection equipment amongst themselves and their clients, as well as have 
unprotected sex with their clients and their intimate partners. Many females are 
coerced to sell sex to finance their own or their partner’s drug use; which elevates their 
risk of HIV infection through unsafe sex (Azima et al, 2015:17& Arpa, 2017:8). Some 
participants raise money through sex work due to adverse socioeconomic conditions; 
this increases their HIV risk (El-Bassel and Strathdee, 2016:6).  
Female nyaope injectors are more probable to participate in transactional sex 
compared to their male counterparts (Scheibe et al, 2016b:113). Poor economic 
standing has been linked with earlier sexual involvement, inconsistent condom use, 
having multiple intimate partners, increased chances that the first sex act is non-
consensual, and a greater probability of having had transactional or physically forced 
sex. Most females choose to participate in transactional sex to finance their lives 
(Ramjee and Daniels, 2013:3). Transactional sex increases the risk of female nyaope 
injectors contracting HIV. The participants reported that they take part in transactional 
sex to raise money for their drug use. The need to get the next fix influences female 
nyaope injectors to participate in transactional sex to raise money when they do not 
have other options of raising money. This practice increases their risk of contracting 
HIV and other blood-borne infections. 
It is not all female nyaope injectors who are proud of engaging in transactional sex. 
One participant indicated that she resented herself after engaging in transactional sex 
for the first time, however, due to the demand of money to be able to maintain the 
using habit, she felt powerless and found herself engaging further in transactional sex. 
She was not proud of engaging in transactional sex but she kept doing it as she 
struggled for money through socially moral way.  
Participants felt that men were taking advantage of female nyaope injectors. Men are 
aware that female nyaope injectors are struggling financially and need money to buy 






sexual favours, in return for a small amount of money. This further breaks down the 
psyche of these females, as their bodies are equated to nothing more than a few 
Rands (UNODC, 2017b:19-21).  
Most females who use drugs are often disempowered to discuss safe sex practices 
with their intimate partners. Sexual risk-taking may be associated to feelings of trust 
in a relationship, or they may be culturally entrenched in the gendered distribution of 
power. Efforts to discuss condom use with an intimate partner can therefore result in 
aggression, isolation and exclusion if taken as an unwelcomed challenge to fidelity 
and privilege within the relationship (GCWA, 2011:5). Gendered cultural beliefs places 
upkeep of an intimate partner above oneself, avoiding conflict, and conserving 
harmony in relationships. This contributes to females’ powerlessness to discuss safer 
sex, even in situations when they feel they are at risk (Stoicescu et al, 2018:3316). 
Participants were not consistently using condom with their intimate partners. The 
attitude of not using condoms with their partners is increasing the risk of them 
contracting HIV. The risk is higher as most of their boyfriends are injecting nyaope 
themselves, and might be sharing injections with other drug users. The participants 
reflected helplessness in negotiating condom use with their intimate partners. They 
feel powerless and have left their health in their intimate partners’ hands.  
Societal customs that supress females and generate imbalanced power relations 
further strengthen injection sharing in intimate partnerships (Marottaa et al 2018:103). 
The participants reported to having injected with used injections with their intimate 
partners. The reasons for sharing injecting equipment are multifaceted. Individual 
factors like knowledge, perceived risk, and a perceived sense of control indisputably 
influences injecting and sharing behaviours (Morris et al, 2019:2). 
Participants reported to have shared injections within the network of people who inject 
drugs, especially with intimate partners. Female nyaope injectors explained that a lack 
of access to clean injections contributed to them sharing injections because the 
withdrawals were unbearable, and at the time when they have to inject, they do not 
think of the consequences of sharing injections. At that point, they indicated that 






 Social interaction  
The theme of social interaction firstly explored the interaction with the family. The 
participants shared how they interacted with their families when they started using 
drugs. The participants shared about their families’ support when they discovered that 
they use nyaope; how they reacted when they learnt that they use nyaope; how they 
reacted when they discovered that participants have transitioned from smoking to 
injecting; as well as perceptions of how family could have reacted if they knew they 
are injecting nyaope and how it felt to be at home.  
Most participants live with their families when they start engaging in substance. When 
their families learn about their drug use, they react. It is reported that families 
experience traumatic experiences. Families experience mixed feelings which includes 
a fear that their child might die, feeling of disappointment or accountability for the 
dependence, and humiliation as a result of being stigmatised by the community as a 
parent who cannot control their children (Masombuka, 2013:99). 
Families extended offered to assist participants when they learnt that participants were 
using drugs. This reflected the supportive nature of the families. They reacted by 
offering support and taking them to centres where they could be rehabilitated.  
Some participants indicated that their families were not happy with them when they 
learnt that they were using nyaope. The families experienced lot of unpleasant 
emotions, they were shocked, angry, surprised and disappointed when they learnt that 
participants use nyaope. Schultz and Alpaslan (2016:100) argue that the initial 
reaction of the family involves shock when they learn about their family member’s drug 
use. The shock is joined with feelings of dismay, rage, frustration, unhappiness, 
disorientation, helplessness, as well as disappointment and shock. The initial surprise 
reaction experienced is not unusual, for when a family learns about the drug use of its 
family members, the family is thrown into shocked and disarray. The families did not 
expect to see their children using nyaope. When they learnt that they are using, they 
did not believe it. They got the shock of their lives. The family felt that the participants 
were killing themselves through injecting nyaope. 
The participants reported that it got worse when their families discovered that they had 






Bluetooth. Drug use and injection invites extensive stigmatisation. Females who use 
drugs may encounter rejection from their relations and communities and discrimination 
in a variety of contexts, including health-sites. As a result, they may be unwilling to 
divulge their drug use and be reluctant to access health services, including drug 
treatment, for fear of discrimination. Social exclusion, stigmatisation, and 
discrimination elevates the HIV risk and weakens HIV prevention and treatment 
(Larney et al, 2015:6).  
Some participants hid their drug injection from their families; their families did not know 
they transitioned. Due to stigma associated with injecting nyaope, the participants 
were of the assumption that if their families knew they were injecting nyaope, they 
would be disappointed in them and might disown them. 
The participants reported that it was not nice to be at home. They felt unwanted and 
not accepted by family members due to drug use. Their “good daughter” image is 
substituted by the junkie image which they have seen in the media (Horitavorn, 
2008:20). 
The participants reported that due to drug use, they were not involved, the way they 
wished to be, in their children’s lives. They believe their drug use affected their 
involvement in their children’s lives. The findings of the study corroborates the findings 
of Kontautaite (2018) and partners who reported that 25 females in their study 
described that mothers were not permitted to contribute in any decision-making related 
to their child’s life, and were poorly involved in the child’s life. The families of female 
nyaope injectors who had children have taken some responsibilities them due to their 
use of nyaope. The families are now managing social grants and welfare of the 
children. 
Social interaction explored the interaction with the community. The community, like 
family, instigates the stigmatisation of female nyaope injectors. Participants reported 
mixed statements with regards to the community reacting to their use of nyaope. Some 
participants reported that instead of the normal discrimination which is perpetuated on 
females who smoke and inject nyaope, some community members expressed love 
and encouragement. It is reported that the community makes things worst by their 






feel uncomfortable and humiliated. Using drugs brings shame and lost face in the 
community and amongst relatives (Horitavorn, 2008:24).  
Once the community learns that particular females have transitioned from smoking to 
injecting, they increase the level of stigma and discrimination. Like the families of 
female nyaope injectors, the community equates the practice of injecting nyaope to 
self-destruction.  
The stigma contributed to female nyaope injectors hiding their injecting, and exposing 
themselves to high risk behaviour and lack of access to harm reduction services. Fear 
of the community knowing that they inject nyaope drives female nyaope injectors away 
from their communities, around people and places they knows, to where they are not 
known. This could make them meet different drug networks which engages in riskier 
behaviours than the ones in their community.  
Social interaction also explored the interaction with health settings, with emphasis to 
health workers. Through this theme, participants shared the difficulties of accessing 
health care services; which has a negative bearing on them when they are pregnant, 
and on how they deal with abscess.  
Female nyaope injectors have different experiences regarding health care institutions 
(most are unpleasant experiences) that makes it difficult for them to seek health care 
services when they are in need. Participants spoke about the stigma they felt and the 
discrimination they experienced from clinicians. The intense stigma directed to female 
nyaope injectors can present an overwhelming obstacle to the opportunity of 
approaching harm reduction services, drug treatment, HIV treatment, sexual and 
reproductive health care. More, especially in culturally conventional societies 
(Pinkham et al, 2012.126). 
Participants highlighted that stigmatisation by health care practitioners makes them 
unwelcomed at the clinic. They further alluded that due to time spent at the clinic, it is 
unbearable to deal with withdrawals. This made it difficult for them to access health 
care services.  
One of the implication of stigma perpetuated on female nyaope injectors was when 
they were visiting clinics when they were pregnant. The participants did not visit their 






accessing health care services disadvantaged them as they did not attend antenatal 
classes. Females who use drugs normally do not take the non-appearance of 
menstruation as a sign of pregnancy; other signs of pregnancy had to be seen before 
they would begin to suspect that they were pregnant. Most females’ pregnancies were 
accidental because of their irregular periods while taking drugs (Horitavorn, 2008:39). 
This is confirmed by Participant 19 when she reported that she was already 7 months 
pregnant when she discovered. The participants did not know they were pregnant until 
it was too late to attend antenatal classes at their local clinic. Participant 10 reported 
that her child was infected with HIV because she went to the clinic late. If she had 
known in time and attended antenatal classes, the health care practitioners would 
have assisted her to be on medication which would have enabled the child to be born 
HIV negative.  
The participants reported that in their injecting practice, they miss and get abscess. It 
was noted that participants deal with the abscess differently. Some participants treat 
themselves and others visit the clinic, but they reported that it is not comfortable to do 
so due to stigmatisation.  
The stigma perpetuated against female nyaope injectors is doing more damage that 
the drug itself. Judgmental and moralising views towards drug users are regularly 
expressed within South African communities; more specifically by health practitioners, 
which is worrisome and demands urgent attention. Sensitisation training for health 
care professionals would capacitate the health care participants to handle the female 
nyaope injectors without stigmatising them.  
Finally, social interaction explored the interaction with the police; the law enforcement. 
The police are caught violating the law with regard to female nyaope injectors. Instead 
of protecting their rights, the police led in violating their rights. The police indirectly 
contribute to needle sharing. Carrying clean needles for fear of arrest contributes to 
needle sharing, which increases the risk of contracting HIV (Chakrapani et al, 2011:4). 
Scheibe et al (2017:2) reports that drug use is criminalised in South Africa, but no laws 
ban the buying or providing injecting equipment. The participants reported that police 
broke and confiscated their needles, and arrested them without charging them in court.  
Police confiscate and break female nyaope injectors’ injections, exposing them to a 






disappointing when police confiscate injections which are provided by harm reductions 
programmes like COSUP with an aim of reducing infections among people who use 
drugs. 
The participants have a history of police arrest. The participants have been arrested 
by the police without being charged in court. They indicated that the police arrested 
them to punish them. They also identified this type of arrest as white door arrest.  
 Raising money 
Female nyaope injectors engage in different means to raise money to feed their habit. 
They do not only engage in sex related risk, as highlighted at the sexual risk section, 
the participants also indicated that they raise money through multiple partners, 
intimate partners, stealing and engaging in transactional sex.  
The participants established a network of sexual partners whom they slept with for 
money. They highlighted that they were able to generate money through multiple 
partners. They also acknowledged that at times, they are involved in criminal activities 
to raise money to buy drugs. Shoplifting, stealing from the community and customers, 
for those who sell sex, came out tops. 
Some participants sell their belongings, while others engage in petty jobs to raise 
money to feed their habits. Participant 3 alluded that she stopped engaging in sex 
work to push trollies. This shows that female nyaope injectors can be self-sufficient in 
their pursuit to make money when their heart is at it.  
Some participants, like Participant 19 and Participant 1, exploited the opportunity by 
demanding higher amount of money which was able to sustain them for longer. This 
means some female nyaope injectors decide to be taken advantage of, or rather, they 
use the unpleasant circumstances to their advantage.  
 Nature of intimate relationship 
Female nyaope injectors’ have multifaceted and lively relationships with their intimate 
partners who also use drugs (Azima, 2015:17). The participants highlighted that they 
desire support, protection and encouragement from their intimate partners, but they 






use drugs, they wish their intimate partner were not using drugs to enable them to stop 
through their support. 
The participants also highlighted that they experienced emotional and physical abuse 
at the hands of their intimate partners. Their intimate partners are verbally abusive and 
also stalked the participants. One participant does not have freedom as she is always 
being watched; what she does, with whom and where. The emotional abuse inflicted 
on female nyaope injectors increases their vulnerability as they start to question their 
self-worth and disturbs communication between the partners. Emotional abuse may 
generate a comparable context of dominance and control, which increases females’ 
probability of participating in risky sexual behaviours. Developing research suggests 
that emotional abuse has comparable damaging impact on females’ health outcomes 
to physical and sexual forms IPV (Stoicescu et al, 2018:3308). 
Verbal abuse contributed to Participant 5 not accessing HIV treatment when she 
tested HIV positive. The participant reported that she had to wait for her partner to be 
arrested before she could be initiated on ARV treatment. This is supported by 
Horitavorn (2008:55) when they argued that the anxiety of others finding out about the 
diagnosis also depresses people from making contact with health services, 
community, and family  
Physical abuse is effected with the aim to capture control of female nyaope injectors 
by their intimate partner. The participants shared how their intimate partners are 
physical with them. Some studies have projected that the occurrence of physical and 
sexual IPV is three to five times higher amongst females who use drugs as compared 
to community-based samples of nondrug-using females (Pinkham et al, 2012:3).  
Despite the negative experiences female nyaope injectors go through at the hands of 
their boyfriends, the participants have indicated that which they like about their 
relationship with their intimate partner. The researcher has observed that participants 
are in an intimate relationship with people who are using drugs. The participants 
reported that they have an open relationship with their partners. They do things 






Intimate partners who are not using drugs could not continue dating females who are 
using drugs, immediately they learnt that their partners were using drugs, they called 
off the relationship.  
 Value of NSPs 
Accessibility and harm reduction education on safe injecting have been rated by the 
participants as important in reducing risks.  
There is evidence that NSPs lessen the possibility of transmitting HIV and other blood-
borne diseases by reducing the proportions of sharing injecting equipment among 
people who inject drugs. WHO endorses distributing 200 needles and syringes per 
person who injects drugs each year (UNAIDS, 2019:19).  
The participants reported that accessibility to clean injections is a huge challenge for 
them. They added that before COSUP was established, they had to buy injections at 
pharmacies, which was not easy for them as they were discriminated against. 
Participants further indicated that they used to get injections from those who have 
been diagnosed with sugar diabetes. 
Harm reduction services, which teach safe injecting, have benefitted the participants 
who have access their services. The programme provided clean needles and 
capacitate female nyaope injectors on how to inject, where to inject, and where not to 
inject. People who use drugs struggle financially, buying injecting equipment can be a 
daunting exercise for them. This will contribute to the elevated probability of reusing, 
and sharing contaminated injecting equipment (Scheibe et al, 2019:2-4). 
Female nyaope injectors were trained on safe injecting when they were accessing 
NSPs programme. People who inject drugs are linked to increased risk of local soft 
tissue bacterial infections, with subsequent serious risk for invasive sepsis, 
pneumonia, and infective endocarditis. Inappropriate cleaning of the skin before 
injecting has been linked with increased risk of skin abscess, leading to severe 
systemic sepsis (Islam et al, 2019:2). High intensity injection drug use behaviour is a 
disposing factor for bacterial infections. Reducing injection occurrence had rapid and 
substantial benefit in reducing risk for serious bacterial infections even in the absence 
of complete cessation (Islam et al, 2019:6). Educating female nyaope injectors on safe 






 Needs of female nyaope injectors 
The participants desire to have access to basic commodities which are necessary for 
survival. Participants reflected the challenges female nyaope injectors face when they 
must buy necessities like toiletries versus buying drugs. Participant 23 reported that 
“there were times were I was not able to do what I want at the time I wanted. If I want 
to get my hair fixed or I want toiletries or pads, it becomes difficult to get those things 
because at that time I would have R30, then my priority would be to smoke, and I do 
not have pads at that time”. Participant 17 reported that she “needed food, needed to 
bath, needed clothes, I needed to live normal”. Participant 2 agrees with Participant 
17, she added that “maybe sometimes they can give us food, to get healthy foods, 
medication maybe if we are sick”.  
Participants highlighted food, medication, toiletries, clothes and taking a bath as their 
basic needs. These needs can be addressed through establishing drop-in centres. A 
drop-in centre offers a chance to provide services that address the broader physical 
and social needs of people who use drugs, beyond harm reduction. This is important 
because these needs normally go unserved when people who inject drugs face 
stigmatisation and isolation. People who inject drugs who do not have anywhere to 
stay are often malnourished. This can seriously worsen any health condition they may 
have. Where possible, drop-in centre may provide nutrition, showers where vagrant 
people will maintain their hygiene, comfortable seating area where people who inject 
drugs can meet, talk and relax in safe environment. Seating areas can also be used 
for support group sessions, and sleeping space where homeless people who do not 
have anywhere to go can rest. Where possible, a residence with camp-beds for short 
sleeps or longer periods of sleep should be made available (UNODC, 2017:123).  
People with a history of injecting drug stated that health was not of a concern during 
periods of active drug injecting, despite a high level of need due to negative attitude 
of health care practitioner, high demand of their addiction, and fear of potential 
consequences (Tweed et al, 2018:3). It is important for government to establish health 
outreach teams that will go to hotspots, and where female nyaope injectors spend their 






The participants reported that they have dreams. Drug use may have delayed and 
wasted their time, but they are determined to stop using drugs so that they can focus 
on improving their lives and that of their families. The participants indicated the need 
to be financially stable and independent. Social function-ability will enable them to 
regain self-worth, as it will allow them to contribute positively in their lives and that of 
their significant others. Having a secure living environment and being financially 
independent also plays important roles in the ability of people with history of using 
drugs to sustain their recovery (Stokes et al, 2018:10).  
One participant indicated that employers should understand that she is injecting 
nyaope and should not use her drug use as a factor not to give her a job. This view 
will be embraced by females who wish to inject drugs.  
It is not everyone who wishes to stop using drugs; service providers should never 
assume everyone’s desire to stop using drugs. Nyaope does not come cheap; when 
tolerance increase, the budget increases. One participant indicated the need to have 
affordable drugs. The affordability of drugs can reduce the economic hardship female 
nyaope injectors face on a daily basis.  
Female nyaope injectors desire access to clean needles; they do not want to share 
needles so accessibility to clean needles will assist them. No participant would like to 
contract HIV or other blood-borne infections. Accessibility to needles enable 
participants not to share, use old needles and to assist those who do not have sterile 
needles. 
 Personal experience 
The participants went through different experiences which had a potential to change 
how they conduct themselves in relation to the risky behavior associated with nyaope 
injecting.  
Female nyaope injectors were encouraged by their intimate partners and social 
network to start injecting nyaope. Socialising with people who inject drugs contributes 
to the probability that one will transition to injecting drugs. Intimate partners played an 
active role in encouraging females to inject drugs. Females are more probable to 
experience their injecting initiation with an intimate partner and to have that partner 






Female nyaope injectors took different periods of time to be able to inject themselves, 
with other participants taking only one week and others taking more than a year without 
injecting themselves. Others reported that they cannot inject themselves even after 
more than year of injecting nyaope. Relying on other people to inject poses a serious 
risk of contracting HIV as females are often the second injectors.  
When females inject themselves, they are able to show independence and autonomy 
as they will inject at their time and wherever they are. The capability to self-inject also 
imparted feelings of competence, independence, control of oneself, and prevention of 
harmful, visible scars on her body (Tuchman, 2015:4). Participants who have not been 
able to inject themselves for a longer period preferred to be injected by someone they 
trust instead of self-injecting. Participants highlighted fear of self-injecting and lack of 
self-trust to perform the injecting. 
The participants reported that the first time of injecting was not a comfortable exercise 
to engage in. They were motivated by the benefits of injecting as the benefits outweigh 
the feeling of the discomfort they experienced.  
As a result of using and injecting nyaope, they create self-stigmatised identities in such 
a way as to make it difficult to have valuable relationships, accepting that they do not 
deserve to be loved. The internalisation of the stigma is associated with low self-
esteem. Apart from being ashamed of themselves, female nyaope injectors 
consistently witness negative attitudes from their communities and families. This 
stigma is influenced by moral judgement. Besides experiencing the stigma in 
communities, the stigmatisation of injecting drugs was regularly encountered in health 
institutions. Regardless of where the stigma comes from, it seems to result in 
separation and social exclusion through biased social processes and institutional 
practices. Self-stigma is steady with other studies which have defined internalised self-
stigma among female nyaope injectors. This in turn leads to feelings of 
embarrassment, low self-esteem, and reduced self-efficacy (Mburu et al, 2018:5).  
Females who use and inject drugs have rights to access sexual and reproductive 
health services timeously. The research has shown that some of the participants do 
not understand issues pertaining to their menstrual cycle, which disadvantages them. 
The participants reported that when they use drugs, they do not fall pregnant. This 






assumptions can lead female nyaope injectors not paying attention, falling pregnant, 
and only realising late that they are pregnant and do not have the option of abortion. 
For example Participant 17 only knew of her pregnancy when she was 5 months in. 
Substance abuse programmes should work with harm reduction programmes. Harm 
reduction comprehensive packages could help female nyaope injectors better manage 
their sexual and reproductive health, therefore preventing unplanned pregnancies and 
improving pregnancy outcomes, including through improved access to prevention of 
vertical transmission of HIV (Pinkham et al, 2012:128). 
 Life after stopping drug use 
The participants highlighted adjustments they experienced, as well as desires to 
experience after stopping the use drugs. The challenges of waking up in the morning 
to raise money for fix was a thing of the past. The participants concur that a life of 
using nyaope is a life of slavery; it is a life no one can live intentionally. The participants 
reported that their life has improved since they stopped using drugs. They are in 
control of their lives more than before and enjoy their current life of not using drugs.  
Community members have mixed emotions and do not treat females who have 
stopped injecting nyaope the same. Some wish them luck on their new journey, while 
others count days before they relapse. 
Families are caught in between trusting the participants or not. Participants wish for 
their families to trust them like before they started using drugs. Some participants 
indicated that their families are happy, while others indicated that their families have 
put them on probation.  
Participants identified self-control which extends to avoiding triggers such as; friends 
who use drugs, places where drugs are sold. These are some of the strategies 
important for maintaining abstinence throughout the recovery journey (Stokes et al, 
2018:9). The participants identified their intimate partners as triggers and have 
instituted plans by separating in the case of Participant 23 and avoiding visiting the 
partner at his place in the case of Participant 16. It is not easy for Participant 16 to 






5.2.3 Objective 3: Interventions to mitigate or reduce the HIV prevalence among 
female nyaope injectors 
The participants reported that to curb HIV prevalence among female nyaope injectors, 
the following intervention must be implemented as matter of urgency: 
• NSPs; 
• Availability of condoms to female nyaope injectors;  
• Accessibility of PrEP to female nyaope injectors;  
• Role of HIV testing;  
• Scarcity work opportunities in South Africa; and  
• Educational intervention will curb HIV prevalence among female nyaope 
injectors 
 
Female nyaope injectors are pressured by lack of accessibility to sterile injections to 
engage in sharing injections. This fuels their vulnerability of contracting HIV and other 
blood-borne infections. Programmes that offer disinfected injecting equipment through 
NSPs are highly effective in decreasing transmissions of HIV and other blood-borne 
infections (UNODC, 2017:62). The participants acknowledge the value of NSPs in 
curbing HIV among female nyaope injectors. They further reported that a lack of 
accessibility to injections can influence them to share among themselves or with other 
injectors. 
NSPs should provide enough injections to enable users not to borrow from other users. 
The programme can use vending machines, outreach teams, and pharmacies to 
guarantee that injecting equipment is easily available and accessible in satisfactory 
amounts to prevent the need to share and reuse needles and syringes (Southwella et 
al, 2019:3). 
NSPs come with controversy; mainly fuelled by the notion of whether a person who 
uses drugs should be seen as a criminal or a patient, and whether it is ethical or lawful 
to provide a person using drugs the means to inject. This assumption is usually held 
by opponents of NSPs who greatly support drug treatment programmes that are based 
on abstinence and ‘‘drug-free’’ treatment for addiction. NSPs have demonstrated to be 
a cost effective way of curbing HIV in other low income settings (Derrick and Clark, 






prevalence and other blood-borne infections, its accessibility will benefit the health 
state of female nyaope injectors.  
Females are more likely to participate in transactional sex and sex work as compared 
to males who inject drugs (Scheibe et al, 2016b:113). Most of participants who engage 
in sex do not use condoms consistently with their intimate partners. The participants 
acknowledge self-determination of females who are injecting nyaope to choose to 
participate in sex work or transactional sex. Risks related with sex work or 
transactional sex can be lowered or reduced by the introduction and correct use of 
condoms during sexual intercourse.  
The participants highlighted that the introduction of PrEP to females who are injecting 
nyaope is long overdue and its accessibility to female nyaope injectors will assist in 
curbing HIV. PrEP is a biomedical strategy, which offers supplementary HIV 
prevention options beyond traditional programmes like condoms for individuals at risk. 
PrEP comes in form of a pill that is taken every day to prevent HIV infection (Walters, 
Reilly, Neaigus and Braunstein, 2017:2). 
PrEP has conceivable worth in the social and sexual networks of people who inject 
drugs where the prevalence of HIV is high. PrEP will appreciate its HIV prevention 
prospects when it is introduced in a way that supplements and reinforces existing harm 
reduction and health promotion activities (Coleman and McLean, 2016:2-4). 
Female nyaope injectors are active members of the community. They are active in 
transmitting and also contracting HIV. Overlooking them might make 90-90-90 plan 
only a dream which will never be realised. Instantaneous HIV diagnosis, proper link to 
care, early treatment, retention in care, and sustained viral suppression are all 
important in reducing morbidity and mortality from HIV, (Mburu et al, 2018:2). 
For HIV testing to be effective, it should reach out to where female nyaope injectors 
are. This is corroborated by (Dos Santos et al, 2011:10) when reporting that HIV 
testing in Pretoria need to be more extensively promoted and made available in places 
accessed by vulnerable people, like female nyaope injectors. HIV testing services 
must go to where to people are, rather than for people to come to where services are. 
Female nyaope injectors are not immune to the lack of employment as they are part 






unemployed persons in South Africa. Female nyaope injectors are affected by 
unemployment. This facilitates their dependence on their intimate partners which fuels 
injecting equipment sharing (Des Jarlais et al, 2012:2). Participants are of the view 
that if they are able to find work, working will disturb their routine of using drugs which 
will reduce the risk of contracting HIV and other blood-borne infections.  
Many females are coerced to sell sex to finance their own and their partner’s drug use. 
Unemployment contributes to risk of contracting HIV infection through unprotected sex 
(Azima et al, 2015:17).  
They reported support groups and awareness education as key interventions that can 
assist in empowering them take informed decision which will influence their decisions 
to protect themselves against HIV infection.  
Forming peer support groups of female nyaope injectors is critical to neutralise the 
self-stigma. It can also reinforce females’ communication skills which assist them in 
their relationships. This will help them to access social and health services (Mburu et 
al, 2018:6). The participants acknowledge that support groups will empower the 
females to engage in safe injecting and other behaviours which will reduce their risk 
of contracting HIV. They further emphasise that the support groups must be conducted 
within communities 
The participants further added that awareness programmes, through different 
communication channels to teach different people the risks of injecting drugs, will 
assist with curbing HIV infection. It is essential for mass media to play a positive role 
in preventing substance abuse amongst the communities by ensuring that appropriate 
messages are communicated. This can be done by educating the communities about 
risk of sharing needles and safe injecting. It can further inform the communities about 
available substance abuse intervention programs that are found within different cities 
or areas (Charlton, Negota and Mistry, 2019:52).  
5.3 Limitations of the study 
The study had the following limitations: 
• Only participants who were accessing service at selected COSUP sites were 






services at other organisations and those who were not aligned to any 
organisation, were not recruited to be part of the study. Not everyone had equal 
opportunity to be recruited for the study.  
• The research employed qualitative research design, the findings cannot be 
generalised to all female nyaope injectors. 
• Some females could not participate in the study because the researcher could 
not give them incentive for the time they spent. If drugs were legal in South 
Africa, the researcher could have bought few packets for each participants so 
that they could participate in the study. The researcher lost an opportunity to 
listen to their lived experience because he could not give them money for drugs.  
• Few studies were conducted on people who inject drugs within the South 
African context; only one study on female nyaope injectors in South Africa was 
conducted by UNODC. The researcher depended on international research for 
literature. More studies on people who inject drugs should be conducted to 
understand the South African drug injecting context better, instead of 
understanding South African drug injecting context using international 
research.  
5.4 Recommendations 
The researcher would like to make the following recommendations based on the 
research findings: 
• South African Police Service should be part of the solution of curbing HIV 
among female nyaope injectors by not confiscating the needles used by female 
nyaope injectors. By confiscating needles from female nyaope injectors, they 
are indirectly facilitating injections sharing. The female nyaope injectors 
indicated that when they experience withdraws, what is important to them is to 
inject, it is not important if the injection is sterile or was used by someone; they 
will use it. Therefore, it is important for female nyaope injectors to always have 
needles in their possession if we desire them not to share injections.  
• Due to the high level of stigma experienced by female nyaope injectors, it is 
imperative that community based organisations that offer substance abuse 
related services should conduct stigmatisation sensitisation workshops as part 






• Department of Health, and Department of Social Development, should jointly 
provide NSP services at their clinics and service points to enable easy access 
of free sterile needles. 
• Stigmatisation perpetuated by health care professionals should be addressed 
by including a module on harm reduction in their training syllabus. 
Stigmatisation perpetuated by health workers contributes immensely to female 
nyaope injectors not visiting their health care centers.  
• Turnaround time at the community health centers should be improved to enable 
current injectors to access health related services. When female nyaope 
injectors spend a long time without using drugs, they experience withdrawals 
that are unbearable. If turnaround time is shortened, the female nyaope 
injectors will visit the community health centers and will not leave before they 
are assisted.  
• Ward based support groups should be established to support female nyaope 
injectors; among other things, they should address self-stigmatisation. The 
ward based support group should also provide support to the family members 
who are affected by substance use. 
• Female nyaope injectors should be afforded opportunities to partake in 
economic activities.  
• Drop-in centres should be established for female nyaope injectors; these centre 
should offer harm reduction services. The Drop-in-centres will attract female 
nyaope injectors to the sites and they will benefit from other health services and 
bathing facilities more especially for those who are homeless.  
 
The researcher has the following recommendations for policy and practice: 
• Department of Health, and Department of Social Development, should jointly 
implement harm reduction service as documented by United Nations Office on 
Drugs and Crime. 
• The provisioning of PrEP should be implemented for female nyaope injectors 







The researcher recommends decriminalisation of drugs. The criminalisation of drugs 
fuels stigmatisation and discrimination against people who inject and use drugs. 
Criminalisation of drug use places PWID in precarious legal situations and estimates 
suggest that 56–90% of PWID will be incarcerated at some stage during their life. 
International agencies and programmes such as UNAIDS and UNODC identify 
criminalisation and punitive laws as a primary reason why the level of decline in HIV 
incidence and mortality taking place globally is not being observed in PWID (DeBeckn 
et al, 2017:358). Criminalisation of drug use has a negative effect on HIV prevention 
and treatment. This negative effect is particularly evident in relation to decreased 
needle and syringe distribution, increased syringe sharing, and an increased burden 
of HIV among PWID (DeBeckn et al, 2017:369). SAHCS released a statement on the 
3rd of June 2019 supporting the decriminalisation; they reported that they support 
evidence-based law and policy-making and that they believe that South Africa will not 
reach its, nor international, HIV or viral hepatitis reduction and treatment targets or 
related public health goals if it does not decriminalise drug use (SAHCS, 2019). 
5.5 Suggestions for further research 
This was a qualitative explorative research; based on what the researcher uncovered 
during the study, it is suggested that more research in the following areas should be 
conducted: 
• Large scale quantitative research on the experience of female nyaope injectors; 
which will recruit participants from different organisations, and those who are 
not aligned with any organisation. 
• The researcher recruited participants at COSUP Sediba; the participants 
indicated that they are homeless. The researcher picked up that the 
experiences of female nyaope injectors who are homeless and those who live 
with their families are different. Those who lives with their families have access 
to bathing facility, while those who are homeless do not have privilege of 
bathing facilities. Therefore, a qualitative study which will separate female 
nyaope injectors who are homeless and those who stay with their families will 







• Research aimed at evaluating whether current substance services available 
address the needs of female nyaope injectors. 
5.6 Conclusion 
This study explored the lived experiences of 24 female nyaope injectors. The 
exploration has brought an awareness of the challenges the female nyaope injectors 
face on a daily basis, and how comprehensive harm reduction can benefit them and 
reduce the risks they encounter daily. South African government, through legislation, 
should endorse comprehensive harm reduction service for females who inject and use 
drugs in order to lower risks of contracting HIV and other blood-borne infections. 
Stigmatisation, in all levels, including health care centers, police and community, 
should be eradicated.  
This chapter discussed summary of key findings, limitations, formulated 
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7. APPENDIX A-H  
A: INFORMED CONSENT FOR PARTICIPATING IN THE STUDY  
Research topic: Exploring the experiences of female nyaope injectors residing in the 
City of Tshwane Municipality, Gauteng 
Dear Prospective Participant, 
You are invited to participate in a research study conducted by Moganki Hendrick 
Lefoka in fulfilment of a MA (Social Behavioural Studies in HIV/AIDS), in the 
Department of Sociology, University of South Africa. The focus of the study is to 
explore and describe the experiences of female nyaope injectors.  
Your participation will involve an interview, which will be tape-recorded. The reason 
for recording the interview is that the researcher would be able to transcribe and 
analyze the data in depth, which will result in more detailed data for the purpose of this 
study. There will also be follow-up questions during the interviews. The University of 
South Africa had granted the research ethical approval, which means the study will 
comply with the code of ethics of scientific research on human participants. 
There are no physical risks involved in conducting the research. Although there might 
be some topics that will be discussed during the interview that might be sensitive to 
the participant or that may cause emotional discomfort. This will be noted by the 
researcher and the necessary precautions will be applied in order to avoid any harm. 
Pre-counselling will be offered before the actual interview. 
Your participation in this research study would contribute towards understanding the 
experiences of female nyaope injectors. The findings may contribute towards 
substance abuse programmes which address the needs of female nyaope injectors. 
The study does not involve monetary compensation for participating. 
Your name and personal details will not be mentioned within this study, you will be 
referred to by a nickname in order to protect personal information about yourself. Hard 
copies of your answers will be stored by the researcher for a period of five years in a 
locked cupboard at UNISA for future research or academic purposes; electronic 
information will be stored on a password protected computer. Future use of the stored 






copies will be shredded and electronic copies will be permanently deleted from the 
hard driver of the computer through the use of a relevant software programme.  
Your participation in this research study is voluntary. This means that you have the 
right to choose whether you want to partake within this study or not, and that you may 
withdraw your consent to participate at any stage during the interview process. You 
will not be penalised in any way if you decide that you no longer want to participate or 
withdraw in the interview process. If you agree to participate in this study, you will be 
given a pre-counselling and this information sheet to keep, and you will be asked to 
sign a written consent form.  
If you have any questions or concerns regarding the interview process and the study 
or if any problems arise from this study- please feel free to contact: 
The researcher: Moganki Hendrick Lefoka  
Cell No: 078 820 7941 or email address: 44043120@mylfe.unisa.ac.za 
Research Supervisor: Dr. T.R Netangaheni 
Mobile Number: 076 189 5087 or email address:  
Coordinator of the Health Sciences Ethics Committee from Department of Sociology: 
Prof Derik Gelderblom 
Landline Number: 012 429 6486 
gelded@unisa.ac.za 
Thank you for taking time to read this information sheet and for participating in this 
study. 
Thank you, Kea leboga. 







B: CONSENT TO PARTICIPATE IN THIS STUDY 
 
I, __________________ (participant name), confirm that I have been informed by the 
researcher, Mr. M.H Lefoka about nature, procedure, potential benefits and anticipated 
inconvenience of participation.  
I have received, read (or had explained to me) and understood the study as explained 
in the information sheet. I have had sufficient opportunity to ask questions and am 
prepared to participate in the study. I understand that my participation is voluntary and 
that I am free to withdraw at any time without penalty. 
I am aware that the findings of this study will be processed into a research report, 
journal publications and/or conference proceedings, but that my participation will be 
kept confidential unless otherwise specified.  
I may, at any stage without prejudice, withdraw my consent and participation in this 
study. I have had sufficient opportunity to ask questions and (of my own free will) 
declare myself prepared to participate in this study 
I have received a signed copy of the informed consent agreement. 
 













C: LETTER TO ORGANISATION(S)  
Mr. M.H Lefoka  






Dear Sir/Madam  
My name is Moganki Hendrick Lefoka. I have registered for MA (Social Behavioural 
Studies in HIV/AIDS), Department of Sociology, University of South Africa. I hereby 
cordially apply for permission to conduct my research at your organisation, which has 
been selected as a suitable research site as it meet both sampling profile and the 
research topics core variables in respect of nyaope injecting.  
My research topic is titled, “Exploring the experiences of female nyaope injectors 
residing in the City of Tshwane Municipality”. The fieldwork aspect of my study entails 
the identification and selection of: 
• 15 Female nyaope injectors 
• 15 Female recovering nyaope injectors 
The sampled of participants will participate in 45 minutes long face-to-face interview 
session at your centre/offices. The data collection instrumentation includes an audio 
recorder and an interview guide. All rights relating to research participants in the study 
will be thoroughly explained to the participants and strictly maintained by the 
researcher. I will also provide details of my academic supervisor for reporting of any 
unprofessional conduct on the part of the researcher.  
All the findings will be formally documented, and preliminary report will be presented 






check whether or not the study results reflects their written or oral input. The 
researcher will provide one copy to your organisation for its institutional memory and 
appreciation of your client’s involvement in this exegetic exercise.  
Should you have any questions or concerns regarding the interview process and the 
study or if any problems arise from this study- please feel free to contact the 
researcher, Moganki Hendrick Lefoka at 078 820 7941, or email me 
44043120@mylfe.unisa.ac.za. 
Your response in the above regard is highly appreciated and any further clarification 
will be honestly responded to by the researcher.  
Thanking you in anticipation. 
Regards 







D: INTERVIEW GUIDE 
D.1: FEMALES WHO ARE STILL INJECTING NYAOPE 
BACKGROUND INFORMATION 
This section of the interview guide refers to the background or biographical information 
will allow us to compare groups of participants. 
Once again, you are assured that your response will remain anonymous. Your 
cooperation is appreciated. The researcher will spend plus / minus 45 minutes with 




Duration using nyaope……………………….. 
INTERVIEW QUESTIONS 
1. How did you start to use nyaope? 
2. What influenced you to inject nyaope? 
3. Who helped you inject the first time you injected 
4. How did your family react after they discovered you are injecting nyaope? 
5. How did your community treat you as a nyaope female injector? 
6. How often did you visit community health centre/Clinic? 
7. What are your experiences with the police? 
8. Have you ever engaged in risky behaviour due to injecting nyaope practice? 
9. What were your needs as a female who injects drugs?  
10. What suggestion do you have about how HIV prevalence can be reduced amongst 






This is the end of the interview. 
Thank you for participating in the study your time is highly appreciated 
D.2 RECOVERING FEMALE NYAOPE INJECTORS 
BACKGROUND INFORMATION 
This section of the interview guide refers to the background or biographical information 
will allow us to compare groups of participants. 
Once again, you are assured that your response will remain anonymous. Your 
cooperation is appreciated. The researcher will spend plus / minus 45 minutes with 




Duration without using nyaope……………………….. 
INTERVIEW QUESTIONS 
1. How did you start to use nyaope? 
2. What influenced you to inject nyaope? 
3. Who helped you inject the first time you injected 
 4. How did your family react after they discovered you are injecting nyaope? 
5. How did your community treat you as a nyaope female injector? 
6. How often did you visit community health centre/Clinic? 
7. What are your experiences with the police? 
8. Have you ever engaged in risky behaviour due to injecting nyaope practice? 






10. What suggestion do you have about how HIV prevalence can be reduced amongst 
female nyaope injectors? 
11. How is life without ejecting nyaope? 
 
This is the end of the interview. 





















































Researcher: Thank you for agreeing to participate in this study, as I have indicated, 
this study is for my Masters. The information which will be collected here, will be kept 
confidential. For the purpose of record keeping, I will use your nickname.  
Participant 1: Yes.  
Researcher: Tell me Participant 1 how did you start to use Nyaope? 
Participant 1: The very first time I tried Nyaope I did not know that it was Nyaope I 
came across some boys from where I come from back at home, they were smoking 
then I wanted to try what they were smoking, then I tried it. It passed a few months 
before I tried it again, when I saw them after then I was hooked I think for some months 
then I quite then again around 2017 December I saw my ex-boyfriend he wanted me 
to give him money because I had money at that time, because I knew what he was 
smoking and I knew what he wanted to use the money for, when he asked for R20 I 
asked him what he wants the money for, but I was asking while knowing then I just 
said let us go and smoke actually I was bored, you see?  
Researcher: Yes. 
Participant 1: Then we went and smoked.  
Researcher: You said you started using with some boys from home?  
Participant 1: Yes.  
Researcher: What was your relationship with those boys?  
Participant 1: Actually there was no relationship it was just people I know around. 
Researcher: Awesome, were you smoking something before you smoked Nyaope, 
what were you smoking?  
Participant 1: I used to smoke cigarette and weed but by the time I was, let me say, 
before I smoked Nyaope I had already quite smoking weed I was smoking cigarette.  
Researcher: Cigarette only?  






Researcher: Ok, when did you start smoking Nyaope because here you said 2017 
December?  
Participant 1: Yes, I smoked for the very first time…  
Researcher: When was that?  
Participant 1: 2012. 
Researcher: 2012. 
Participant 1: Yes. 
Researcher: And for how long?  
Participant 1: Maybe for a couple of months then I quit, then I relapsed again in 2017 
until now.  
Researcher: So you, 2012 you started using… 
Participant 1: Then I stopped in the same year.  
Researcher: Same year, then you started using again in 2017 up until now?  
Participant 1: Yes.  
Researcher: Ok, so with injecting when did you start to inject?  
Participant 1: I think it was around January last year.  
Researcher: January 2018? 
Participant 1: Yes.  
Researcher: What influenced you to inject?  
Participant 1: My boyfriend because sometimes when we do not have money, he was 
injecting and I was not  






Participant 1: … this other time he said let me allow you to try, because mostly he 
would say that but I would refuse but on that day because we only had one bag, then 
he mixed then that is how I started.  
Researcher: So you used his injection?  
Participant 1: No he had … 
Researcher: Clean! 
Participant 1: … it was my own because at that time I thought it was a matter of concern 
to use your own, like I did not know I hadn’t really known much about the whole 
injection thing, I thought maybe it is a matter of safety because I thought everyone 
uses their own injection like they do in clinics use it once then throw it away it is only 
then that I have learnt that you can reuse the injection.  
Researcher: Ok, so you used a clean needle the first time you injected? 
Participant 1: Yes. 
Researcher: Where did you get that needle? 
Participant 1: He bought them, he used to go to town to buy rock when he goes to 
town he would buy injections. 
Researcher: In your life since you started to inject have you shared any needle before?  
Participant 1: Yes I have shared a needle.  
Researcher: Whom did you share with? 
Participant 1: My Boyfriend.  
Researcher: You shared with your boyfriend, how many times roughly if you could 
recall? 
Participant 1: I think 5 times.  
Researcher: So many times? 






Researcher: When was the last time you shared?  
Participant 1: A few weeks back when I was back at home, I think two weeks back.  
Researcher: When you were back home, what contributed for you to share when you 
were back at home?  
Participant 1: He did not have an injection, actually we had but it blocked, so he asked 
if he can use mine.  
Researcher: accessibility was the issue there, at which you did not have access to 
clean needles that is why he used yours? 
Participant 1: Yes. 
Researcher: Ok, by the time you started to share needles with him did you think of 
contracting the like of HIV and Hepatitis? 
Participant 1: Actually to be honest with him because he is my boyfriend and I used to 
sleep with him I did not see the need.  
Researcher: As a need, what you are saying is that you have never shared with 
someone outside your relationships.  
Participant 1: Yes, only my boyfriend.  
Researcher: Only your boyfriend, the first time you injected who helped you to inject? 
Participant 1: He injected me.  
Researcher: He injected you? 
Participant 1: Yes.  
Researcher: How comfortable were you?  
Participant 1: (Laughing) from the scale of 1-10 I was uncomfortable at all because 
eish you know when you are not used to needles it is uncomfortable but as you go 
along … 






Participant 1: Yes.  
Researcher: But now, the first time you injected what made you not to turn back and 
say ‘no let us not inject’?  
Participant 1: Actually after he injected me the feeling I felt it was quite pleasant that 
is what made me to even continue.  
Researcher: To continue, how do you raise money to buy drugs?  
Participant 1: That is a struggle. 
Researcher: Struggle, how do you struggle/hustle? 
Participant 1: Eish you know back at home I used to steal from my parents when I was 
back at home, my boyfriend mostly is the one who would try but before I could afford 
it because I was in school and I had allowance. My parents would give me money so 
I could afford it until I stopped school that is when things became much tougher… 
Researcher: Much tough yes.  
Participant 1:… I was mostly dependent on him he used to be the one who provided 
most if he does not have I would have to go out and make a plan, if I go home I would 
beg and if I do not get anything I would steal sometimes I would, eish there were even 
times when I had to sleep with someone for money.  
Researcher: For money. Ok currently you are dating, are you seeing someone 
currently?  
Participant 1: Yes.  
Researcher: How is your relationship with him, or how many boyfriends do you have?  
Participant 1: I have one.  
Researcher: You have one boyfriend, how is the relationship with him? 
Participant 1: It is fine besides the drugs we fight a lot about drugs.  






Participant 1: Sometimes he would rob me like even though we are both feeling the 
same way he would be selfish then he would take more then give me less, make me 
take water just dilute water, those are the things we fight mostly about.  
Researcher: What do you love about your relationship with him?  
Participant 1: I can be myself around him.  
Researcher: And what do not you like in your relationship with him?  
Participant 1: I hate that we both smoking.  
Researcher: That you are both smoking, and what else?  
Participant 1: I can say that he is a bad influence but love him  
Researcher: He is a bad influence how, because of drugs?  
Participant 1: Yes and he can tell me sometimes, he would push me and say ‘baby go 
home go ask your mother’ you see?  
Researcher: Yes.  
Participant 1: sometimes he would tell me go and steal at your home your mother has 
a lot of money, such things. 
Researcher: And you do not like things like those? 
Participant 1: Yes.  
Researcher: And what else do not you like about your relationship? 
Participant 1: (Laughing) the fact that sometimes I have to lie about where I got the 
money if I have money I lie. 
Researcher: You lie to whom? 
Participant 1: To him, if I did not get it in a way I know is comfortable.  
Researcher: Like engaging in sex work and stuff?  






Researcher: You are not comfortable to discuss, he is not aware that at times you 
have to sleep with people to make money.  
Participant 1: No he is not.  
Researcher: Ok, have he expressed himself about how he would feel if it happens?  
Participant 1: Yoh, a lot of times, because he used to tell me like he used to say I 
mustn’t be like maybe So and So, because they sleep with people for money. People 
can know that I am doing that they will look down on him and me also, he would say 
things like that, when he said that it hurts because I know like, eish it feels like bad you 
know?  
Researcher: Hmm (nodding), so initially you said you do not usually you were 
comfortable using the same needle with your boyfriend because you sleep with him?  
Participant 1: Yes.  
Researcher: have you discussed the issue of condom use with your boyfriend?  
Participant 1: Not really, like in the first early stage of our relationship I used to ask him 
for protection and he was from jail so I did not know, but as time went on … 
Researcher: What changed because initially you asking what changed that?  
Participant 1: To be honest I do not know, I guess we got too comfortable.  
Researcher: With each other?  
Participant 1: Yes.  
Researcher: But how comfortable are you to discuss condom use with him? 
Participant 1: Actually I wouldn’t be scared maybe if I were to tell him about condoms 
maybe he would think that I am cheating.  
Researcher: He would think you are cheating?  
Participant 1: Yes, but I would not be uncomfortable.  






Participant 1: Eish they did not like it especially my mother, she was really angry, they 
were pissed off I think.  
Researcher: Ok, they knew that you were using Nyaope? 
Participant 1: Yes.  
Researcher: But after transitioning from smoking Nyaope to injecting, how did they 
look or how did the reaction change towards you?  
Participant 1: Actually my mom when she discovered that I am injecting and I lied to 
her, I was telling her that I am trying to quite but to think at that same period I was, I 
had recently told her she has discovered the needles, she expressed a lot of concerns, 
that it means you cannot stop because you are even worse than before.  
Researcher: What about your community, how did they react when they learnt that 
you are injecting?  
Participant 1: The community to be honest once they know you start to smoke Nyaope, 
injection or not they start to look down upon you. They do not take you as a person 
anymore to them you are just a thing.  
Researcher: Just a thing! How did that make you feel?  
Participant 1: Bad but what could I have done? I was already in that situation.  
Researcher: When was the last time you visited a health care clinic?  
Participant 1: Around March if I am not mistaken.  
Researcher: What were you doing there?  
Participant 1: I took my baby for clinic then when I was there I just, because my 
boyfriend had borrowed someone the injection, so I was concerned. I wanted to check 
HIV.  
Researcher: Have you ever, do you have any history of abscess?  
Participant 1: What is abscess? 






Participant 1: Oh yes 
Researcher: How many times did it happen?  
Participant 1: Twice I think.  
Researcher: Twice,  
Participant 1: But before even if I missed I did not become swollen but when I put 
pressure on it that is when it becomes… it has been twice. 
Researcher: Ok, let us talk about this twice. It happened the first time, how did you 
deal with it?  
Participant 1: I can say self-medication.  
Researcher: Self-medication, so what made you not to go to clinic?  
Participant 1: I was embarrassed. 
Researcher: You were embarrassed?  
Participant 1: Yes.  
Researcher: Ok, the second time?  
Participant 1: Still I did not go to clinic.  
Researcher: You self-serviced yourself? 
Participant 1: Yes.  
Researcher: Ok. 
Participant 1: I just let it heal.  
Researcher: Just to ask, as a woman, are you on any prevention method?  
Participant 1: Currently no.  
Researcher: How would you make sure you do not get pregnant because as you were 






Participant 1: When I know my weeks like this week I am ovulating, I do not sleep with 
him.  
Researcher: You do not sleep with him? Ok.  
Participant 1: and you know normally my boyfriend and I since we both into Nyaope, 
sex is not a priority.  
Researcher: Is not a priority?  
Participant 1: We only have sex sometimes.  
Researcher: Sometimes? 
Participant 1: Yes.  
Researcher: So what is your experience with the police?  
Participant 1: The? 
Researcher: The police, your experience with the police, have you ever had any 
encounter with them?  
Participant 1: No, but from what I have seen they used to arrest people with a needles. 
Researcher: So they will arrest you if you if they find you with a needle?  
Participant 1: As far as I know for drugs, but I have never been in that situation or 
arrested.  
Researcher: Have you engaged any activity, risky activity or behaviour due to injecting, 
due to the need to use drugs? 
Participant 1: Not that I can remember but I can say when I use my injection because 
I do not know who else injected with my injections  
Researcher: But now have you engaged in any risky behaviour due to drugs? 
Participant 1: Yes. 






Participant 1: Like sleeping with someone, especially when you sleep with someone 
you do not have a relationship with and you do not know that person, maybe they can 
kill you or what that is mine.  
Researcher: Sleeping with someone and what else? 
Participant 1: Stealing.  
Researcher: Stealing from the family or from community members?  
Participant 1: From family and the community, but I myself I do not steal around, I only 
steal at home because I am a girl, I cannot even jump but from what I have seen 
around people can go and steal from someone and they can be beaten by the 
community.  
Researcher: So, when you said that at times you sleep with people for money, how 
does that happen, where do you get those people and how do they approach you? 
Participant 1: Actually the very first guy I slept with it was someone I know you see? 
Someone I know from the community.  
Researcher: Ok, hmm.  
Participant 1: He saw that I was not fine, I was shaking so I went by the shops to buy 
cigarette because I did not have money to buy the (Nyaope), he said you are not fine 
you look sick, he knows (that I am smoking) because they used to see, then he said 
escort me I want to take something in my room then we will come back then I said if 
you can give me at least R20.00 I will escort you. He then said let us go I will give you, 
when we got there he said I will give you R100. If you sleep with me and at that time I 
was desperate so I took it then I slept with him.  
Researcher: Did sex with that guy happen once or he came for more? 
Participant 1: Yes, he did but then it got annoying because I resented myself 
afterwards, but then I still did it again I think around three times but the last time I got 
so aggressive I started insulting him because when I think about it, it just eish (silent). 
Then the other guy actually this one is an older person so, he is also from around he 






opportunity that this person will give me money, he used to give me R200.00 every 
time I see him, when I ask him he would always give me. This other time he said I 
must come to his place but then I did not know he was staying then he directed me 
and I was scared because I know his children and his wife but he called me to another 
place that is when we slept. 
Researcher: So now as a woman who inject drugs, what are your needs? 
Participant 1: My needs? 
Researcher: Yes.  
Participant 1: Ok, I to have access to drugs.  
Researcher: To have access to drugs! 
Participant 1: Or maybe the cheaper price we can buy them for R10.00 it would be 
better and to have access to needles but at this stage I am trying to quite I want to go 
to rehab. 
Researcher: You are saying if like those are your needs too, but because you want to 
quit rehab is also on the list.  
Participant 1: Yes because right now I am currently within that process that is why I 
came here, but let us say I was not in the process of wanting to quite I would really 
want to have access to drugs, access to clean needles and stigma of being seen as 
Nyaope and for people to respect us.  
Researcher: For people to respect you? 
Participant 1: Yes.  
Researcher: Now I need you to help me with suggestions, if it was CAP HIV incidents 
or cases amongst woman who use drugs, what do we need to do? 
Participant 1: Can you please repeat the question. 
Researcher: If we must CAP the HIV incidents. If we must stop new cases of HIV 
incidents on females who use drugs or woman who inject drugs basically what do we 






Participant 1: Actually to prevent the spread of HIV I would suggest maybe giving them 
needles.  
Researcher: Giving them needles and what else? 
Participant 1: … to use on their own because some the ones I have here around 
Pretoria they are sex workers encourage them to use protection at all times and but 
obviously you cannot give them drugs but I would suggest if it was possible to make it 
possible for them to have drugs at least like two dose a day, morning and in the night 
just to sleep.  
Researcher: in the absence of any questions I would like to thank you for giving me 
this opportunity to have an interview with you, like I promised this information will 
remain as confidential as possible and your name will not be used on any document 
but for record keeping and administration we will stick to your nickname which is 
Participant 1.  
Participant 1: Yes.  
Researcher: Miss Participant 1 thank you again for providing me with this opportunity 
thank you.  
Participant 1: Thank you  
